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ABSTRACT OF THE DISSERTATION
MicroRNA Gene Expression States Underlying Individual Variation in Aging and Lifespan in
Isogenic C. elegans
by
Holly Kinser
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2020
Assistant Professor Zachary Pincus, Chair

Average lifespan differs greatly between species, but lifespan among same-species individuals is
also highly variable. While much effort has been devoted to uncovering longevity-associated
traits and lifespan-extending perturbations in humans and model organisms, how differences in
lifespan arise between individuals is unknown. Studies of human identical twins demonstrate that
surprisingly little of the variation in lifespan between individuals can be explained by genetics
and shared environment. Furthermore, even genetically identical C. elegans reared in highly
homogeneous environments display a degree of variability in lifespan similar to that of outbred
human populations. Thus, longevity must be determined at least in part by non-genetic, nonenvironmental processes of stochastic origin. Understanding what these processes are and how
they arise may provide key insights into why some individuals live longer or age more
successfully than others.
We hypothesized that some of the variability in lifespan results from early-life stochastic
differences in expression of important regulatory genes, initiating persistent gene expression
states that ultimately determine lifespan and cause otherwise identical individuals to diverge on
x

different aging trajectories. This dissertation aims most principally to prove the existence of such
regulatory genes (e.g., “biomarkers of lifespan”) and characterize the resulting gene expression
states that define long- and short-lived individuals in C. elegans, a model organism and
workhorse in aging biology.
As described herein, the most straightforward approach to identifying biomarkers of lifespan is
to first screen for genes whose expression early in life correlates with or predicts future longevity
among homogenous individuals. However, this approach presents significant technical
challenges. Large populations of C. elegans must be observed to generate statistically significant
results, yet single-worm resolution is required to accurately measure lifespan. Lifespan
measurements, which are typically taken manually through microscope observation, are
laborious and subject to operator bias and technical error. In the first part of this dissertation, we
describe a novel high-throughput screening platform that can identify biomarkers of lifespan
from fluorescent gene expression libraries in C. elegans. This platform utilizes liquid-based
culturing techniques, automated fluorescence microscopy, custom software, and modified flatbed
scanners to screen thousands of individual animals in parallel. We found that our methods
consistently select mir-71, a known biomarker of lifespan, as a positive hit. Furthermore, our
workflow is generalizable to any number of lifespan or aging screening applications requiring
high throughput.
In the second part of this dissertation, we used a high-density, single-animal culture device to
examine the relationship between future lifespan and expression of 22 different microRNA
(miRNA) reporters (PmiRNA::GFP) in individual C. elegans with unprecedented temporal
resolution. miRNAs, short non-coding RNAs that repress translation of many target transcripts,
have been identified as both positive and negative markers of future longevity in C. elegans.
xi

miRNAs do not only act as biomarkers of lifespan but also as functional determinants of
longevity, promoting or antagonizing longevity in C. elegans through canonical aging pathways.
We showed that expression levels of nearly half of the miRNA reporters we tested effectively
predict future lifespan, indicating that long- vs. short-lived individuals are highly divergent in
terms of gene regulation. These lifespan-predictive reporters represent diverse spatial and
temporal expression patterns, suggesting that the regulatory states underlying long and short life
are not specific to a particular tissue or a single regulatory process. We further found that the
gene-regulatory processes reported on by two of the most lifespan-predictive transgenes are
distinct from the insulin/insulin-like growth factor (IGF-1) signaling (IIS) pathway. Last, we
demonstrated a hierarchy among several reporters expressed in different tissues, suggesting that
they act as readouts of an organism-wide, cell-nonautonomous process that acts to set each
individual’s lifespan.
The work presented in this dissertation improves our understanding of aging and lifespan
variability among wild-type, unperturbed, and isogenic individuals, which has not been wellstudied in the field. We have linked longevity to specific gene expression states among
homogenous individuals, which will provide a basis for further study into how these states arise
and their functional consequences on aging and lifespan.

xii

Chapter 1: Introduction
1.1 Motivation and Aims

With few exceptions, the deteriorative process of aging and the associated constraint on lifespan
affects all organisms, from the invertebrates Saccharomyces and C. elegans to mammalian
species like mice and humans. Once thought to be a haphazard, immutable process of inevitable
decay, we now know that aging is subject to genetic control. Cynthia Kenyon’s discovery of an
extraordinarily long-lived C. elegans mutant (daf-2) in the early 1990s1 propelled decades of
research to identify other modulators of aging and lifespan in model organisms. While many
genetic perturbations and environmental conditions that shift average lifespan of a population
have been described since, little thought has been given to lifespan of the individual. Regardless
of mean value, lifespan curves are necessarily distributions, made up of short-lived and longlived (relative to the mean) subpopulations. What drives an individual into either subpopulation
is currently unknown.
Interestingly, variability in lifespan persists in the absence of genetic and environmental
variability. Isogenic, wild-type C. elegans reared under standardized laboratory conditions still
display a broad distribution of lifespans, implying that individual lifespan is determined
stochastically or by random chance. Random determination of lifespan does not mean
unregulated, but rather that the gene regulatory states leading to long or short life are established
by chance. For example, stochastic differences in expression of important regulatory genes can
have cascading effects on downstream targets, sending otherwise identical animals into divergent
gene expression states that ultimately determine lifespan.

1

Identifying the regulatory genes and resulting expression states underlying lifespan variability
would improve our understanding of aging in wild-type individuals, which has not been wellstudied to date. Furthermore, functional relationships between such regulatory genes and their
targets may also implicate networks and pathways previously unknown to be involved in aging.
This dissertation aims to characterize the gene expression states that distinguish long-lived from
short-lived individuals in isogenic populations, using the nematode C. elegans as a model. We
accomplished this by screening for fluorescent transcriptional reporters whose expression
predicts individual lifespan (e.g., “biomarkers of lifespan”), using both a high-throughput,
automated platform we created and a single-animal culture device previously developed by our
lab. This dissertation focuses primarily on microRNAs (miRNAs) as potential biomarkers of
lifespan; miRNAs are important post-transcriptional regulatory genes that are known to play an
important role in aging and lifespan. We were able to identify multiple miRNA reporters that
predict longevity and provide analysis of the pathways and processes these constructs do (and do
not) report on. Our work provides new insight into the biology of wild-type aging and how
differences in lifespan may arise between individuals.

1.2 Summary of Chapters

This dissertation consists of five total chapters. The remainder of Chapter 1 provides an
overview of the current methods and technologies used for high-throughput screening in C.
elegans, with a focus on tools for immobilization, single-animal culture, and automated image
acquisition and phenotyping. This chapter also summarizes the role of microRNAs as modulators
of aging and longevity in both C. elegans and mammalian species, with a specific focus on aging
in wild-type individuals.

2

In Chapter 2, we present a platform that utilizes liquid culture in 384 well plates, automated
microscopy, modified flatbed scanners, and custom software to enable high-throughput,
automated screening for fluorescent reporters that predict lifespan in C. elegans. We show that
our platform is able to accurately and automatically measure lifespan, greatly reducing the
manual labor and time required for screening. We used this platform to screen a library of over
40 fluorescent reporters, identifying both known and novel biomarkers of longevity. However,
our methods also enable any number of lifespan or aging studies requiring high throughput and
collection of phenotypic data.
In Chapter 3, we examine the relationship between future lifespan and the expression of 22
different microRNAs, using a library of integrated promoter::GFP constructs. We showed that
expression levels of nearly half of these reporters effectively predict future lifespan well before
death, indicating that prospectively long- vs. short-lived individuals are highly divergent in terms
of gene regulation. We also present findings demonstrating that the gene-regulatory processes
reported on by two of the most lifespan-predictive transgenes are distinct from the
insulin/insulin-like growth factor (IGF-1) signaling (IIS) pathway. Last, we provide an analysis
of dual-reporter strains that shows a hierarchy among several reporters expressed in different
tissues, suggesting that they act as readouts of an organism-wide, cell-nonautonomous process
that acts to set each individual’s lifespan.
Chapter 4 presents a targeted analysis of a transcriptional reporter corresponding to the miRNA,
lin-4, which we found to predict lifespan in Chapter 3. To supplement this work, we used an
independent lin-4 reporter, zaIs1, and showed that it also robustly predicts individual lifespan.
We demonstrate that knocking out the endogenous lin-4 locus eliminated the correlation of the
lin-4 reporter (Plin-4::GFP) with lifespan, and knockdown of the canonical lin-4 target lin-14
3

also reduced the lifespan-predictive power of Plin-4::GFP. Both lines of evidence indicate a
potential role for lin-4 and target lin-14 in setting adult lifespan in a wild-type, isogenic
population.
Chapter 5 summarizes the main conclusions of this dissertation and their significance in the field
of aging, as well as ideas for future studies that build upon our work.

1.3 High-throughput Screening Methods in C. elegans
This section is adapted from a publication2 co-authored with Zachary Pincus.

1.3.1 Abstract

The nematode Caenorhabditis elegans is widely used as a model organism. C. elegans is small
in size, self-fertilizing, and inexpensive to cultivate and maintain, greatly lending to its utility as
a whole-animal model for high-throughput screening (HTS). However, the use of this organism
in large-scale screens presents unique technical challenges, including reversible immobilization
of the animal, parallel single-animal culture and containment, automation of laser surgery, and
high-throughput image acquisition and phenotyping. These obstacles require significant
modification of existing techniques and the creation of new C. elegans-based HTS platforms. In
this section, we outline these challenges in detail and survey the novel technologies and methods
that have been developed to address them.

1.3.2 Introduction

The nematode Caenorhabditis elegans is widely used as a model organism in a number of fields,
particularly as a screening tool. C. elegans offers the utility of a whole-animal model with the
simplicity and convenience of single cells: the animal has well-defined tissues, distinct organ
systems, and exhibits a variety of complex behaviors, yet its small size, short reproductive cycle,
and ability to self-fertilize make it simple and inexpensive to maintain on both solid and liquid
4

media.3,4 These characteristics also make C. elegans an attractive candidate for high-throughput
screening (HTS), particularly for screens for modulators of aging and lifespan. However, there
exist several challenges in using C. elegans for large-scale screens, including immobilizing the
animal for imaging and manipulation and housing individuals in parallel for longitudinal study,
This review will discuss some of the available tools and methodologies that have been developed
to address each of these challenges, followed by a short survey of recently developed
technologies for high-throughput image acquisition and phenotypic scoring in C. elegans.

1.3.3 Methods for reversible immobilization

Nematodes are mobile animals, and changes in movement provide a useful readout for screening,
particularly in aging and longevity studies. This characteristic also presents a significant
challenge in using C. elegans for applications that require near-complete immobilization of the
subject organism, like high-magnification imaging. Immobilization is most commonly achieved
by placing the animal on an agar pad with glue5 or polystyrene beads6, or using paralytic drugs
like sodium azide7 and levamisole.8 None of these methods are practical for most HTS
workflows. Gluing individual animals is time consuming and irreversible, preventing subsequent
study of the animal; the use of polystyrene beads, while allowing for animal recovery, still
requires manual transfer of individual animals. Paralytics can be applied to many individuals at
once, and immobilization is reversed upon sufficient dilution of the drug. However, these
compounds unavoidably affect the physiology of the animal, and removal/washout of the drug is
difficult to achieve in multiwell plates without specialized equipment. Promising new
immobilization methods have been reported that offer high-throughput reversibility, however.
While the utility of most of these methods has only been demonstrated in microfluidic devices
thus far, potential exists for application to other HTS platforms.
5

A variety of mechanical methods have been used to automatically and reversibly immobilize
animals in microfluidic devices. Arrays of tapered microchannels or ‘clamps’ have been
described that immobilize and subsequently release over a hundred animals in parallel.9 Another
mechanical method uses pressure to deflect a flexible membrane made of polydimethylsiloxane
(PDMS), an optically clear, gas-permeable polymer widely used in microfluidic devices, as a
means for immobilization. Under pressure, the membrane forms a tight seal around the animal,
‘pinning’ it to a glass surface. This type of design has been used to immobilize animals for
fluorescence imaging and nanosurgery of axons.10–12
Pluronic F127 (PF127), a copolymer that undergoes reversible liquid-to-gel transitions at
physiological temperatures (around 22° C), is another promising alternative to traditional
immobilization agents. The utility of PF127 has been demonstrated in several microfluidic
devices, using water baths or warming to room temperature to control the sol–gel transition of
the PF127 solution.13,14 Upon gelation, animals were sufficiently immobilized for high-resolution
imaging, with comparable image quality to that obtained by immobilization with sodium azide.
A simpler and more versatile PF127 immobilization technique that does not require microfluidics
has also been developed. Animals in PF127 solution are placed on a photo-absorbing layer, and
triggering gelation is achieved by tuning the intensity of a halogen lamp directed at the sample.15
PF127 has also been successfully incorporated into a droplet-based microfluidic device that
generates up to 250 microdroplets of PF127 containing individual L1 larvae.16 Upon sol-gel
transition, motion is sufficiently reduced for imaging under high-magnification objectives.
Carbon dioxide has been shown to immobilize worms in the context of a microfluidic device,
although the mechanism of action is unclear.10 Increasing the local concentration of CO2 to
around 75% within the device provided over two hours of immobilization with no long-term
6

effects on animal behavior. CO2 immobilization also reduces the photobleaching of fluorophores,
which is known to be exacerbated by a high-oxygen environment. Thus, this method is suitable
for long-term, time-lapse fluorescence imaging and could feasibly be adapted to nonmicrofluidic platforms.
Cooling C. elegans as a means of immobilization has been employed with some success in both
microfluidic and multiwell plate formats. Thermal immobilization is advantageous because it is
reversible, does not cause any physical deformation of the animal, and is one of the few methods
that can eliminate pharyngeal motion, which is important for applications like laser
microsurgery.17 Microfluidic devices that briefly cool animals to 3–4°C have been used to
immobilize animals for neuronal and even synaptic imaging.17,18 Combined with automated
image analysis and sorting, this method allowed for high-throughput screening of 20,000 mutants
for abnormal synaptic phenotypes. In order to apply thermal immobilization to 96-well plates, an
array of cooling pins can be inserted directly into individual wells.19 Each element of the array is
controlled independently so that animals are only exposed to cold temperatures immediately
before or during image acquisition. This device is theoretically compatible with robotic handling
and could increase the throughput of screens that require imaging the same individuals at
multiple time points.

1.3.4 Parallel single-animal culture and containment

C. elegans are typically cultivated on plates or in bulk liquid20, where a large population of
animals can be easily maintained and studied for days to weeks. This approach is highthroughput and adequate for when phenotypes can be pooled to discern changes at the population
level. However, single-animal observation is more suitable for measurements of dynamic events
or longitudinal studies. Longitudinal single-animal culture and observation can be performed by
7

depositing individuals onto separate plates21, but this method is low-throughput and allows the
animal to leave the field of view. Moreover, for high-resolution microscopy, animals need to be
transferred (potentially repeatedly) from the culture medium to a microscope slide, which is both
tedious and potentially injurious to the animal. In order for single-animal culture to be feasible
for HTS, methods are needed to combine individual containment with the ability to cultivate
large numbers of animals in parallel in a manner compatible with microscopy. A variety of novel
nematode housing methods have been developed to address these needs.
Microfluidic devices, consisting of features patterned into PDMS, have proven suitable
residences for individual C. elegans, and a number of microfluidic platforms capable of short22,23
and long-term nematode confinement are now available.14,24–26 These devices generally consist
of an array of liquid-filled chambers that confine individuals for the duration of the experiment.
Since the size of the animal changes drastically during its life cycle, chambers are designed to
accommodate individuals within a set range of developmental stages, from early14 to late24,25
larval stage animals and adults.26 More recently, a device that can successfully house embryos
through the entirety of development and adulthood has been described.27 The chambers in such
devices are typically connected to flow channels that can be used to deliver chemical compounds
for screening or exchange waste and fresh media if long-term culture is required. Throughput is
largely dependent on the number of chambers, and as many as 48 have been patterned onto a
single device.22
Detailed HTS-compatible protocols for liquid culture of C. elegans in 96- and 384-well
microtiter plates have also been made available28–31, and ultra high-throughput screens have even
been performed in 1536-well plates.32 Each well can act as a compartment for individual
animals; provided that the bottom of the plate is transparent, phenotypes are easily observed with
8

an inverted microscope. Multiwell plate-based methods have been used successfully to screen
compound libraries for modulators of lifespan33,34, induction of gene expression32,
pathogenicity35,36, and protein aggregation.37
Other unique culture systems for isolating individual C. elegans have been developed from a
variety of materials. A 45×45 array of microcompartments molded from agarose hydrogel and
sealed with a glass coverslip was constructed to culture early larval stage animals (L1–L2) for
several days.38 The size and depth of the wells were designed to restrict movement and confine
animals to the same focal plane, allowing for detailed confocal imaging. A protocol on how to
adapt the microcompartments to different larval stages, including dauers, was recently
published.39 A similar device molded from polyacrylamide, which is less prone to tearing than
agarose, has also been used to house and observe early larval stage animals.40
Using novel polymer chemistry, a culture system consisting of polyethylene glycol gel pads
cross-linked to glass slides has also been developed.41 Eggs are picked onto drops of bacterial
slurry deposited on the pad, which is then sealed with a layer of PDMS to trap the animals within
the confines of the drop. Provided that sterile strains are used, this system allows for high
resolution imaging of individual animals over the course of their entire lifespans.
Microdroplets of buffer or media surrounded by oil have been used to encapsulate individual
nematodes.42,43 The small size of these droplets allows for large-scale parallel containment,
minimal consumption of reagents, and rapid compound exchange. Devices capable of
automatically generating large arrays of animal-containing droplets have been described for
assessing neurotoxin effects in high throughput.44,45 A version of these devices has been outfitted
for substance exchange between the droplets and inflow of media, allowing for parallel long9

term culture of 160 newly hatched animals to adulthood.46 The Caenorhabditis-in-Drop method
(CID) is a microdroplet-based system developed for studying quiescence in larval animals but
capable of culturing animals for up to five days. NGM microdroplets containing FUDR to
prevent reproduction and concentrated bacteria as a food source are deposited onto a PDMS chip
and covered with mineral oil, and individual animals are manually placed into the droplets.42

1.3.5 Tools for high-throughput image acquisition and phenotyping

There are many approaches to assessing physiological function and behavior in C. elegans,
including locomotion, response to stimuli, reporter expression, and lifespan. Coupling such
measures with high-throughput screens requires robust, automated scoring of the phenotype of
interest. Here we will briefly survey a variety of novel technologies and image-analysis tools
capable of automated phenotype scoring and that are currently compatible with or easily adapted
to C. elegans-based HTS.
A fully automated, high-throughput method for assessing worm motility has been developed
through a novel application of the cell monitoring system xCelligence.47 This technology was
originally designed to measure cell confluence via changes in electrical impedance, as measured
across micro-electrodes embedded in the base of specially designed 96-well plates. This readout
can be readily converted to a motility index, as swimming nematodes repeatedly come into
contact with the electrodes and cause changes in conductivity. It should be noted that this system
has only been tested on parasitic nematode species thus far, but could feasibly be utilized with C.
elegans. Another commercially available system for tracking C. elegans movement in microtiter
plates, the WMicrotracker, uses infrared microbeams to quantify motion in real-time.48
Microbeams passing through the bottom of each well are scattered by moving animals. This
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allows changes in movement over time to be detected and measured in conventional multiwell
plates.
Microfluidic arenas containing grids of pillars which C. elegans can use to crawl as if on solid
surfaces (‘artificial dirt’) have been used as highly controlled environments for locomotory and
behavioral measurements, and are compatible with introduction and removal of different
compounds for screening.49 Such designs may also be adaptable to long-term individual or group
culture, though no such applications have yet been published.
Using a very different technical approach, the C. elegans ‘Lifespan Machine’ was developed to
measure lifespan of large C. elegans populations in high throughput.50 The platform is based on
widely available and inexpensive flatbed scanners, which can obtain resolutions of 8 µm for
imaging animals on agar plates. Scanners, each holding 16 plates with ~35 animals each, are
kept in temperature-controlled incubators and are controlled by automated software tools. This
system can easily acquire a large number of time-lapse images of thousands of animals and is
suitable for large-scale screening. The automated image analysis pipeline associated with this
platform is designed to quantify lifespan; however, because movement or lack thereof between
serial images is used to determine lifespan, this method could potentially be adapted to directly
measure movement phenotypes.
A number of image analysis tools have also been made available for scoring complex C. elegans
phenotypes from images acquired on different HTS platforms. WormToolbox is a software
package designed to analyze image outputs from high-content, liquid-based screens in multiwell
plate format.51 Bright field images are processed to outline wells and delineate single worms
from clusters of overlapping animals. The software is then able to obtain measurements of
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texture, fluorescence intensity, opacity, and curvature for individual animals and can use these
measurements to reliably distinguish living from dead worms. A program capable of assessing
multiple phenotypes from images or video of animals on solid plates has also been developed.52
This system includes image acquisition software as well as programs for measuring lifespan,
crawling speed, body size, and egg laying. The Multi-Worm Tracker (MWT), a computer vision
application that tracks individual C. elegans in real-time, is a useful tool for automating analysis
of locomotor and behavioral outputs.53 To identify individual worms and their positions in each
frame of the video feed, the MWT segments objects that are darker than the background by a
predetermined threshold. A worm whose location in the current frame resides within a 10 pixel
region of a worm’s position in the previous frame is tracked as the same individual. A
complementary offline program, Choreography, can extract information about crawling speeds
as well as the frequency of reversals, turns, and bending motions. With the ability to track up to
120 individuals per plate, the MWT is suitable for analyzing chemotaxis, habituation and other
behavioral readouts in high throughput.

1.3.6 Current limitations and emerging technologies

The tools and methods described above have significantly advanced the development of C.
elegans-based HTS and its utility in the field; however, there remain several limitations to be
considered when using C. elegans for certain HTS applications. The animal’s impermeable
cuticle and arsenal of xenobiotic genes reduce the uptake of many small molecules, presenting
additional complexities and cost considerations for high-throughput drug screening.54,55 A screen
of more than a 1000 small molecules found that for the vast majority, the internal concentration
accumulates to less than half of that applied externally. The results of the screen were used to
build a ‘small-molecule structure-based accumulation model’ (SAM) that can predict which
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compounds are likely to accumulate and show bioactivity in C. elegans.56 The use of this model
may compensate for any deficiencies in drug uptake by prioritizing small molecule leads and
improving screening efficiency.
In addition, the requirement for bacterial co-culture means that many compounds may be
metabolized by bacteria in ways that alter their efficacy or otherwise challenge interpretation of
results. A recent study showed that small molecule absorption in C. elegans is dependent on the
method of delivery and whether the animals are cultured with live or heat-killed E. coli,
suggesting that the efficiency of drug uptake may be improved by optimizing screening
conditions.57 A related example is that the effect of metformin application on C. elegans lifespan
was shown to be mediated via bacterial metabolism.58,59
Another ongoing limitation is the lack of available tools for transiently inducing gene expression
in C. elegans, which may be desirable for some HTS workflows. While viral vector transfection
is widely used for this purpose in cell-based systems and is readily amenable to HTS, no similar
tools currently exist in the nematode. Some success in cell-specific induction of transgene
expression has been achieved through the use of hsf-1 mutant strains, which lack the protein
responsible for mounting the heat shock response. Animals are transformed with constructs
containing hsf-1 coupled to a cell-specific promoter as well as the transgene of interest under the
control of a heat-shock-responsive promoter; shifting the animals to higher temperatures induces
transgene expression with both temporal and spatial control.60 To circumvent the need for cellspecific promoters, infrared lasers have been used to provoke heat shock and resultant transgene
expression in specific cell types and tissues.61 Spatial resolution has been improved through the
application of pulsed infrared lasers, allowing for induction of gene expression in individual
neurons.62,63 However, this method requires generation of a different transgenic strain for each
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gene of interest, which remains low-throughput and labor-intensive. The emergence of the
computer-assisted microinjection (CAMI) system, a new platform that automates transgenesis in
C. elegans, may prove promising in alleviating this bottleneck.64
Unique among all other animal models, C. elegans is compatible with both microfluidic devices
and multiwell plates, providing the basis for truly high-throughput screens using these animals.
With the recent technical advances in C. elegans handling, culture, and phenotyping reviewed
above, it is now increasingly possible to conduct mass screens in whole, intact organisms for
mutations or chemical compounds that alter complex phenotypes such as lifespan.

1.4 MicroRNAs as Modulators of Longevity and the Aging
Process
This section is adapted from a publication65 co-authored with Zachary Pincus.

1.4.1 Abstract

MicroRNAs (miRNAs) are short, non-coding RNAs that post-transcriptionally repress
translation or induce mRNA degradation of target transcripts through sequence-specific binding.
miRNAs target hundreds of transcripts to regulate diverse biological pathways and processes,
including aging. Many microRNAs are differentially expressed during aging, generating interest
in their use as aging biomarkers and roles as regulators of the aging process. In the invertebrates
C. elegans and Drosophila, a number of miRNAs have been found to both positive and
negatively modulate longevity through canonical aging pathways. Recent studies have also
shown that miRNAs regulate age-associated processes and pathologies in a diverse array of
mammalian tissues, including brain, heart, bone, and muscle. Here we present an overview of
these studies, highlighting the role of individual miRNAs as biomarkers of aging and regulators
of longevity and tissue-specific aging processes.
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1.4.2 Introduction

Aging is a complex, systemic physiological process characterized by progressive degradation,
loss of function, and reduced repair capacity of an animal’s tissues and organ systems. Loss of
physical integrity leads to an increased risk of mortality and susceptibility to multiple age-related
pathologies, including neurodegenerative disorders, cardiovascular disease, osteoporosis,
sarcopenia, and cancer.66 As the average human life expectancy and proportion of elderly
individuals in the population continues to increase, there is mounting interest in uncovering the
molecular mechanisms underlying aging and related pathologies.67 A better understanding of
these mechanisms may allow for the extension of not only average lifespan but healthy life
expectancy, or the number of years spent free from age-related morbidities.68
Decades of research in the short-lived invertebrate C. elegans have uncovered multiple genetic
pathways that regulate aging and lifespan. Loss-of-function mutations in daf-2 and age-1,
components of the insulin/insulin-like growth-factor signaling (IIS) pathway, were the first
genetic manipulations shown to dramatically extend lifespan in C. elegans.1,69 Since then,
genetic analysis has identified multiple pathways that modulate lifespan, including rapamycin
(mTOR) signaling, sirtuins, and mitochondrial respiration.70 Most lifespan-extending
interventions discovered thus far act through the IIS and/or mTOR signaling pathways.
Importantly, these pathways and their function in aging are well-conserved in mammalian
species, including humans.
MicroRNAs (miRNAs) have been increasingly recognized as important regulators of the aging
process and modulators of longevity. miRNAs are short (19-22 nucleotides), non-coding RNAs
that generally repress translation or induce mRNA degradation of target transcripts through
sequence-specific binding to the 3’UTR.71 While lin-4, the first microRNA discovered, was
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found in C. elegans, miRNAs are ubiquitous across plant and animal species.72 At the time of
publication, over 1,900 human miRNAs have been cataloged in miRbase
(http://www.mirbase.org), and nearly 60% of all human transcripts are predicted to be regulated
by miRNAs.73,74 The miRNA regulatory network is extensive, as each miRNA may target
hundreds of different transcripts and each transcript may be targeted by multiple miRNAs.
miRNA-mediated regulation is central to a number of biological processes, including
developmental timing, cell death, and proliferation; likewise, dysregulation of miRNAs has been
implicated in human disease, particularly cancer.71
In this section, we will first review miRNAs that are known to regulate longevity and canonical
aging pathways. While most knowledge of longevity-regulating miRNAs is derived from work
in C. elegans, multiple reviews that extensively cover this topic are available elsewhere.75–77 The
remainder of the sectionwill focus on the role of miRNAs in mammalian aging to maximize
relevancy to humans. Because mammalian aging is characterized by organ-level functional
decline that varies greatly between systems78, we discuss the involvement of miRNAs separately
in aging of the brain, heart, bone, and muscle. We have chosen to highlight miRNAs that have
been studied in the context of normal aging in these organs rather than in specific age-related
pathologies, although there is some degree of overlap. Due to recent interest in the field, we will
also discuss the use of circulating miRNAs as biomarkers of aging and longevity in humans. This
section will conclude with a perspective on remaining areas of research and the potential for
therapeutic applications of miRNAs in human aging.

1.4.3 miRNAs in Longevity

A number of miRNAs have been shown to directly influence lifespan through well-described
aging pathways, including insulin/insulin-like growth factor (IGF-1) signaling (IIS), target of
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rapamycin (TOR) and translation signaling, sirtuin deacetylases, mitochondrial/reactive oxygen
species (ROS) signaling, and DNA-damage response.75 These pathways represent adaptive
mechanisms aimed at maintaining organismal homeostasis in response to molecular damage,
changes in nutrient availability, and other forms of physiologic stress. Most knowledge about
longevity-modulating miRNAs has been derived from work on invertebrates; however, many of
the components and functions of miRNA-targeted aging pathways are also conserved in
mammalian species. miRNAs that regulate longevity in C. elegans, Drosophila, and mouse are
described in detail below.

Table 1.1.: miRNAs that directly regulate lifespan in the model organisms C. elegans, Drosophila, and mouse with
orthologs in humans. Positive and negative modulators of lifespan are shown in blue and orange, respectively.
Orthologs that have not yet been demonstrated to directly regulate lifespan in their respective species are shown in
black.
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C. elegans
The heterochronic miRNA lin-4 was the first non-coding RNA reported to influence lifespan.79
Loss of function of lin-4 reduces lifespan, while overexpression of lin-4 or knockdown of its
target lin-14 extends lifespan. Lifespan extension via loss of lin-14 is dependent on DAF-16, a
downstream transcription factor in the insulin signaling pathway.79 miR-71, miR-238, miR-246,
and miR-239, all of which are upregulated with age, have also been characterized as longevity
modulators.80 miR-71, miR-238, and miR-246 expression positively correlate with lifespan in
isogenic wild-type individuals, while miR-239 expression negatively correlates with future
lifespan.41 Furthermore, mir-71, mir-238, and mir-246 loss-of-function mutants are short-lived,
and mir-239 mutants are long-lived compared to wild-type; over-expression confers opposite
effects for mir-71, mir-246, and mir-239.80 miR-71 and miR-239 have been shown to exert their
effects on lifespan through insulin/IGF-1 and DNA damage checkpoint pathways.41,80 miR-71 is
also required for lifespan extension induced by either germline loss or dietary restriction.81,82
Evidence suggests that miR-71 acts in a feedback loop with miR-228, a negative regulator of
longevity, and the SKN-1 and PHA-4 transcription factors to mediate lifespan in response to
dietary restriction.81 miR-71 has also been shown to regulate other important aspects of C.
elegans biology, including post-starvation survival and development in larval animals, neuronal
differentiation, proteostasis, and olfaction.83–85 While miR-71 is indispensable for normal
lifespan in C. elegans, this miRNA does not appear to be well-conserved in other species.
Regardless, the multifunctionality of miR-71 demonstrates how microRNAs can act as a
common node between different pathways.
Loss-of-function mutations in miR-34, a highly conserved miRNA, greatly extends lifespan
through regulation of autophagy genes atg4.1, bec-1, and atg9; atg9 has been confirmed as a
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direct target of miR-34a, a mammalian member of the miR-34 family.86 Interestingly,
upregulation of miR-34 enhances survival under stress conditions and is regulated by DAF-16 in
this context; Argonaute binding data suggests that miR-34 is likely to target daf-16, forming a
negative feedback loop.87
In addition to miRNAs, components of the miRNA-guided silencing and processing machinery
also regulate lifespan in C. elegans. Adult-specific loss of argonaute-like gene-1 (alg-1), required
specifically for miRNA function and processing, results in significantly shortened lifespan.88
Surprisingly, loss of function of alg-2, long considered redundant in function with alg-1, caused
lifespan extension. The alg-1 and alg-2 lifespan phenotypes are dependent on the insulin/IGF-1
signaling pathway, with alg-1 positively regulating DAF-16 targets and alg-2 repressing their
expression.88
Drosophila
In Drosophila, the majority of miRNA loss-of-function mutations appear to have a negative, if
any, effect on lifespan; lifespan-extending mutations are generally sex-specific and result in a
modest increase in longevity.89 miR-125, a well-conserved homolog of lin-4, in addition to the
well-conserved and co-transcribed (in Drosophila) miRNA let-7, has been shown to modulate
lifespan in a sex- and tissue-specific manner.90,91 Loss of mir-125 or let-7 results in shorter
lifespan and early-onset age-associated neurodegeneration in males. While both directly target
transcription factor Chinmo, a regulator of neuronal development, only miR-125 exerts its effects
on lifespan through Chinmo repression.90 Neuronal overexpression of let-7 or mir-125 extends
or reduces lifespan, respectively, in females; ubiquitous overexpression of either miRNA reduces
lifespan. Let-7 expression in neurons confers the opposite effect in males, significantly
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shortening lifespan.91 The role of the let-7 complex and its members in determination of lifespan
is clearly complex, and neuron-specific targets remain to be identified.
Contrary to observations in C. elegans, loss of the conserved miRNA mir-34 reduces lifespan
and promotes early-onset neurodegeneration.92 These phenotypes are rescued by partial loss of
miR-34 target Eip74EF, a component of steroid signaling; this pathway is necessary for normal
development and has been previously implicated in aging.93 Overexpression of mir-34 also
extends lifespan; however, whether this extension depends on suppression of Eip74EF is
unknown.92 Similarly, loss of mir-1000 shortens lifespan and exacerbates age-related
neurodegeneration through targeting of the glutamate transporter VGlut.94 The role of miR-34
and miR-1000 in age-related neurodegeneration is discussed in more detail in subsequent
sections.
For short-lived miRNA mutants, overexpressing the gene product also commonly results in a
short-lived or otherwise deleterious phenotype. mir-282 mutants are short-lived and have a
reduced hatching rate compared to wild-type animals, while mir-282 overexpression causes
larval lethality.95 Targeting of rutabaga, an adenylate cyclase expressed specifically in the
nervous system, may be responsible for these phenotypes; however, it is unknown whether this is
the primary function of miR-282. Similarly, loss or overexpression of mir-277, which is
downregulated with age, shortens lifespan.89,96 Overexpression of mir-277 results in upregulation
of genes involved in branched chain amino acid (BCAA) catabolism and directly targets two
enzymes in the pathway, CG8199 and CG5599. This overexpression also activates TOR kinase
in cell culture, possibly through accumulation of BCAA metabolic intermediates; however, an
increase in mTOR signaling has not been directly linked to miR-277’s effect on lifespan. One
exception to short-lived miRNA mutants is mir-305: knockdown of mir-305, which is normally
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downregulated with age, modestly extends lifespan.97 Overexpression of mir-305 reduces
lifespan and exacerbates age-related decline in movement and protein homeostasis. Ectopic
expression results in downregulation of genes involved in innate immunity; however, no direct
targets have been confirmed.
Mouse
Few lifespan-modulating miRNAs have been described in mammalian species, as genetic
manipulations and lifespan studies are much more difficult to execute. To date, miR-17 is the
only microRNA that has been reported to directly extend lifespan in a mammalian model.
Transgenic mir-17 mice, which ubiquitously overexpress mir-17, are long-lived and exhibit
reduced senescence across multiple organ systems.98 miR-17 directly targets insulin receptor
substrate (Irs1) and adenylate cyclase 5 (Adcy5) to inhibit senescence through multiple
downstream effectors. Suppression of Adcy5 allows for binding of the RGS2-HIF-1a complex to
the promoter of Mkp7, inducing its expression; MKP7 then inhibits mTOR signaling through
dephosphorylation of mTOR. The role of miR-17 in promoting longevity is unexpected since it
is generally considered to be an oncogene; however, this may be confounded by the activity of
other members of the cluster from which miR-17 is transcribed.99
Differential regulation of miRNAs in long-lived mouse models may inform as to other miRNAs
involved in longevity. The long-lived Ames dwarf mice, which derives its longevity from
pituitary defects and growth hormone deficiencies, is also known to have reduced insulin/IGF-1
signaling and increased insulin sensitivity.100 Aged Ames mice show increased expression of
miR-470, miR-681, and miR-669b in the brain compared to wild-type animals.101 These
miRNAs all directly target the Igf1r transcript, suppressing expression of Igf1r and the
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phosphorylated forms of FOXO3 and AKT, two components of the insulin/IGF-1 signaling
pathway. Multiple miRNAs are also upregulated in aged Ames mouse liver tissue compared to
controls, including miR-27a.102 miR-27a directly targets two members of the polyamine
synthesis pathway, ornithine decarboxylase (Odc1) and spermidine synthase (Srm). This
regulation may contribute to Ames mouse longevity as an anti-tumor mechanism, as polyamine
metabolism is required for cell proliferation and is often dysregulated in cancer.103

Figure. 1.1: miRNAs with functional roles in normal aging of the brain, heart, skeletal muscle, and bone. miRNAs
that appear to play a beneficial, detrimental, or ambiguous role in the aging process are colored coded in blue,
orange, or black, respectively.
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1.4.4 miRNAs in the aging brain
Normal aging in the human brain is characterized by both morphological and functional
changes. Brain weight declines steadily with age, total myelination length decreases, and
cortical volume is lost as neurons in the front and temporal lobes shrink in size.104 Altered
protein homeostasis, characteristic of multiple age-associated neurodegenerative diseases like
Alzheimer’s and Parkinson’s, is also common in normal aging. Increased presence of βamyloid, tau, and α-synuclein aggregates are observed in a significant fraction of aged
individuals in the absence of significant cognitive impairment or disease presentation.105
Reduced brain function and progressive cognitive decline also occur with aging, bringing
about impaired learning, memory formation, and processing speed.106 A number of studies
have shown that the miRNA profile of the brain changes with normal aging in mammalian
species 107–109 and is differentially regulated in different regions of the brain.110 The process of
normal brain aging is complex and poorly understood; thus, the role of miRNAs has been most
extensively studied in the context of neuropathologies associated with age. Here we summarize
available evidence on the role of miRNAs in normal brain aging.
miR-34, which is highly conserved in C. elegans, Drosophila, mice, and humans, has been
identified in a number of brain aging studies. In Drosophila, miR-34 is upregulated with age in
the brain and is required for maintaining healthy brain tissue and function.92 mir-34 mutants
have short lifespans, early-onset neurodegeneration, and a faster rate of increase in ageassociated transcripts in the brain compared to controls, indicating that miR-34 accelerates the
rate of brain aging. Conversely, upregulation of miR-34 extends lifespan and improves
neurodegeneration induced by polyglutamine aggregation; modulation of these phenotypes
relies on repression of the A isoform of Eip74EF (E74A), a steroid signaling transcription
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factor. Interestingly, Eip74EF is required for normal development, suggesting that miRNAsilencing of developmental genes in adulthood may be necessary for healthy aging.92 Recent
evidence has shown that miR-34 also modulates brain aging in Drosophila by targeting two
components of the polycomb repressive complex 2 (PRC2), Pcl and Su(z)12. Reduction of
PRC2 activity resulted in brain transcriptomic profiles associated with youth, including
upregulation of chaperone proteins.111 The accelerated aging experienced by mir-34 mutants
may be caused by failure to repress activity of PRC2, allowing silencing of genes that are
associated with healthy brain aging. miR-1000, which is enriched in the central nervous system
and decreases progressively with age, also plays a neuroprotective role in aging Drosophila.94
mir-1000 mutants have dramatically shorter lifespans, disordered movement, and early onset of
neurodegeneration compared to wild-type counterparts. These phenotypes result from derepression of direct target vesicular glutamate transporter (VGlut), dysregulation of presynaptic
glutamate release, and subsequent glutamate excitotoxicity leading to neuronal cell death.
Although miR-1000 appears to be Drosophila-specific, the seed sequence (region that binds to
the 3’UTR of the target transcript) is largely similar to that of mammalian miR-137. miR-137
has also been demonstrated to target a glutamate transporter (VGluT2) in mouse neurons. Loss
of mir-137 leads to increased neuron death, indicating a potentially similar role in regulating
neurodegeneration.94
Members of the miR-34 family appear to play a different, less beneficial role in mammalian
brain aging compared to their invertebrate counterparts. A mammalian member of the miR-34
family, miR-34c, may actually contribute to cognitive decline associated with normal and
pathological brain aging. miR-34c is upregulated in mouse hippocampus in both normal aging
and Alzheimer’s disease (AD) models, as well as in humans with AD.112 Overexpression of
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miR-34c in hippocampus of young mice results in memory impairment associated with old age
and decreased expression of target sirtuin 1 (Sirt1), a positive regulator of lifespan. Another
family member, miR-34a, is upregulated with age in both mouse brain and blood samples,
while expression of target Sirt1 declines inversely in both tissues. The correlation between
miR-34a/Sirt1 expression in the blood and brain may make them valuable biomarkers for
noninvasive detection of brain aging, a tissue which is normally inaccessible.113 Interestingly,
calorie-restricted mice do not show an age-dependent upregulation of miR-34a in the brain,
which is observed in ad libitum controls.114 Conversely, the anti-apoptotic gene Bcl2, a direct
target of miR-34a, is upregulated with age in the brain tissue of calorie-restricted mice but
downregulated in controls. In vitro repression of Bcl2 by overexpression of miR-34a caused
increased cell death and caspase expression, suggesting that the beneficial effects of calorie
restriction on aging and longevity may be mediated through miR-34a. The study showed that
two other age-regulated brain miRNAs, miR-181-a-1* and miR-30e, behave similarly to miR34a.114
Aggregation of beta amyloid (Aβ) in the brain, a hallmark of normal and pathological brain
aging, results from abnormal processing of amyloid precursor protein (APP) by the enzyme
BACE1. Evidence suggests that there may be a number of Bace1-targeting miRNAs that are
dysregulated in the brain with age.115 However, most of these miRNAs have been studied
specifically in the context of Alzheimer’s disease, and their role in normal aging is unclear.
One exception is miR-186, the expression of which decreases with age in the mouse brain
cortex.116 In vitro overexpression of miR-186 suppresses Bace1 to reduce Aβ formation; it
follows that age-induced downregulation of miR-186 and resulting upregulation of Bace1 may
set the stage for Aβ accumulation and development of disease.
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Age-associated upregulation of the miR-29 family in mouse brain, particularly miR-29a and
miR-29b, results in dysregulation of microglia and increased neuroinflammation, a hallmark of
brain aging. Igf1 and fractalkine ligand Cx3cl1, known inhibitors of microglia activity, are
directly suppressed by miR-29a/b, and both targets are reduced in the brain with age.117 Under
inflammatory conditions, miR-29b expression is induced and specifically suppresses Igf1 in the
microglia, suggesting that the age-associated increase in miR-29 expression may be part of a
detrimental feedback response to increasing inflammation in the aged brain. miR-29 is also
induced in the brain neurons of killifish as part of an adaptive response to age-associated iron
accumulation, a process ubiquitous in model invertebate and mammalian organisms.118 miR-29
regulates iron homeostasis through targeting Ireb2, which codes for an RNA-binding protein
that promotes intracellular transport of iron in the brain. It appears the upregulation of miR-29
with age may be part of a broad response to counteract age-associated phenotypes in the brain.
Surprisingly, knockout of mir-29 in the brain does not significantly affect lifespan in mice,
although knockouts trended towards shorter lifespan.119

1.4.5 miRNAs in aging muscle
Sarcopenia, a progressive, age-related loss of skeletal muscle mass and function, is highly
prevalent in older adults and is associated with frailty, impaired balance, falls, and reduced
quality of life. Loss of normal muscle movement and function leads to a reduction in physical
activity, exacerbating muscle loss and increasing elderly individuals’ susceptibility to
permanent disability, metabolic disorders and other aging pathologies 120. The pathophysiology
of sarcopenia is multifactorial and not fully understood, although reduced IGF-1 signaling,
chronic inflammation, muscle fiber denervation, and increased myostatin/SMAD signaling
have all been implicated in disease development.121 Expression profiling in mouse122–124,
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primate125, and human126–128 skeletal muscle has revealed a number of miRNAs dysregulated
with age. A subset of these miRNAs, including miR-181a, miR-434-3p, miR-431, miR-29,
and miR-126, have been found to play a role in the underlying pathology of sarcopenia,
modulating processes like apoptosis, senescence, and IGF-1 signaling in aging muscle cells.
miR-181a is downregulated in muscle from aged mice123,124 and rhesus monkeys.125 Protein
levels of Sirt1, a direct target of miR-181a, increase with age in the skeletal muscle; in vitro,
miR-181a negatively regulates myotube diameter through repression of Sirt1.123
Downregulation of miR-181a with age may be part of a compensatory mechanism to
counteract muscle loss; interestingly, this downregulation is mitigated by calorie restriction in
primates, possibly reflecting delayed muscle aging.125 Regardless, a functional role for miR181a specifically in the context of aged skeletal muscle remains to be described.
miR-434-3p is also downregulated with age in mouse skeletal muscle.124,129,130 in vitro, miR434-3p protects myotubes from TPEN-induced apoptosis and reduces caspase activation
through target eukaryotic translation initiation factor 5A1 (Eif5a1), a pro-apoptotic gene.
Increased protein levels of eIF5A1 are also observed in aged skeletal muscle, suggesting that
dysregulation of miR-434-3p may contribute to muscle loss by promoting apoptosis through
de-repression of Eif5a1.129 Age-related reduction in muscle expression of miR-434-3p is also
reflected in serum of old mice, highlighting its potential use as a circulating biomarker for
muscle aging.130 Another potentially protective miRNA, miR-431, is downregulated in
myoblasts from old mice compared to younger individuals.131 Exogenous expression of miR431 restores myogenesis in old myoblasts through suppression of Smad4, a component of the
SMAD transcriptional complex known to inhibit the regenerative capacity of muscle cells.
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Both overexpression of miR-431 and knockdown of Smad4 in vivo improved muscle
regeneration in aged mice, highlighting the therapeutic potential of miR-431 in muscle aging.
Unlike the other muscle-expressed miRNAs described here, miR-29 is upregulated with age in
rodents132 and a progeria mouse model.133 In vivo overexpression of miR-29 induces
senescence and inhibits muscle cell proliferation in young skeletal muscle through suppression
of targets Igf1, P85α, and Bmyb.132 Downregulation of these mediators of muscle growth and
proliferation by miR-29 may contribute to muscle loss. Evidence from Ugalde et al. suggests
that the age-related induction of miR-29 family expression is caused by accumulation of DNA
damage. miR-29 is upregulated as part of the DNA damage response and represses Ppm1d
phosphatase, a negative regulator of p53 activity.133 Thus, miR-29 may play a pivotal role in
muscle cell survival and proliferation with age and serve as a promising therapeutic target for
sarcopenia.
Recent evidence from Rivas et al. showed that a reduction in muscle hypertrophic response to
resistance exercise, a possible contributor to sarcopenia, is also regulated by miRNAs.
Interestingly, changes from baseline in the miRNA expression profile post-exercise were
observed in young but not old human skeletal muscle, suggesting that elderly individuals may
have a reduced transcriptional response to activity.127 One such dysregulated miRNA, miR126, was significantly lower in older individuals at baseline and downregulated in response to
exercise in young but not old men. Inhibition of miR-126 significantly increased Akt and
FOXO1 activation in myotubes upon IGF-1 anabolic stimulation, demonstrating a possible role
for miR-126 in muscle growth suppression and the age-dysregulated hypertrophic response.
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1.4.6 miRNAs in aging bone
Progressive bone loss, a consequence of normal aging in humans, typically begins after age 30
and is accompanied by significant structural and compositional changes that predispose elderly
individuals to osteoporosis.134 Osteoporosis is a chronic disease in which bone resorption
exceeds formation, causing pathologic changes to bone microarchitecture, mass, and strength
that dramatically increase lifetime fracture risk. Osteoporosis-related fractures commonly
occur in the hip or spine, negatively impacting individual mobility and quality of life while
significantly increasing mortality.135 Age-related deregulation in bone remodeling, the cycle of
bone removal by osteoclasts and bone deposition by osteoblasts, is a key process underlying
disease.136 miRNAs are increasingly recognized as playing a role in this complex process,
presenting new therapeutic targets to prevent bone disease and resulting frailty in the
elderly.137
Recent work suggests that miR-21 plays a role in mammalian osteocyte apoptosis138, a process
that increases with age and contributes to bone loss by recruiting and promoting osteoclast
activity.139 miR-21 expression is significantly decreased in aged mouse bone, and genetic
knockdown of miR-21 induces osteocyte death through increased expression of target
phosphatase and tensin homolog (Pten), a pro-apoptotic gene.138 Evidence supports a model
where miR-21 lies downstream of connexin43 (Cx43), which codes for a gap junction protein
that also decreases with age and protects against osteocyte apoptosis; however, the exact
relationship between Cx43 and miR-21 has yet to be characterized.138 miR-21 is also
downregulated in bone marrow mesenchymal stem cells from mice and humans with estrogen
deficiency/ovariectomy-induced osteoporosis, and promotes osteoblast differentiation and bone
formation in vivo.140 In this disease context (and possibly normal aging), TNF-α was found to
29

suppress miR-21 expression and increase expression of direct target Spry1, a negative regulator
of FGF and ERK-MAPK signaling, ultimately impairing osteogenesis and bone formation.
miR-21 may also modulate osteoporosis through targeting Reck, a negative regulator of matrix
metalloproteinases involved in osteogenesis; Reck knockdown improves bone loss in
ovariectomy-induced osteoporotic mice.141 Surprisingly, another study has shown that miR-21
knockout protects against bone loss and resorption in both normal aging and ovariectomyinduced osteoporosis; these effects are attributed to reduced osteoclast differentiation mediated
by direct target Pdcd4.142 The role of miR-21 in maintaining bone homeostasis in normal and
pathological aging is clearly complex and merits further study.
The miRNA content of bone marrow-secreted microvesicles changes with age and may
contribute to bone’s reduced capacity for growth and repair. miR-183-5p, a member of the
miR-183 cluster, is highly expressed in aged mouse bone marrow-derived extracellular
vesicles. When these vesicles are absorbed by young bone marrow stromal cells (BMSCs),
mir-183-5p inhibits BMSC proliferation and bone formation.143 miR-183 also induces
osteoclast differentiation in bone marrow-derived macrophages through target heme
oxygenase-1 (Ho1), suggesting that miR-183 plays a role in age-related bone loss by affecting
both adsorption and resorption processes.144 miR-31, a miRNA found in senescent endothelial
cell-secreted vesicles, is elevated with age in human plasma and upregulated in osteoporotic
men compared to healthy controls. Vesicular miR-31 inhibits osteogenic differentiation
through target Fzd3, a Wnt5a receptor.145
Another age-related miRNA, miR-214, is upregulated with age in bone from osteoporotic
humans and mice. miR-214 inhibits osteoblast activity and mineralization through target Atf-4,
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and in vivo overexpression of miR-214 in osteoblasts significantly decreases bone
formation.146 miR-214 is also essential for osteoclastogenesis and promotes this process
through target Pten and subsequent activation of the PI3K/Akt pathway.147 Inhibition of miR214 in osteoblasts of aged ovariectomy-induced osteoporotic mice improves bone mass,
architecture, and formation of new bone.146 Conversely, overexpression of miR-214 in
osteoclasts in vivo leads to increased osteoclast activity and bone loss.147
Recently, osteoclast-derived exosomal miR-214 has been found to play a significant role in
inhibition of osteoblast activity and bone formation.148,149 miR-214 is secreted from osteoclasts
in miRNA-enriched exosomes, which are internalized by osteoblasts to inhibit their activity
both in vitro and in vivo. Furthermore, blocking exosome release or inhibiting miR-214 in
osteoclasts increases osteoblast activity and bone formation in ageing ovariectomized
mice.148,149 Levels of miR-214 in serum exosomes of elderly women with fractures not only
reflect expression levels in bone tissue, but negatively correlate with bone formation, making
miR-214 both a potential biomarker of bone loss and a therapeutic target.148
With age, BMSCs preferentially differentiate into adipocytes rather than osteoblasts, leading to
increased fat accumulation in bone marrow and reduced bone growth.150 The switch from
osteogenic to adipogenic differentiation is promoted by miR-188, which is elevated with age in
both mouse and human BMSCs.151 miR-188 targets Rictor and Hdac9, important bone
metabolism genes, in BMSCs, activating the adipocyte differentiation transcription factor
PPARy and increasing BMSC differentiation into adipocytes rather than osteoblasts.151 As
such, aged miR-188 knockout mice show increased osteoblastic bone formation, reduced bone
loss, and less fat accumulation in bone marrow compared to wild-type. Interestingly, no
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difference was observed between the two backgrounds in young animals, suggesting that miR188 acts specifically during aging. Furthermore, BMSC-specific injection of miR-188 inhibitor
was also able to increase bone formation in aged mouse.151 Similar to miR-188, miR-218 is
also elevated in aged mouse BMSCs and a direct regulator of Rictor; however, miR-218
promotes bone loss by inhibiting osteoblast adhesion and survival, preventing formation of
new bone rather than affecting differentiation.152 Due to their negative effects on bone
formation, both miR-218 and mir-188 are potential therapeutic targets for age-related bone
loss.

1.4.7 miRNAs in the aging heart

Age is the prevailing risk factor for the development of cardiovascular disease (CVD), a leading
cause of mortality in the 65 and older population.153 Part of the age-associated risk for CVD
stems from morphological and functional changes that occur in the heart during the normal aging
process. In the human heart, the number of myocytes progressively declines while the presence
of fibrotic tissue and lipid deposition increases with advancing age. Functionally, cardiac output
and maximum heart rate generally decrease with age, and impairment of diastolic function and
ventricular loading can be observed.154 These changes, along with a decline in cardiac repair
mechanisms and capacity for self-renewal, set the stage for the development of cardiac pathology
in elderly individuals.155 Cardiovascular disease commonly presents with the occurrence of a
myocardial infarction (MI); aged individuals are at much higher risk for experiencing a MI and
are less likely to survive than their younger counterparts. The elderly are also at higher risk to
develop chronic heart failure as a result of the MI compared to younger patients.156 The
expression of miR-21, miR-22, miR-34a, and the miR-17-92 cluster is significantly altered in
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normal cardiac aging and age-related cardiac pathologies and important functional roles these for
miRNAs in both processes have been described.
miR-21 is highly expressed in the heart tissue of aged mouse compared to young animals 157 and
is strongly induced in the post-MI infarction zone by TGF-β1.158,159 Through repression of its
targets Jagged1 and Smad7, miR-21 mediates the cardiac fibroblast-to-myofibroblast transition
and subsequent formation of fibrotic tissue in the heart, a key pathology in post-MI cardiac
remodeling.158,159 Gene therapy targeting miR-21 in cardiac nonmyocytes reduced pathogenic
remodeling and functional impairment in a mouse cardiac disease model, making inhibition of
miR-21 an attractive therapeutic strategy for improving disease outcomes in humans post-MI.160
Circulating levels of miR-21 have also been used to successfully identify patients experiencing
aortic stenosis-induced fibrosis161 and acute MI162, demonstrating the potential utility of miR-21
as a diagnostic biomarker for cardiac fibrosis and disease.
miR-22 expression progressively increases with age in mouse and human cardiac tissue.163,164 In
mice, miR-22 regulates senescence in cardiac fibroblasts through mimecan (osteoglycin/Ogn), a
direct target of miR-22 that decreases with age in the myocardium.163 Interestingly, mimecan
knockout mice show significantly higher mortality post-MI compared to wild-type, as well as
increased cardiac dysfunction and collagen abnormalities.165 Cardiomyocyte-specific
overexpression of miR-22 causes hypertrophy and impaired diastolic function, mediated through
repression of Pparα, Sirt1 and Pgc1α (direct interaction has been demonstrated for Pparα and
Sirt1).166 Conversely, inhibition of miR-22 in aged rat cardiomyocytes reduces hypertrophy and
activates myocardial autophagy, a critical process for maintaining cardiac function with age 164.
Pharmacological inhibition in aged mouse post-MI also improves cardiac function and
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pathological remodeling.164 miR-22 may be a promising therapeutic target for both normal aging
and MI-related cardiac pathologies.
miR-34a expression is induced in the aging mouse heart and promotes age-associated
cardiomyocyte death and decline in cardiac contractile function.167 miR-34a is also induced postMI, and miR-34a inhibition reduces cell death, fibrosis, and functional decline associated with
heart attack.167–169 These effects are in part mediated through targeting of the protein phosphatase
Pnuts, an apoptosis inhibitor and regulator of telomere maintenance and DNA damage
response.167 Cardiomyocyte survival post-MI is regulated through targets Bcl2, Ccnd1, and
Sirt1, which are known to play roles in ageing and cell cycle activity 168. Interestingly, miR-34a
expression is protective against ischemia-reperfusion injury post-MI, suggesting that the
therapeutic role for this miRNA is complex.170
The miR-17-92 cluster, which consists of six individually transcribed miRNAs (miR-17, mir18a, miR-19a, mir-19b, miR-20a, and miR-92a-1), has been implicated in a number of agerelated processes and diseases.99 Expression of all cluster members is downregulated with age in
heart failure-prone (but not heart failure-resistant) mice, and miR-18a, miR-19a, miR-19b are
specifically depleted with age in failed but not healthy human heart tissue.171 miR-18a and mir19a/b regulate pro-fibrotic genes Ctgf and Tsp1 in aged cardiomyocytes, affecting collagen
synthesis and fibrotic remodeling.171 miR-17 has been shown to suppress senescence and
apoptosis in mouse myocardium and cardiac fibroblasts through targeting of Par4, a proapoptotic protein.172 miR-17 also targets Timp1 and Timp2, tissue inhibitors of
metalloproteinases, to prevent excessive proteolysis and cardiac remodeling; inhibiting miR-17
in vivo prevents this remodeling and improves cardiac function post-MI.173
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1.4.8 Circulatory miRNAs as biomarkers of aging and longevity

miRNAs are secreted from cells into peripheral bodily fluids through microvesicles and
exosomes, either in association with RNA-binding proteins like Argonaute 2, or bound to high
density lipoproteins.174 These ‘circulatory’ miRNAs have been observed in at least twelve
different human bodily fluids, including blood, saliva, cerebrospinal fluid, amniotic fluid, breast
milk, and urine.175 Circulatory miRNAs are highly abundant, stable, and have been demonstrated
to change with chronological age and development of age-related pathologies, sparking interest
in their use as noninvasive “biomarkers of aging”, i.e. parameters that predict longevity better
than chronological age itself.176 An accurate, noninvasive biomarker of aging would have a
variety of potential diagnostic and therapeutic applications, providing the ability to identify and
intervene for individuals who are experiencing accelerated aging and measure the efficacy of
therapeutic interventions aimed at reducing the rate of aging. Recent studies (2013 to present)
have measured differential miRNA expression between young and aged individuals in several
different peripheral fluids, including serum177–179, plasma180,181 and saliva.182 Efforts to link
circulating miRNA profiles directly to lifespan in humans have also been reported.183,184 These
studies are described in brief below.
Circulating miRNAs have been profiled in serum of old (mean age of 64.6 years) and young
individuals (mean age of 30.5 years), and miR-181a-5p, miR-1248, and miR-151a-3p were
identified to be significantly downregulated with age.177 miR-1248 and miR-151-5p were also
found to be downregulated in serum of aged rhesus monkeys, demonstrating similarities of agerelated changes in miRNA expression across aging models. Target prediction and pathway
analysis of miR-181a-5p, miR-1248, and miR-151a-3p showed overlapping involvement in
inflammatory pathways, consistent with the relationship between chronic inflammation and
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aging.177 Another study profiling miRNAs in serum from adults of various ages found miR-29b,
miR-106b, miR-130b, miR-142-5p, and miR-340 to be downregulated with age, while miR-92a,
miR-222, and miR-375 increased in expression.178 Bioinformatic analysis indicated that cancer,
an age-related pathology, was the most common disease predicted to be affected by differential
expression of these miRNAs; similarly, the most common functions of predicted age-dependent
miRNA targets were roles involving the cell cycle, proliferation, and transcription. A large,
population-based study comparing plasma between 374 young and old human individuals found
miR-126-3p, miR-30c-5p, miR-30b-5p, miR-210, miR-142-3p, and let-7a-5p to increase with
age, and miR-93-5p to decrease with age.181 In a rare example of overlap, an independent study
also found mir-126-3p to be upregulated in aged human plasma.180
The ability to link circulatory miRNA expression with not only age but future longevity would
be of great prognostic value; however, few of these studies have been conducted due to the rarity
of longitudinal human datasets that include lifespan. One such study used serum samples
collected longitudinally from short-lived (58-75 years) and long-lived (76-92 years) participants
of the Baltimore Longitudinal Study of Aging.183 24 miRNAs were found to be significantly
upregulated and 73 significantly downregulated in long-lived individuals; six of these miRNAs,
miR-211-5p, miR-5095, miR-1225-3p, miR-374a-5p, miR-340-3p, and miR-376c-3p, were both
differentially expressed and correlated with individual lifespan. Of the validated targets of this
subset of miRNAs, 24 encode gene products associated with aging processes, including a DNA
repair protein (PARP1) and insulin signaling pathway receptors (IGF1R, IGF2R). Another report
aiming to link circulating miRNAs with longevity used plasma samples from the National Heart,
Lung, and Blood Institute Twin Study.184 Five monozygotic twin pairs with a difference in
lifespan of at least 5 years were analyzed, using a plasma sample collected at middle age
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(average of 46 years) and archived. The study found that miR-3615 and miR-619 were
significantly higher in short-lived twins compared to their long-lived co-twin; however, these
results were not significant once multiple hypothesis correction was applied.
Multiple studies have demonstrated an association between circulatory miRNA expression and
age or longevity in humans. However, there is little overlap between studies, even among those
utilizing the same sample type, making it difficult to develop a ‘gold standard’ miRNA
biomarker of aging. Some of the discrepancies may be explained by differences in study design,
participant demographics, and miRNA profiling methods. Regardless, circulating miRNAs
remain a promising opportunity as noninvasive biomarkers of aging.

1.4.9 Conclusions and perspectives

miRNAs play important regulatory roles in the complex process of aging, targeting a diverse
array of transcripts and pathways – in some cases organism-wide and others in a tissue-specific
manner. Multiple miRNAs that directly modulate longevity in the invertebrates C. elegans and
Drosophila have been identified, including those that extend lifespan upon overexpression. Some
of these longevity-promoting miRNAs, including lin-4, let-7, and miR-34 are well-conserved in
humans, presenting the possibility that modulating expression of such miRNAs could extend
human lifespan. However, only one lifespan-modulating miRNA, miR-17, has thus far been
reported in a mammalian species. It remains to be seen whether other longevity-promoting
miRNAs will be discovered in mammals and whether they will be relevant to human longevity.
Regardless of their conservation in higher-order species, studies of lifespan-modulating miRNAs
in model organisms have greatly contributed to our understanding of the molecular mechanisms
and pathways involved in aging.
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Many miRNAs are differentially expressed with aging across multiple organs and tissues in
mammals, and some have been demonstrated to regulate processes associated with age-related
decline, including sarcopenia, bone loss, cognitive decline, and cardiac dysfunction. However, it
is important to note that significant up- or down-regulation of a miRNA with age only suggests
rather than proves an important role in the aging process. Additional genetic studies examining
the effects of miRNA knockdown or overexpression will be critical to demonstrate direct
regulatory roles for miRNAs in aging. Such studies are often performed in disease models of
age-related pathologies, which provide valuable insights into aging dysfunction. However,
examining the function of miRNAs in the context of natural aging, which may be mediated by
processes that are distinct from age-related pathologies, will also be of significant value. These
studies will also be necessary to determine whether direct modulation of miRNA expression is
feasible and effective for therapeutic applications. The tissue-specificity of miRNA expression
and action, particularly in mammalian species, also presents additional complexity to
understanding their role in aging. A miRNA may have different targets, functionality, and effects
on aging and lifespan depending on the tissue in which it is expressed. Thus, tissue-specific
knockdown or overexpression of miRNAs will be highly relevant to understanding a miRNA’s
effect on aging in mammalian systems.
Many studies have shown that differential expression of miRNAs in circulating biological fluids
(circulatory miRNAs) is correlated to aging and lifespan in humans. These findings, along with
the ease of obtaining samples from human patients, has generated significant interest in their use
as noninvasive biomarkers of aging and gauges of individual decline. Such a biomarker would
have significant diagnostic and therapeutic potential, providing the ability to identify cases of
accelerated aging and measure the efficacy of therapeutic interventions aimed at addressing
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aging. However, there is little concordance between published findings (even those using the
same sample type), most likely due to inter-individual variation and differences in study design
and technique. As such, a ‘gold-standard’ circulatory miRNA biomarker of aging does not yet
exist. More studies on diverse populations and analytical standardization may serve to address
this issue.
There are many aspects of miRNA involvement in longevity and aging that remain to be
understood. While target genes have been identified for many of the miRNAs discussed in this
review, it is likely that for a given miRNA, many of its targets have yet to be discovered.
Because miRNAs show marked changes in expression during aging, these changes are expected
to significantly influence expression of many target genes, with broad and significant impacts on
health and functionality of the aging individual. Continuing to identify genes that are regulated
by aging-associated miRNAs will provide further insight into the pathways and processes that
underly aging. While much has been done to identify regulatory targets for age-associated
miRNAs, regulation of the miRNAs themselves is almost entirely unexplored. Identifying the
upstream factors that mediate differential miRNA expression will be critical in understanding
how and why the aging process is set into motion.
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Chapter 2: A high-throughput, liquid-based
screening platform for predictors of lifespan
in C. elegans
2.1 Abstract

Lifespan is highly variable between members of the same species. Surprisingly, this variability
cannot be attributed to genetics and environment alone, as even isogenic C. elegans individuals
raised under homogeneous conditions display highly variable lifespans. Instead, this variability
may result from stochastic differences in expression of specific genes that cause individuals to
diverge onto short- or long-lived aging trajectories. Identifying such genes (e.g., “biomarkers of
lifespan”), most directly by screening for genes whose expression correlates with future lifespan
in C. elegans, would improve our understanding of the expression states and functional pathways
that underlie longevity. However, this approach has been precluded by multiple technical
challenges, namely longitudinal study at single-worm resolution with high throughput. To
overcome these challenges, we developed a scalable, primarily automated platform to measure
gene expression and lifespan of thousands of C. elegans individuals in parallel. Our workflow
utilizes liquid culture in 384 well plates, automated microscopy, modified flatbed scanners, and
custom software to generate archivable, high-quality data with minimal user input. We used our
platform to screen for fluorescent transcriptional reporters that predict lifespan, validating our
methods on the known longevity biomarker Pmir-71::GFP. However, our methods also enable
any number of lifespan or aging studies requiring high throughput and collection of phenotypic
data.
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2.2 Introduction

Nearly all organisms experience age-related functional decline and the resulting constraint on
lifespan.185 However, this process is hardly uniform, as lifespan varies greatly between
individuals of the same species—in C. elegans, some wild-type individuals live three times
longer than their genetically identical brethren.186 Why some individuals live longer than others
is not yet understood. Determining what events or traits, if any, direct these individuals onto
long-lived trajectories may shed light on the biological mechanisms that underlie aging.
The nematode C. elegans is highly suitable for lifespan studies due to its ability to self-fertilize
and produce large numbers of genetically identical progeny, effectively controlling for genetic
variation.187 Furthermore, C. elegans can be reared under uniform environmental conditions.
Surprisingly, populations of isogenic C. elegans raised in identical laboratory environments still
display a wide range of lifespans, indicating that nature and nurture alone fail to explain
disparities in longevity.186
Thus, variation in lifespan must be largely stochastic, or highly dependent on random events.187
Stochastic processes can cause otherwise identical organisms to differ at the molecular level,
where the precision of gene expression is limited by extrinsic and intrinsic “noise” (e.g. flux in
concentration and location of polymerases and transcriptional proteins, occurrence and ordering
of microscopic reactions, etc.).188 In other words, isogenic organisms in controlled environments
will still exhibit random differences in gene expression due to “built-in” biological noise. These
differences, if amplified and reinforced by feedback loops, could result in different gene
expression states with functional consequences on individual aging and lifespan. We hypothesize
that expression of certain genes may serve as predictive biomarkers of longevity even early in
life before the process of aging can be directly observed.70
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A high-throughput screen for expression of genes that correlate with lifespan is an unbiased,
comprehensive approach to identifying biomarkers of lifespan in C. elegans; furthermore,
functional relationships between biomarkers may implicate networks and pathways previously
unknown to be involved in aging. However, several technical challenges have precluded the
undertaking of such a screen. Large populations of worms must be observed to generate
statistically significant results, yet single-worm resolution is required to accurately measure
lifespan. Lifespan measurements, which are typically taken manually and involve observing a
worm’s response (or lack of) to prodding with a platinum wire, are unfeasible for highthroughput studies and subject to operator bias and technical error.9
Building on advancements in high-throughput culturing methods and the development of the
“Lifespan Machine” for computerized lifespan determination10, 11, we present a high-throughput,
primarily automated platform to screen for predictive biomarkers of aging and longevity in C.
elegans. Deviating from the original Lifespan Machine protocol, our screen utilizes 384 well
optical imaging plates to house worms for fluorescence imaging and subsequent lifespan study.
We modified flatbed scanners specifically for imaging 384 well plates in order to acquire highresolution images of individual worms in each well over time. These methods are supported by
custom image analysis software that automates lifespan determination based on movement
scores and hidden state modeling. We used Pmir-71::GFP expression, which has previously been
shown as a positive predictor of lifespan, as a positive control to validate our methods.41 We then
used our platform to screen nearly 40 different promoter::GFP reporters at multiple timepoints to
identify novel biomarkers of lifespan. Our methods allow for correlations to be drawn between
expression of any microRNA or transcription factor fused to a reporter fluorophore (widely
available in libraries) and lifespan with minimal “hands-on” time and high throughput.
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2.3 Materials and Methods
2.3.1 Population synchronization and sterilization

Worm populations were grown on Escherichia coli OP50 on NGM plates at 20ºC until large
numbers of gravid (egg-laying) adults had developed. Worms were removed from plates by
gently washing with M9 buffer (42.3 mM Na2HPO4, 22 mM KH2PO4, 85.6 mM NaCl, 1 mM
MgSO4) with .02% Tween and collected in 2 mL tubes. Gravid adults were allowed to settle by
gravity before total volume was reduced by aspiration. A 2:1 solution of household bleach and 5
M NaOH was added, with the resulting solution vortexed periodically for five minutes or until
the majority of worms had disintegrated and eggs could be seen floating freely in solution. The
reaction was quelled with the addition of M9 followed by centrifugation. Supernatant was
removed from the resulting pellet, which was then resuspended in M9; this wash step was
repeated a total of five times. The eggs were then transferred to a fresh tube and allowed to
nutate overnight, producing a synchronized population of L1 larvae. Larvae were transferred to
OP50-NGM plates and allowed to develop to the late L4 larval stage at 23.5°C (approximately
46 hours after transfer). Worms were then washed onto OP50-NGM plates with 40 uM 5-fluoro2’-deoxyuridine (FUdR) to sterilize the population, which was maintained on OP50-NGM +
FUdR until sorting into 384 well plates. Animals were transferred to fresh plates as necessary to
prevent nutrient depletion.

2.3.2 Worm sorting into 384 well plates

Synchronized populations of worms were removed from plates by washing with M9 + .02%
Tween at either young adulthood (3 to 4 days post-hatch (dph)) or middle age (7 dph). Worms
were deposited into the sample cup of a large object flow cytometer (COPAS BIOSORT; Union
Biometrica) with 15-20 mL M9. A time of flight (TOF) spectrum was acquired from the sample
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and gated to select for adult worms and exclude eggs and other small debris. Individual worms
were then sorted into 384 well optical imaging microplates (Corning) containing 10 uL of M9,
with one worm deposited per well.

2.3.3 Fluorescence image acquisition

The 384 well plate was enclosed in a sealed chamber on an inverted microscope (Leica), and
humidified carbon dioxide was pumped into the chamber to immobilize the animals for imaging.
Brightfield, GFP fluorescence, and autofluorescence images were acquired for individual wells
with custom image acquisition software at exposures of 2 ms, 70 ms, and 70 ms, respectively.
After completion of the imaging protocol, the plate was removed from the chamber and sealed
with optical film.

2.3.4 Fluorescence image analysis

We wrote custom worm-finding software to automatically extract fluorescence measurements
from individual well images. The software uses Canny edge detection to distinguish the largest
object in the field of view (excluding the well itself) as the worm object, generating a mask that
can then be applied to the fluorescence image (Figure 2.1).

Figure 2.1: Worm finding for automated fluorescence imaging. Brightfield image of a single PmiRNA::GFP reporter
strain individual (left), mask generated by worm-finding software (middle), and mask applied to an image capturing
dim autofluorescence (right).
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Because edge detection can erroneously select pieces of debris or air bubbles, we also created a
software tool that allows masks to be manually verified and quickly corrected as needed for each
image. Once the outline of the worm is accurately defined in the masked image, a suite of
fluorescence measurements can be extracted. We calculated a total of 11 measurements: 99th
percentile intensity, 95th percentile intensity, maximum intensity, median intensity, fluorescence
expression area, fluorescence expression area fraction, fluorescence expression area mean, high
expression area, high expression area mean, summed high expression area, and integrated
(summed) intensity. The size of the worm can also be simply calculated by summing the number
of pixels enclosed by the mask.

2.3.5 Bacterial food preparation

Bacterial food for liquid culture was prepared by first inoculating a 5 mL liquid culture of OP501 (streptomycin resistant strain) in LB + 100 ug/mL streptomycin, picking a single colony from a
streaked LB-streptomycin plate stored at 4°C. The culture was allowed to grow overnight or
approximately 12 hours, at 37°C in a shaking incubator; this was then used to inoculate a 500
mL culture, which was also allowed to grow overnight. The culture was transferred into preweighed falcon tubes and spun down to pellet the bacteria. The supernatant was aspirated
followed by resuspension in sterile water and centrifugation, for a total of three wash steps.
Bacterial pellets were weighed after drying, suspended in S-complete to a final concentration of
100 mg/mL, and then stored at 4ºC.

2.3.6 Worm liquid culture

We adapted a previously published 96-well plate liquid culture protocol31 for use in 384 well
plates. Single worms were cultured in the individual wells of a sealed 384 well plate over the
course of 30-40 days at 23.5°C on a plate shaker to allow for oxygen dissolution. After imaging,
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liquid culture components were added to a final concentration of 6 mg/mL OP50-1, 10 ug/mL
nystatin, and 200 ug/mL streptomycin to prevent fungal and bacterial contamination. FUdR was
also added to a final concentration of 120 uM per well to maintain worm sterility. Final volume
was kept at 60 uL per well to ensure adequate headspace and oxygen dissolution.

2.3.7 Lifespan image acquisition and scanner modification

Images of each plate were acquired at 2400 dpi by modified flatbed scanners at ten-minute
intervals, for a total of three scans per acquisition period. Triplicate sets of scans were collected
over a minimum thirty-day period with one to three days elapsing between sets. Scans were
collected on a flatbed document scanner (Perfection v700 Photo; Epson) that had been modified
according to the ‘Lifespan Machine’ protocol; these modifications include mounting fans on the
sides of the scanner and altering the lens position to raise the focal plane, making it suitable for
microplates.50 Plates were also positioned on a glass microscope slide platform for slight
elevation (~1 cm) and improved focus.

2.3.8 Automated lifespan determination

We wrote custom software that uses motion to distinguish living and dead worms, automating
traditional manual methods. First, individual wells are extracted from serial images of the entire
384 well plate acquired on the same day from the flatbed scanners. Absolute difference images
are created by subtracting the serial scanned images from one another. A score is then calculated
for each well by averaging the absolute difference image (after Fourier transforming and filtering
the image). We found that a simple threshold was not sufficient to distinguish scores derived
from living and dead animals, as aged individuals generally move much less than young
individuals. In addition, we also observed that aged animals were often stationary on one day,
only to resume movement the next. Thus, we relied on implementation of a Hidden Markov
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model to more accurately estimate lifespan, treating each day’s score as a sequence of observable
events that is the output of hidden states (e.g., an animal’s state of being alive or dead). We used
manually annotated images of living and dead individuals to initialize the probability matrix for
transition from a living to a dead state at each age, given the score derived from the difference
images. Expectation maximization was then used to determine the most likely state sequence and
timepoint of death for each individual. We also created software to display the entirety of serial
images of individual wells so that lifespans could be evaluated manually as necessary.

2.3.9 Worm strains

All reporter strains except Pmir-71::GFP;spe-9(hc88) were provided by the Caenorhabditis
Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs
(P40 OD010440). Please note that Pmir-71::GFP had been previously crossed into the
temperature-sensitive sterile mutant background spe-9(hc88)41; for consistency with the previous
publication, we maintained Pmir-71::GFP in this background. All strains were maintained at
20°C using standard culture conditions unless otherwise noted.

2.3.10 Software availability

All software is freely available for download at https://github.com/zplab.

2.4 Results
2.4.1 A scalable platform for high-throughput, automated screening

While screens in the model organism C. elegans take on a number of different forms2,189,
throughput is a primary concern for any screening study, particularly for those where lifespan or
age-related phenotypes are the primary readout. Furthermore, higher throughput allows for a
greater number of animals to be screened and thus greater statistical power to be obtained, which
is critical for highly variable, noisy, or subtle phenotypes. While our study was designed for
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screening through fluorescent reporter libraries to identify genes that predict lifespan in wildtype C. elegans, we aimed to develop a versatile, high-throughput, and primarily automated
platform that could facilitate any number of screens requiring longitudinal monitoring of
individual animals. An overview of the screening workflow is shown in Figure 2.2.

Figure 2.2: Overview of screening workflow. (1) COPAS biosorter deposits individual animals from a synchronized
promoter::GFP population into a 384 well plate, at a density of one animal per well. (2) The plate is exposed to CO2
in a sealed chamber to reversibly paralyze the animals for imaging. (3) Custom software is used to automatically
acquire brightfield and fluorescence images of each individual on an inverted microscope. These images are then
sent to an image processing pipeline for segmentation and fluorescence measurements. (4) Plates are sealed and
time-lapse images are taken daily on a modified Epson scanner. (5) Custom software is used to process scanner
images and extract individual lifespan based on movement between frames.
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Briefly, A large object flow cytometer (COPAS biosorter) is used to deposit individual worms
from a synchronized promoter::GFP population into 384 well optical imaging plates at a density
of one worm per well. For our screen, the synchronized animals were aged to either young
adulthood (3-4 days post-hatch (dph)) or middle age (7 dph), to find both early- and later-life
predictors of longevity. To measure gene expression for individual animals, high quality
fluorescence images are required; however, imaging unanesthetized animals in liquid culture
results in blurry images, as the animals are allowed unrestricted movement in three-dimensional
space (e.g. “thrashing” behavior). While immobilization of C. elegans is typically achieved with
the anthelmintic levamisole8, the compound is fatal to the animal with prolonged exposure and
requires laborious “wash-out” steps if used in liquid culture. Carbon dioxide (CO2) has
previously been used to temporarily and reversibly immobilize C. elegans over an air-liquid
interface in a microfluidic device10; because 384 well plates contain a similar interface, we
thought CO2 could be an effective immobilizing agent in our system. We applied humidified
CO2 at 10 psi beginning fifteen minutes prior and throughout the duration of fluorescence image
acquisition. We find that the CO2 treatment is sufficient to allow for non-blurry images and
minimal movement between brightfield and fluorescence images, which is critical for the success
of automated worm segmentation (Figure 2.3).
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Figure 2.3: Immobilization of animals for fluorescence imaging. Brightfield image (left), output of automated worm
segmentation (center), and 70 ms exposure GFP fluorescence image (right) of a 3 dph Pmir-243::GFP individual.
Note that minimal movement occurs between the brightfield and fluorescence image acquisition, allowing for the
worm mask (derived from the brightfield image via automated segmentation) to be applied to the fluorescence
image without losing expression information.

In contrast to levamisole, the CO2 is simply removed by exposing the plate to ambient air, after
which we observe the animals to quickly recover their normal mobility. Liquid culture
components31 are added and the plates are sealed for the duration of the experiment (see
Methods). Daily time-lapse imaging for lifespan determination is performed by modified flatbed
scanners50 (Figure 2.4) that acquire high-resolution images of individual worms simultaneously,
where failure of the animal to move between images is used to define death. These methods are
supported by custom image analysis software that automates lifespan determination.

50

Figure 2.4: Photograph of modified Epson scanner. The 384 well plate is elevated on glass microscope slides to
improve image focus. Additional glass microscope slides are used to ensure positioning of the plate remains
consistent between acquisitions.

2.4.2 Automated lifespan analysis reproduces user-evaluated lifespans

Our protocol followed a daily scanning schedule, where the entirety of each 384 well plate was
scanned three times, with a ten-minute delay between scans to allow for sufficient movement of
the animals. We wrote custom Python software that runs the SANE (http://www.saneproject.org) backend, allowing for customization of image acquisition parameters and
parallelization of scans on multiple lifespan machines. Although we ran only two machines
simultaneously, the number of scanners that can be run in parallel is limited only by physical
space. We also attached a printed QR code encoding the strain name and date onto each plate and
configured our software to automatically read the QR code and save image files to a
corresponding folder. This feature is very useful for small-scale experiments and likely necessary
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for massively parallel screens, especially those in which plates are moved in and out of lifespan
machines.
Our image-processing pipeline first extracts individual wells from each serial whole-plate image.
Each individual’s daily set of well images are registered and subtracted from one another to
generate difference images. The individual is then given a score based on the mean of the
difference images (Figure 2.5). The score can then be compared to thresholds derived from
manually annotated images of living and dead animals to determine the status of the individual.

Figure 2.5: Difference images for lifespan measurement. Individual well images of the same individual extracted
from a whole-plate image (top). Images are taken ten minutes apart. Difference images generated by subtracting
each individual well image show movement between images (bottom).

While young animals move robustly between serially scanned images, resulting in large
differences between images and high scores that allow them to be easily and automatically
categorized as living, this movement slows dramatically with age. We found that on any given
day, aged animals can move little between images or not at all, only to resume detectable
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movement the next day. Thus, a simplistic “thresholding” approach that determines time of death
when an individual’s score falls below an arbitrary threshold will often underestimate lifespan
(Figure 2.6).

Figure 2.6: Lifespan scores over time for three individual animals (red, green, and blue). Lifespan scores derived
from an empty well are shown for comparison (yellow). Arrows indicate manually evaluated time of death for each
individual. An example threshold for separating living and dead worms (or empty wells) is shown in the black
dashed line.

Instead, we incorporated a Hidden Markov model (HMM) into our automated lifespan analysis
to estimate time of death. An HMM is a probabilistic model that determines the most likely
series of “hidden” or unknowable states to generate a sequence of observations. In our
application of HMM, the series of hidden states is the status of an individual animal (e.g. living
or dead), and the output generated by these states is the movement scores derived from the
difference images.
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In order to validate the automatically-determined lifespans generated by our software, we
manually evaluated lifespans from the same images used by the software. We created a tool that
allows for a user to quickly and easily annotate lifespan by looking at a “storyboard” of the timelapse images for each individual and select the last timepoint at which movement was observed
(Figure 2.7). If software-generated lifespans were previously determined, the tool will
automatically place the cursor at that timepoint, reducing scrolling time by the user.

Figure 2.7: Tool for user annotation of individual lifespan. (a) Daily images of an individual animal across three
subsequent scans. (b) For user annotation, the three subsequent scanned images are collapsed into a single timelapse series for each day, played as a movie. The user moves the cursor to select the timepoint at which no
movement is observed in the movie.
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We performed manual evaluation for 63 experimental runs (25 screened at middle age and 38 at
young adulthood), encompassing a total of 17,795 individuals. Figure 2.8 shows all manually
evaluated survival curves (top) and the corresponding automatically-generated survival curves
(bottom) for experimental runs started with young adult (a) and middle aged (b) animals. Overall
survival curves for both young adult and middle aged animals show close agreement between
human- and software-generated curves (Figure 2.8c; median lifespan = 11.0 vs. 9.5 days and
12.0 vs. 12.0 days, respectively). Unsurprisingly, our software tends to slightly underestimate
lifespan. Animals tended to exhibit very subtle movement near end-of-life timepoints (e.g. slight
turn of head only), which can be difficult for the software (and even a human user) to distinguish
from background. Regardless, the accuracy of our automated lifespan software is sufficient for
screening purposes and can easily be monitored with our manual evaluation tool.
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Figure 2.8: Comparison between manually evaluated and automatically generated survival curves. (A) Manually
evaluated (top) and automatically generated (bottom) survival curves from 38 experimental runs of 28 different
reporter strains screened at young adulthood (3-4 dph). (B) Manually evaluated (top) and automatically generated
(bottom) survival curves from 25 experimental runs of 16 different reporter strains screened at middle age (7 dph).
(C) Composite survival curve of all middle aged and young adult replicates generated from evaluated lifespans
(solid line) or automatically generated lifespans (dashed line).
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We also wanted to ensure that the mean lifespans we observed were comparable to those
obtained by more conventional culturing methods. We did not find an exact comparator in the
literature to our conditions (animals cultured on plates at 23.5°C and transferred to liquid culture
at 3 or 7 dph); however, our mean lifespans fall within range of those obtained using a similar
temperature or culturing medium (Table 2.1).

Culture medium Temperature (°C)

Mean lifespan
(days)

Reference

Liquid 25.5

8.89-10.92

Klass (1977)190

Liquid 20.0

19.3-23.3

Gruber et al.
(2009)191

10.7

Pincus et al. (2011)41

14.0-14.1

This paper

Solid 23.0
Solid, transfer to 23.5
liquid at 3 or 7 dph

Table 2.1: Mean lifespans reported in the literature using various culture conditions.

2.4.3 Screening platform selects Pmir-71::GFP, a known predictor of lifespan,
as positive hit
To determine whether our platform can identify bona fide predictors of lifespan, we validated
our methods with Pmir-71::GFP, a reporter of mir-71 expression that is known to correlate
positively with lifespan in C. elegans.41 mir-71 expression is upregulated with age and has been
characterized as a modulator of longevity, with mir-71 loss-of-function mutants being shortlived.80 miR-71 acts through insulin/IGF-1 and DNA damage checkpoint pathways41,80 and is
also required for lifespan extension induced by either germline loss or dietary restriction.81,82
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We reasoned that for our screen to be useful for identifying other predictors of lifespan, our
methods should be able to robustly identify known lifespan biomarkers, such as mir-71, as
positive hits. We chose to measure mir-71 expression at 7 dph, as expression at this timepoint
has been previously associated with peak predictivity.41 Of our three biological replicates, all
showed a strong positive correlation of Pmir-71::GFP expression with lifespan (Figure 2.9).
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Figure 2.9: Pmir-71::GFP expression correlates with individual longevity. (a) Regression on Pmir-71::GFP
expression (95th percentile intensity) and software- (purple) or user-generated (green) lifespan. Each row is an
individual biological replicate. (b) Survival curves from software- (purple) or user-generated (green) lifespans.

Importantly, this positive correlation was captured when regressing expression on lifespans
generated automatically by our software (Figure 2.9a, purple). This result indicates the softwaregenerated lifespans are sufficiently accurate to identify positive hits in a screen for predictors of
longevity.

2.4.4 Large-scale screening for novel promoter::GFP predictors of lifespan
Due to the success of our methods in identifying Pmir-71::GFP as a positive predictor of

lifespan, we sought to extend our screen to other promoter::GFP reporters, most of which
originate from the same library as Pmir-71::GFP.192 We performed our screen in two rounds. For
the first round, we reared animals on standard NGM plates until young adulthood (3-4 dph),
when we measured expression (via fluorescence) and transferred the animals to liquid culture in
384 well plates. Our inclusion criteria for this round of screening was relatively unbiased,
requiring only that the reporters were integrated into the genome. The second round was
performed similarly, except expression was measured and the animals were transferred at middle
age (7 dph). For the second round of screening, we only included reporters that were sufficiently
bright; because animals become increasingly autofluorescent with age, automatically
distinguishing dim promoter::GFP fluorescence from autofluorescence is much more difficult.193
By screening for predictors at lifespan at two different timepoints, we hoped to identify both
early- and late-life predictors of lifespan. We screened a total of 44 and 33 different reporter
strains at young adulthood and middle age, respectively (Table 2.2). We took a total of 11
different expression measurements (see Methods) and report a measure as correlating if the
correlation coefficient is equal or greater than .05 and the p value is less than .05.
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Gene Number of
Manually
correlating
validated
expression
lifespans?
measurements
in young
adulthood

Number of
Manually
correlating
validated
expression
lifespans?
measurements
in middle age

acs-19 --

--

0

✗

copb-1 --

--

0

✗

cpna-2 --

--

0

✓

his-72 --

--

0

✗

let-7 0

✓

2/2

✓

lin-4 0

✓

--

--

M03F4.3 --

--

0

✗

mig-10 --

--

0

✗

mir-1 0

✓

0

✓

mir-2 0

✓

--

--

mir-35-41 0

✓

0

✓

mir-42-44 0

✓

0

✗
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mir-45 0

✓

0

✗

mir-47 0/0/0/0

✓

0

✓

mir-48 0

✓

0

✗

mir-51 0/0

✓

0

✓

mir-52 0

✗

--

--

mir-53 0

✗

0

✓

mir-59 0/0

✓

0

✗

mir-60 0

✓

--

--

mir-63 0/0

✓

2/0

✓

mir-71 --

--

5/6/8

✓

mir-75 0

✓

--

--

mir-76 0

✓

--

--

mir-79 0

✓

0

✗

mir-81 0

✗

--

--

mir-84 0

✗

--

--

mir-85 0

✗

0

✗
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mir-90 0

✓

0

✓

mir-227-80 0

✗

--

--

mir-228 0

✗

0

✓

mir-234 0

✗

0

✗

mir-235 0

✓

--

--

mir-236 0

✓

--

--

mir-238 0

✓

--

--

✓

--

--

mir-241 0

✓

0

✓

mir-242 0

✓

0

✗

mir-243 0

✗

--

--

mir-244 0

✓

0

✓

mir-246 0

✗

0

✓

mir-247-797 0

✗

--

--

mir-251 2/0

✓

--

--

mir-255 0

✓

0

✗

mir-240-786 0/0
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mir-259 0

✗

--

--

mir-265 0

✗

--

--

mir-266 0

✗

--

--

mir-360 0

✓

0

✓

mir-392 0

✗

--

--

mir-784 0

✓

0

✗

mir-788 0

✗

0

✗

pgp-12 --

--

0

✗

vit-2 --

--

0

✗

Y32H12A.8 --

--

0

✗

ZC13.1 --

--

0

✓

Table 2.2: Results of screen for promoter::GFP predictors of lifespan. A total of 44 and 33 different reporters were
screened at young adulthood and middle age, respectively. The number of lifespan-correlating expression
measurements (out of 11 total) is listed; if multiple replicates were performed, these are listed and separated by a ‘/’.
A ‘✓ ‘ symbol indicates that manual evaluation of lifespans was performed, while a ‘✗ ‘ indicates that softwaregenerated lifespans were used. ‘--‘ listed for a timepoint indicates that screening was not performed.

Other than Pmir-71::GFP, we found one other reporter, Plet-7::GFP, that reproducibly predicted
individual lifespan when measured at the middle age timepoint (Figure 2.10). Over two
biological replicates, we found Plet-7::GFP expression, as measured by expression area and
integrated fluorescence, predicts lifespan with a correlation coefficient of .05 to .08. Notably, the
software-generated lifespans are sufficient to confidently select Plet-7::GFP as a positive hit in
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the first biological replicate, but fall slightly below the significance threshold in the second. Out
of the 44 reporters we tested at early-life timepoints, we did not find any that predict individual
lifespan; early-life predictors of lifespan may therefore be less common than later-life ones, or
possibly nonexistent.
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Figure 2.10: Plet-7::GFP identified as predictive reporter by unbiased screen. Regression on Plet-7::GFP expression
and software- or user-generated lifespan (purple and green, respectively) is shown for an initial (a) biological
replicate and a second (b) confirmatory replicate.

2.5 Discussion

Building on previously developed high-throughput culturing methods and the “Lifespan
Machine”10, 11, we designed an automated platform that enables large-scale screens for
fluorescent biomarkers of lifespan in C. elegans (Figure 2.2). Unlike prior technologies, our
platform uses 384 well plates for culturing thousands of individual animals in parallel, combined
with modified document scanners and a suite of software tools for automated lifespan analysis.
Compared to traditional methods for measuring lifespan, which necessitate daily observation and
manipulation of animals under a microscope, our protocol minimizes the amount of human
capital required. The modified scanners take serial images of all individuals on a plate in parallel,
which are then processed by software to automatically and accurately determine lifespan (Figure
2.8). These images are archived and can be reviewed at the researcher’s convenience if manual
evaluation of lifespan is desired. With our software tool that displays serial images as movie
clips and automatically records user annotation of lifespan, we found that manual evaluation of
lifespan for a three-week long experiment encompassing hundreds of animals takes at most a few
hours (Figure 2.7).
Our platform is highly scalable, with the limiting factors being number of scanners and the
human capital needed to maintain animals prior to sorting into 384 well plates. Total setup time
for a 384 well plate, which includes dispensing animals with the biosorter, fluorescence imaging,
and adding liquid culture reagents, takes a single researcher only two to three hours to complete
(about half of which is true “hands-on” time). We found that the majority of hands-on time was
spent transferring 384 well plates between incubators and our scanners for imaging. Housing a
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large number of machines in an incubator or temperature-controlled room, where the 384 well
plates could simply be maintained in place on the scanner, would greatly increase throughput.
We initially tested our screening platform on Pmir-71::GFP, a reporter that had been previously
shown to predict lifespan in a solid agar culture system.41 We obtained similar results, finding
that Pmir-71::GFP expression measured at 7 dph (approximately middle age at 23.5°C) is a
strong predictor of future lifespan (Figure 2.9). Pmir-71::GFP expression at this single timepoint
accounts for 12-18% of the variability in lifespan between identical individuals reared in a
homogeneous environment. In an attempt to identify novel fluorescent reporters that predict
lifespan, we screened 44 and 33 different reporters at young adulthood and middle age,
respectively. We found one reporter, Plet-7::GFP, that had a modest predictive value for future
lifespan when measured at middle age (Figure 2.10). let-7 has been well studied in C. elegans for
its role in developmental timing and is highly conserved across mammalian species, including
humans. Because loss-of-function mutations result in developmental abnormalities and
lethality194, it is difficult to study the role of let-7 in aging and lifespan using traditional genetic
perturbations. Screening strategies like ours that utilize naturally occurring variability in
expression rather than gene knockouts to look for associations with lifespan, are well-suited for
studying essential genes such as let-7.
One limitation of our screen is that expression measurements are taken at a single timepoint, as
the addition of bacteria and liquid culture components precludes serial image acquisition.
Because different reporters may be predictive at different days of life, selecting a single
timepoint for measurement will inevitably result in some predictive reporters being overlooked.
For some reporters, the change in expression over time, which is not accessible with our
platform, may be a more predictive metric of future lifespan. Furthermore, our methods deviate
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from traditional protocols of rearing C. elegans, relying primarily on liquid culture rather than
solid agar plates. Substantial differences have been noted between C. elegans reared in these
conditions. For example, animals in liquid culture are typically longer and thinner, which may be
due to the swimming and thrashing behavior unique to the liquid environment.195 Animals in
liquid culture also exhibit significant differences in gene expression compared to their solid
culture counterparts.196 Therefore, it is possible that a gene found to predict lifespan in liquid
culture will not do so in other culture conditions (and vice versa); however, this does not appear
to be true for Pmir-71::GFP, which predicts lifespan in our liquid-culture based platform and on
solid media.41 Whether the predictive power of Plet-7::GFP generalizes to other culture
conditions remains to be seen.
In summary, we have created a powerful new platform for performing screens for biomarkers of
lifespan in wild-type C. elegans. All of the equipment and reagents used are standard and easily
accessible for most labs, and no technical expertise or coding proficiency is required. Our
platform is able to fully automate image acquisition as well as fluorescence and lifespan
measurements, greatly reducing the time and manual labor required for large-scale screening. We
were able to screen over 40 different reporters at multiple timepoints, successfully identifying
both known and novel biomarkers of individual longevity. While we designed our system for
screening fluorescent reporters that correlate with lifespan, the tools we created are highly
modular and applicable to many different C. elegans studies: our platform could easily be used
for screening small molecule libraries or even RNAi clones that affect lifespan, movement, or
progeny production.
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Chapter 3: Global, cell non-autonomous
aging drives individual lifespan among
isogenic C. elegans
This section is adapted from a manuscript under review co-authored with Matt Mosley, Isaac
Plutzer, and Zachary Pincus.

3.1 Abstract

Across species, lifespan is highly variable between individuals within a population. Even
genetically identical C. elegans reared in highly homogeneous environments display a degree of
variability in lifespan similar to that of outbred human populations. We hypothesized that some
of this variability results from persistent inter-individual differences in expression of important
lifespan-determining genes. As a test, we examined the relationship between future lifespan and
the expression of 22 different microRNAs, using a library of integrated promoter::GFP
constructs. Surprisingly, expression levels of nearly half of these reporters could effectively
predict future lifespan well before death. This indicates that prospectively long- vs. short-lived
individuals are highly divergent in terms of gene regulation. The ten lifespan-predictive reporters
represent diverse spatial and temporal expression patterns, suggesting that the regulatory states
underlying long and short life are not specific to a particular tissue or a single regulatory process.
We further found that the gene-regulatory processes reported on by two of the most lifespanpredictive transgenes are distinct from the insulin/insulin-like growth factor (IGF-1) signaling
(IIS) pathway. Last, an analysis of dual-reporter strains demonstrates a hierarchy among several
reporters expressed in different tissues, suggesting that they act as readouts of an organism-wide,
cell-nonautonomous process that acts to set each individual’s lifespan.
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3.2 Introduction

Across the tree of life, lifespan not only varies greatly between species, but also varies strikingly
among individuals of the same species.197 Much effort has been devoted to discovering genetic
and environmental factors associated with longevity in humans198–200, and many lifespanextending perturbations in model organisms like C. elegans have been discovered.1,70,201
However, little is known about how differences in lifespan arise between individuals within a
population. Studies of identical twins demonstrate that lifespan is not particularly heritable,
estimating that at most 30% of the variation in human lifespan can be attributed to genetics
alone.202–205 Moreover, properly accounting for assortative mating likely reduces that figure to
less than 10%.206 Similarly, non-heritable factors like shared environment explain very little of
the remaining variation between individuals.202,203,205 Thus, human longevity appears to be
determined at least in part by non-genetic, non-environmental factors which may therefore be of
stochastic origin. Understanding what these processes are and how they arise may provide key
insights into why some individuals live longer than others.
While these questions are difficult to study in humans, the self-fertile hermaphrodite C. elegans
is an ideal model for investigating the role of stochastic events in the aging process. Even
genetically identical C. elegans raised in highly standardized environments have widely different
lifespans, displaying a degree of variability similar to that of genetically diverse human
populations.41,186,207,208 Specifically, the coefficient of variation (CV) of lifespan in inbred C.
elegans is comparable to that of outbred human populations (CV estimates for C. elegans range
from 0.19–0.23 vs. 0.17–0.21 in humans).50,208–210 The genetics of C. elegans aging are well
understood70 and its external environment is easily controlled. Furthermore, the short lifespan
(≈2 weeks at 20oC), ability to generate genetically identical clones, and optically transparent
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body of C. elegans make the organism a tractable model to study how and why differences in
lifespan arise between identical individuals.
It is often assumed that differences in lifespan between individuals are the result of differences in
the random accumulation of damage over time. That is, by chance, some individuals encounter
more frequent or injurious assaults from their external and internal environment than others,
resulting in paths that become increasingly divergent with age. In this model, differences in
exogenous damage precede late-life biological differences between individuals (e.g. differences
in gene expression), and ultimately differences in lifespan.
An alternate hypothesis, however, is that pre-existing biological differences lead some
individuals to be more vs. less tolerant to exogenous damage in the first place – which would
then produce differences in ultimate lifespan. This might come about by a mechanism such as
hormesis, in which individuals exposed to a biological stressor upregulate stress-response
programs that persist past the original exposure and confer resistance to future stresses.211–213 It is
thus not farfetched to imagine that chance events early in life might cause some individuals but
not others to stochastically enter into organismal states of (for example) heightened stressvigilance, effectively committing them to longer future lifespans. Even small, stochastic
fluctuations in the activity level of key regulatory genes could become stabilized and amplified
by positive feedback loops, locking different individuals into distinct biological states. Indeed,
feedback-stabilization of mutually exclusive gene-expression states is a hallmark of fate
commitment decisions, from the lysis vs. lysogeny switch in bacteriophage lambda214 to lineage
commitment in hematopoiesis215 and other cell types.216,217
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If long vs. short life is the result of stable differences in the gene-regulatory programs executed
by different individuals, then long- and short-lived individuals should be distinguishable early in
life by the expression of genes that are regulated by those programs. In other words, we propose
that identifying genes whose expression early in life is predictive of future lifespan would
provide strong evidence that differences in gene regulation and expression can lead previously
identical individuals toward different lifespans. Indeed, several genes and regulatory processes
have been identified whose expression, long before death, predicts future lifespan in isogenic C.
elegans.41,218–220 Expression of hsp-16.2 after exposure to heat shock has been shown to correlate
with the degree of hormetic lifespan extension afforded by that heat shock.219 Likewise,
expression of sod-3, a stress response gene often used as a reporter for the activity of the IISresponsive transcription factor DAF-16, has been shown to correlate with lifespan when
measured at middle age in unperturbed individuals.218 Other more phenomenological predictors
of lifespan, such as movement208,221, size41,208, redox state220, and accumulation of
autofluorescent material41,208,222 have also been described.
MicroRNAs (miRNAs), short non-coding RNAs that repress translation of many target
transcripts, have been identified as both positive and negative markers of future longevity in C.
elegans. Expression of mir-71 and mir-246 (measured via fluorescence of promoter::GFP
constructs) positively correlates with future lifespan in isogenic individuals, while expression of
mir-239 negatively correlates.41 Genetic manipulation of these miRNAs directly extends (mir-71,
mir-246) or shortens (mir-239) lifespan through the insulin/insulin-like growth factor (IGF-1)
signaling (IIS) and DNA damage response pathways, demonstrating that genetic predictors of
lifespan may also act as functional determinants of longevity.80 Other miRNAs have also been
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shown to both promote or antagonize longevity in C. elegans through canonical aging
pathways.79,81,86
While multiple predictive biomarkers of lifespan have been previously reported, these studies
have been limited by throughput and temporal resolution, testing limited sets of genes and
observing relatively small populations at relatively long time intervals. To address these
limitations, we employed a high-density individual culturing device developed by our lab208,223
and automated microscopy and image processing to identify additional miRNA biomarkers of
longevity. We chose to examine miRNAs because they regulate gene expression of many targets,
they have been previously implicated in aging and lifespan, and, unlike transcription factors,
their activity is well-represented by fluorescent promoter::GFP reporters. We screened 22
PmiRNA::GFP reporter strains and found ten in which GFP levels robustly predict future lifespan
among isogenic C. elegans. We used two of the most lifespan-predictive miRNA reporters,
Pmir-47::GFP and Pmir-243::GFP, to investigate the specific pathways underlying stochastic
variation in longevity. Our findings demonstrate that unlike most known biomarkers of
longevity, these reporters are independent of the IIS pathway in their ability to predict lifespan;
however, the microRNAs mir-47 and mir-243 themselves are not functional determinants of
lifespan. Analysis of dual reporter strains indicates that there is redundancy between predictive
PmiRNA::GFP reporters, indicating that they act in a hierarchical pathway that reports on a
shared, cell non-autonomous lifespan determinants. Overall, we find evidence that a large
fraction of microRNA promoters (and perhaps all promoters) are engaged by transcriptional
programs that reflect future lifespan. We find little evidence that these programs are specific to
certain tissue types; indeed it appears that at least three GFPs redundantly report on a single,
organism-wide, cell-nonautonomous transcriptional state that is associated with future lifespan.
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At a minimum, this state reflects early changes in organismal physiology leading to early vs. late
death; at most, this state may in fact determine those physiological changes.

3.3 Results
3.3.1 Longitudinal observation of PmiRNA::GFP reporters

To understand the molecular mechanisms that underlie lifespan variability in wild-type C.
elegans populations, we sought to identify miRNAs whose expression predicts future lifespan
among genetically identical individuals reared in homogeneous environmental conditions. We
reasoned that if inter-individual differences in miRNA expression are directly involved in setting
eventual lifespan (or alternatively, are downstream reporters of a lifespan-determining factor or
pathway), expression of that miRNA should correlate with future longevity at timepoints that
occur substantially earlier than death. In other words, expression of the miRNA should act as a
lifespan biomarker, distinguishing long-lived individuals from their short-lived counterparts well
before death. We selected 22 integrated miRNA fluorescent reporters (PmiRNA::GFP) from a
larger library of 73 transgenic strains192, using only our ability to detect reporter fluorescence in
unanesthetized animals at 5× magnification on an upright compound microscope (which requires
exposure times < 100 ms) as the selection criterion. Most of the miRNAs corresponding to the
selected reporters have no reported function, and in particular, no lifespan phenotype upon
knockout (Table 3.1).
miRNA

Expression
pattern

Time window of
detectable
expression

Regulatory
function

Lifespan
phenotype

let-7

Ubiquitous

Embryo–death

Developmental
timing 224

–

Ubiquitous

L1–death

Developmental
timing225

lin-4(e912) are
short-lived; lin-4

lin-4

73

overexpression
extends lifespan 79
mir-1

mir-228

Pharynx

Embryo–death

Regulates synaptic
function226

–

Neurons

Embryo–death

–

mir-228(n4382)
are long-lived;
mir-228
overexpression
shortens lifespan
81

Uterus, gonad
sheath

L3–death

Defecation 227

–

mir-241

Hypodermis

L1–4 dph

Developmental
timing 228

–

mir-242

Neurons

Embryo–death

–

–

Intestine

Embryo–death

–

–

Gonad sheath

L4–death

–

mir-246(n4636)
are short-lived;
mir-246
overexpression
extends lifespan80

Pharynx

Embryo–death

–

–

Hypodermis,
vulva

Embryo–death

–

–

mir-51

Intestine

Embryo–death

Developmental
timing 229,
regulates
GABAergic
synapses 230

–

mir-59

Vulva

L4–death

–

–

Intestine

Embryo–death

Oxidative stress
response231

mir-60(n4947) are
long-lived under
oxidative stress
conditions231

Intestine

Embryo–death

–

–

hypodermis

Embryo–4 dph

–

–

mir-240-786

mir-243
mir-246

mir-360
mir-47

mir-60

mir-63
mir-788
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hypodermis

Embryo–5 dph

Proteoglycan
homeostasis 232

–

Neurons

Embryo–death

–

–

Body wall muscle,
intestine

Embryo–4 dph

–

–

Pharynx, vulva

L1–death

Developmental
timing 228

–

mir-85

Gonadal sheath,
uterus,
spermatheca

L2–death

–

–

mir-90

Body wall muscle,
vulva

Embryo–death

–

–

mir-79

mir-793
mir-794
mir-84

Table 3.1: miRNAs corresponding to PmiRNA::GFP reporters selected for this study and the predominant expression
pattern and time window of expression, as observed at 5× magnification. Published regulatory functions and lifespan
phenotypes for each miRNA are noted. Bold text indicates miRNAs that we found to be predictive of lifespan in this
current study, as measured by correlation of PmiRNA::GFP expression with lifespan.

Each reporter was crossed into the temperature-sensitive sterile strain spe-9(hc88) and examined
in a high-density single animal culture device previously developed by our lab (Figure 3.1a)
208,223

maintained at 25oC.

75

Figure 3.1: PmiRNA::GFP expression over time. (a) Schematic of high-density single animal culture device and
representative brightfield and fluorescent images acquired from a single Pmir-47::GFP; spe-9(hc88) individual. (b)
Timecourse of Pmir-47::GFP expression for a single animal from hatch until death (left). Expression is measured as
the maximum pixel intensity within the image region comprising that individual, from images acquired every four
hours. LOWESS regression showing the average population timecourse of Pmir-47::GFP expression, collated from
five biological replicates comprising more than 400 individuals (right). (c) Population timecourse of expression for
all PmiRNA::GFP reporters. (Fluorescent values are in arbitrary units; in all cases the bottom of the y-axis is
approximately the noise floor of the camera sensor).
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For each PmiRNA::GFP;spe-9 strain, we collected bright-field and fluorescence images of each
individual every 4 hours from hatch until death. Using an in-house image analysis pipeline, the
C. elegans in each brightfield image was automatically identified, defining a mask that separates
“worm pixels” from the image background. As described below, the fluorescence intensity of the
set of “worm pixels” at each timepoint was summarized to measure PmiRNA::GFP expression
over time within a single individual (Figure 3.1b, left). We then averaged the fluorescence
measurements across all individuals to capture the overall population trend in expression of each
reporter over time (Figure 3.1b, right, and 3.1c). For some reporters, such as Pmir-788::GFP,
expression analysis was limited to shortened time windows, as reporter fluorescence became
indistinguishable from background autofluorescence over time (see Table 3.1).
In order to analyze the relationship between gene expression and lifespan, we needed to convert
images of GFP fluorescence (containing many thousands of pixel intensities within the “worm
pixels” corresponding to a single animal) into a single summary statistic that captures the overall
“reporter expression level”. This is often done by simply taking the average fluorescence
intensity within the worm region. However, because the reporters we examined vary greatly in
spatial and temporal expression pattern as well as absolute intensity, we found that no single
summary statistic, such as the mean, was appropriate in all cases to robustly capture expression
levels of each different reporter, or to distinguish GFP from background autofluorescence. For
example, while taking the mean intensity across all “worm pixels” can often reliably measure the
fluorescence of a bright PmiRNA::GFP reporter expressed in a large tissue such as the intestine,
the same mean may mostly capture intestinal autofluorescence for a reporter that is dim, or
expressed only in a smaller tissue like the pharynx or vulva (Figure 3.2).
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Figure 3.2: Representative fluorescence images taken of individuals at 3 dph (top right panels) and 7 dph (bottom right panels)

from each PmiRNA::GFP reporter strain. The masks produced from automatic image segmentation are at left and color-coded to
show worm pixels captured by a 95th percentile (magenta), 99th percentile (orange) and 99.9th percentile (blue) intensity
threshold.

Furthermore, expression of most reporters decreases with time while autofluorescence increases,
further challenging robust, automated detection of reporter expression with measurements like
mean intensity. Thus, we calculated a number of potential summary statistics, including 95th
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percentile intensity, the mean of pixels over the 99th percentile intensity, and maximum intensity
(see Methods), and for each reporter selected the one that most reliably captured bona-fide
PmiRNA::GFP expression in both young and aged animals (Table 3.2).
Our selection was based on manual comparisons of images of reporter expression with maps
identifying the set of pixels measured by each summary statistic (i.e. if the pixels at the 95thpercentile intensity level were never co-localized with reporter-gene expression, the 95th
percentile intensity was not considered an appropriate summary statistic). Figure 3.2 shows
examples of such maps. Among plausible summary statistics, we selected those which produced
the least measurement noise timepoint-to-timepoint. For reporters that were both dimly
expressed and localized to restricted spatial regions (Pmir-1::GFP, Pmir-59::GFP, and Pmir241::GFP), we manually annotated each image to demarcate regions of reporter expression and
improve quality of the measurements (see Methods).

3.3.2 PmiRNA::GFP reporters are predictive biomarkers of future lifespan

In order to qualitatively visualize any correlative relationship between PmiRNA::GFP expression
and longevity, we binned each PmiRNA::GFP reporter strain population into cohorts based on
eventual lifespan (Figure 3.3a) and plotted average reporter expression for each lifespan-cohort
over time (Figure 3.3b and d).
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Figure 3.3: PmiRNA::GFP expression vs. future lifespan. (a) Survival curve for Pmir-47::GFP; spe-9(hc88)
individuals pooled from five biological replicates. Animals are binned into color-coded quintiles based on eventual
lifespan. The number of individuals in each quintile is indicated. (b) LOWESS regression of each quintile’s average
Pmir-47::GFP expression ( as measured by maximum intensity per individual at each timepoint) is plotted over time
for the quintiles in panel a. (c) Joint regression of both the mean level of each individual’s Pmir-47::GFP expression
between 5 and 8.5 days post-hatch, and the slope of that expression over that time, against future lifespan yields an
R2 of 0.313. Each dot represents an individual animal and is color-coded based on lifespan. (d) Cohort-level
expression timecourse and joint regression of slope and mean expression against future lifespan for all
PmiRNA::GFP reporters. This mean and slope were measured across the optimal time window for each reporter’s
correlation with future lifespan (specified in Table 3.2). Correlation coefficients exceeding 0.15 are indicated by
bolded text.
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For a subset of PmiRNA::GFP reporters, the average expression level and rate of change of
expression differed substantially between cohorts in mid- to late- adulthood, indicating that
reporter expression may be predictive of individual lifespan. To test this quantitatively, we
performed a multivariate regression on each individual animal’s average level of GFP expression
and the trend in GFP expression (positive or negative slope) against future lifespan (Figure 3.3c
and d; Table 3.2). Because the temporal dynamics of the PmiRNA::GFP reporters vary
substantially, we used a sliding time window to determine the optimal span of expression data to
include in the regression for each reporter. Using 3 days post-hatch (dph; approximately the first
day of adulthood) and the 90% population survival timepoint as bounds, the beginning and end
timepoints of a window were moved independently at 12 hour intervals to cover all possible
time-spans within the bounds. For example, if the overall bounds were 3 to 4 days post-hatch, we
would examine regressions performed on windows of: 3 to 3.5 dph, 3 to 4 dph, and 3.5 to 4 dph.
The window that resulted in the maximum correlation of expression with lifespan was selected
(Table 3.2).

miRNA

N

Measure of
pixel
intensity

Time
window
(dph)

Slope R2

Mean R2

Joint R2

Joint 95%
CI

let-7

289

99th
percentile

6.0–9.5

0.024

0.012

0.041

[-0.002,
0.085]

lin-4

193

Mean over
99th
percentile

4.5–9.0

0.211

0.029

0.212 (+)

[0.124,
0.306]

mir-1

79

Maximum
(head)

6.0–7.5

0.102

0.025

0.117

[0.008,
0.234]

mir-47

403

Maximum

5.0–8.5

0.158

0.158

0.313 (+)

[0.240,
0.388]

mir-51

87

Maximum

8.0–8.5

0.025

0.048

0.098

[-0.010,
0.211]

81

mir-59

104

95th
percentile
(vulva)

4.5–5.0

0.002

0.092

0.092

[-0.020,
0.186]

mir-60

221

99th
percentile

7.5–8.5

0.035

0.238

0.277 (+)

[0.137,
0.402]

mir-63

139

99th
percentile

5.0–9.5

0.118

0.053

0.135

[0.047,
0.230]

mir-79

86

Maximum

3.5–4.0

0.005

0.010

0.025

[-0.033,
0.076]

mir-84

142

99th
percentile

9.0–9.5

0.000

0.091

0.091

[-0.016,
0.187]

mir-85

187

99th
percentile

3.5–7.0

0.157

0.052

0.166 (+)

[0.075,
0.257]

mir-90

181

95th
percentile

8.0–8.5

0.014

0.215

0.229 (+)

[0.116,
0.340]

mir-228

157

Mean over
99th
percentile

5.0–7.0

0.194

0.070

0.239 (+)

[0.129,
0.350]

mir-240786

172

95th
percentile

7.5–8.5

0.043

0.268

0.291 (-)

[0.168,
0.419]

mir-241

97

99th
percentile
(head)

3.0–3.5

0.013

0.037

0.051

[-0.038,
0.133]

mir-242

111

Maximum

4.5–5.5

0.050

0.010

0.051

[-0.041,
0.130]

mir-243

339

Mean

3.5–7.5

0.299

0.110

0.328 (+)

[0.254,
0.409]

mir-246

187

95th
percentile

6.5–8.5

0.124

0.124

0.225 (+)

[0.124,
0.332]

mir-360

99

Maximum

4.0–5.0

0.070

0.000

0.070

[-0.032,
0.157]

82

mir-788

187

Maximum

3.0–3.5

0.000

0.005

0.006

[-0.029,
0.037]

mir-793

175

Maximum

6.0–10.0

0.166

0.091

0.224 (+)

[0.146,
0.312]

mir-794

91

Maximum

3.0–3.5

0.009

0.082

0.093

[-0.032,
0.209]

Table 3.2: Correlation of PmiRNA::GFP reporters with lifespan. A joint regression of slope and average expression
against lifespan was performed using a sliding time window (minimum width of 12 hours) beginning at 3 days posthatch. The optimal time window and highest correlation achieved is reported. R2 values exceeding 0.15 are indicated
by bolded text. The 95% confidence interval (CI) for each joint correlation coefficient is also shown. The direction
of correlation, derived from the individual regression on slope and mean expression (which we observed to always
correlate in the same direction), is indicated by (+) or (-), respectively.

Note that using a single, fixed time-window between 3 days post-hatch and the 90% survival
timepoint largely recapitulates these results (Table 3.3).
miRNA

N

let-7

Time
window
(hours
post-hatch)

Slope r2

Mean r2

Joint
regression
R2

Joint 95%
CI

283

99th
percentile

72–233

0.002

0.007

0.013

[-0.016,
0.040]

197

Mean over
99th
percentile

72–212

0.162

0.014

0.165

[0.071,
0.26]

72

Maximum
(head)

72–192

0.086

0.002

0.091

[-0.035,
0.19]

408

Maximum

72–201

0.257

0.104

0.287

[0.22, 0.35]

83

Maximum

72–236

0.002

0.015

0.015

[-0.067,
0.11]

104

95th
percentile
(vulva)

72–150

0.044

0.031

0.067

[-0.037,
0.14]

218

99th
percentile

72–210

0.117

0.101

0.174

[0.061,
0.27]

lin-4

mir-1

mir-47

Measure of
expression
intensity

mir-51

mir-59

mir-60

83

mir-63
138

99th
percentile

72–231

0.121

0.025

0.138

[0.036,
0.24]

86

Maximum

72–120

0.035

0.002

0.038

[-0.043,
0.11]

142

99th
percentile

72–231

0.006

0.059

0.059

[-0.04,
0.15]

184

99th
percentile

72–172

0.177

0.041

0.177

[0.10, 0.26]

173

95th
percentile

72–221

0.101

0.142

0.172

[0.076,
0.29]

151

Mean over
99th
percentile

72–170

0.122

0.019

0.125

[0.039,
0.22]

160

95th
percentile

72–228

0.178

0.187

0.232

[0.13, 0.33]

97

99th
percentile
(head)

72–120

0.023

0.013

0.039

[-0.035,
0.10]

98

Maximum

72–204

0.004

0.031

0.037

[-0.040,
0.11]

343

Mean

72–176

0.305

0.091

0.326

[0.25, 0.40]

193

95th
percentile

72–200

0.120

0.024

0.128

[0.053,
0.20]

87

Maximum

72–191

0.018

0.018

0.027

[-0.044,
0.093]

187

Maximum

72–96

0.010

0.003

0.010

[-0.023,
0.039]

177

Maximum

72–237

0.158

0.046

0.169

[0.079,
0.26]

91

Maximum

72–96

0.001

0.055

0.058

[-0.045,
0.15]

mir-79

mir-84

mir-85
mir-90

mir-228

mir-240786
mir-241

mir-242

mir-243
mir-246

mir-360

mir-788

mir-793

mir-794

Table 3.3: Fixed-time-window correlation of PmiRNA::GFP reporter expression with lifespan. A joint regression of
slope and average expression against lifespan was performed using a window starting at 72 hours post-hatch and
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ending at the 90% survival timepoint. R2 > 0.15 is indicated by bolded text. The direction of correlation, derived
from the individual regression on slope and mean expression (which we observe to always correlate in the same
direction), is indicated by (+) or (-), respectively. The 95% confidence interval (CI) for each correlation coefficient
is also shown. The number of individuals, measure of expression used, and time window in which the regression
was performed are also reported.

Expression of ten of the 22 tested PmiRNA::GFP reporters exhibited an ability to reproducibly
predict lifespan with a joint correlation coefficient (R2) of at least 0.15: the reporters for miRNAs
lin-4, mir-47, mir-60, mir-85, mir-90, mir-228, mir-240-786, mir-243, mir-246, and mir-793
(Table 3.2). As a reminder, the R2 value in this case represents the fraction of total interindividual variation in lifespan that can be accounted for by the inter-individual variation in
measured GFP levels of a single reporter. (We have found empirically that below R2=0.15,
correlations with future lifespan are not generally robust across experimental replicates.)
The ability to predict lifespan does not appear to be a generic property of promoter::GFP
constructs, as over half of the examined reporters did not correlate substantially with lifespan.
Furthermore two non-miRNA reporters we tested, Pmyo-2::GFP and Pcpna-2::GFP, were not
substantially predictive of lifespan (Figure 3.4 and Table 3.4).
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Figure 3.4: non-miRNA reporter expression vs. future lifespan. Expression of non-miRNA reporters Pcpna-2::GFP
and Pmyo-2::GFP is plotted over time for each lifespan cohort. Regression on both the slope and average of
individual Pcpna-2::GFP expression 7–8 days post-hatch and future lifespan yields an R2 of 0.123, while regression
on Pmyo-2::GFP expression 4.5–6.5 days post-hatch and future lifespan yields an R2 of 0.112.

Reporter

N

Measure of
expression
intensity

Time window
(hours posthatch)

Slope r2

Mean
r2

Joint R2

Joint 95%
CI

cpna-2

65

99th
percentile

175–192 (S)

0.112

0.006

0.123

[0.007,
0.242]

cpna-2

64

99th
percentile

72–196 (F)

0.007

0.017

0.018

[-0.081,
0.093]

myo-2

171

Maximum

108–156 (S)

0.107

0.005

0.112

[0.024,
0.191]

myo-2

163

Maximum

72–168 (F)

0.069

0.009

0.071

[0.004,
0.144]

Table 3.4: Expression of non-miRNA reporters vs. lifespan. Expression of non-miRNA reporters Pcpna-2::GFP and
Pmyo-2::GFP is plotted over time for each lifespan cohort. Regression on both the slope and average of individual
Pcpna-2::GFP expression 7–8 days post-hatch and future lifespan yields an R2 of 0.123, while regression on Pmyo2::GFP expression 4.5–6.5 days post-hatch and future lifespan yields an R2 of 0.112.

Moreover, the optimal time window for regression (i.e., the time window of expression data
producing the maximum correlation coefficient value) varied between reporters, suggesting that
the reporters may provide readouts of different phases of the aging process. Some reporters
exhibited broad (at least 2 days) optimal time windows spanning young adulthood (Pmir243::GFP, Pmir-85::GFP) or mid-to-late adulthood (Plin-4::GFP, Pmir-47::GFP, Pmir228::GFP, Pmir-246::GFP, Pmir-793::GFP). Other reporters like Pmir-60::GFP, Pmir-90::GFP,
and Pmir-240-786::GFP were optimally predictive in narrower time windows centered at late
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adulthood. For the latter set of reporters, regression on the average expression value tended to be
more predictive of future lifespan than the slope of the best fit line. For the earlier predictors,
regression on the slope of the best fit line tended to be more predictive or equally predictive to
the regression on the average expression value. Neither the maximum expression value an
individual achieved nor the timepoint at which maximum expression was reached were
substantially predictive of future lifespan for any of the PmiRNA::GFP reporters (Table 3.5).
miRNA

N

Measure of
expression
intensity

Time
window
(days posthatch)

Max
expression
r2

p value

Day of max
expression
r2

p value

let-7

283

99th
percentile

72–233

0.000

0.989

0.001

0.681

lin-4

197

Mean over
99th
percentile

72–212

0.000

0.853

0.001

0.638

mir-1

72

Maximum
(head)

72–192

0.012

0.307

0.010

0.353

mir-47

408

Maximum

72–201

0.000

0.779

0.020

0.004

mir-51

83

Maximum

72–236

0.030

0.116

0.001

0.798

mir-59

104

95th
percentile
(vulva)

72–150

0.000

0.912

0.002

0.670

mir-60

218

99th
percentile

72–210

0.003

0.425

0.025

0.019

mir-63

138

99th
percentile

72–231

0.002

0.640

0.000

0.956

mir-79

86

Maximum

72–120

0.020

0.190

0.008

0.402

mir-84

142

99th
percentile

72–231

0.005

0.397

0.005

0.388

mir-85

184

99th
percentile

72–172

0.010

0.169

0.070

0.000

87

mir-90

173

95th
percentile

72–221

0.013

0.138

0.028

0.028

mir-228

151

Mean over
99th
percentile

72–170

0.022

0.071

0.027

0.044

mir-240786

160

95th
percentile

72–228

0.122

0.000

0.030

0.028

mir-241

97

99th
percentile
(head)

72–120

0.009

0.347

0.000

0.905

mir-242

98

Maximum

72–204

0.002

0.669

0.000

0.878

mir-243

343

Mean

72–176

0.001

0.534

0.028

0.002

mir-246

193

95th
percentile

72–200

0.011

0.142

0.042

0.004

mir-360

87

Maximum

72–191

0.000

0.916

0.007

0.438

mir-788

187

Maximum

72–96

0.006

0.299

0.001

0.682

mir-793

177

Maximum

72–237

0.004

0.400

0.002

0.517

mir-794

91

Maximum

72–96

0.050

0.032

0.000

0.855

Table 3.5: Peak expression does not predict lifespan. Correlation coefficients and p values for regression of lifespan
against the whole-life maximum value of PmiRNA::GFP expression (measured as noted), or the day that that
maximum value was achieved.

A positive correlation between Pmir-246::GFP expression and lifespan has been previously
published and lin-4 and mir-228 are known to play roles in longevity and the aging process;
however, to our knowledge, an association with lifespan and expression of the other miRNAs in
unperturbed C. elegans has not been reported (Table 3.1).
In each case, extended lifespan was correlated with retention of young-adult gene-expression
levels and/or trends. Specifically, all reporters except for Pmir-240-786::GFP both decreased in
expression throughout aging and correlated positively with future lifespan. Conversely, Pmir240-786::GFP increases in expression with age (Figure 3.1) and was negatively correlated with
future lifespan. In other words, for reporters where expression levels start high and decrease over
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time, long lifespan is predicted by high (“youthful”) expression levels and a delay in their
decline. By the same token, for Pmir-240-786::GFP, with low young-adult expression that
increases with age, extended periods of “youthful” low expression predict extended lifespan.
We next examined how the lifespan-predictive power of the PmiRNA::GFP reporters changes
throughout adulthood. For every 24-hour period post-hatch, we jointly regressed each
individual’s average expression and the slope of the expression trend over those 24 hours against
that individual’s eventual lifespan (Figure 3.5a).
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Figure 3.5: Lifespan-predictive ability vs. time. (a) Construction of correlation plot for Pmir-47::GFP. Mean and
slope of expression values for each individual during a sliding 24-hour time window, starting at 3 dph, were
regressed against future lifespan. The regressions for 48–72 hours (window centered at 3 dph, left) and 192–216
hours (9 dph, right) are shown. At center, the correlation coefficient from each regression is plotted against the age
at the middle of the regression window (solid line). The survival curve for the population is overlaid (dashed line).
The 90% survival timepoint is indicated by the green arrow. (b) Correlation plots for remainder of predictive
PmiRNA::GFP reporters.

The resulting correlation coefficient was then plotted over time to illustrate how the predictive
power of the reporter changes with aging (Figure 3.5a and b). Using this approach, we found that
expression of predictive PmiRNA::GFP reporters generally begins to correlate with future
lifespan when measured at mid- to late-adulthood, becoming more predictive over time.
Comparing the correlation plot with the population survival curve revealed that reporter
predictivity peaks simultaneously with the beginning of population die-off, continuing to
significantly correlate with lifespan as more individuals in the population perish (Figure 3.5a and
b). However, reporters do not simply correlate with imminent death, as for this analysis we
excluded individuals that perished within the 24-hour time window. Moreover, excluding those
that perish within the subsequent 24 or even 48 hours does not abolish predictive power for most
reporters (Figure 3.6).
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Figure 3.6: Lifespan predictive ability vs. time restricting survival window. Mean and slope of PmiRNA::GFP
expression in a sliding 24-hour window was regressed against future lifespan, only for individuals surviving the
subsequent 24 hours (green), 48 hours (purple) and 72 hours (orange). The resulting correlation coefficients were
plotted against the middle of the window in which expression was measured and overlaid with the survival curve for
the population (gray). The 90% survival timepoints are shown with green arrows.

None of the reporters we examined showed substantial correlation with future lifespan at
timepoints less than 5 days post-hatch (roughly young adulthood). This result would be expected
if reporter expression levels were identical across individuals early in life, with individuals’
expression levels only diverging later in adulthood. (A so-called “transcriptional drift” scenario.)
However, we found that inter-individual variability in reporter levels is present and is largely
consistent throughout life (Figure 3.7).
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Figure 3.7: LOWESS trends for expression of predictive PmiRNA::GFP reporters over time (solid line) and standard
deviation (dashed line).

This suggests that only at mid-adulthood do existing inter-individual differences in
PmiRNA::GFP expression become coupled to the aging process and future lifespan.
Interestingly, we found that autofluorescence intensity, a phenomenological measure that
negatively correlates with lifespan222, is predictive of future longevity at approximately the same
time in adulthood as are most of the PmiRNA::GFP reporters we examined (Figure 3.8).
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Figure 3.8: Lifespan-predictive ability of autofluorescence vs. time. Mean and slope of PmiRNA::GFP expression
(green) and the 95th percentile of autofluorescence intensity (purple) for each individual during a 24-hour time
window were regressed on future lifespan. The resulting correlation coefficient was then plotted against the
corresponding timepoint and overlayed with the survival curve for the population (gray). The 90% survival
timepoints are indicated by green arrows.

However, we find that PmiRNA::GFP expression and autofluorescence with lifespan provide
largely non-redundant information with respect to future lifespan, based on near-additivity of
correlation coefficients (Table 3.6).
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miRNA

N

Time
window
(hours
posthatch)

GFP slope
r2

GFP
mean r2

Auto slope r2

Auto mean r2

Summed
r2

Joint
R2

lin-4

197

72–212

0.162

0.014

0.140

0.037

0.353

0.302

mir-47

408

72–201

0.257

0.104

0.062

0.030

0.453

0.313

mir-60

218

72–210

0.117

0.101

0.145

0.059

0.421

0.241

mir-90

184

72–172

0.101

0.142

0.076

0.084

0.403

0.304

mir-228

173

72–221

0.122

0.019

0.090

0.100

0.331

0.204

mir240786

160

72–228

0.178

0.187

0.009

0.031

0.405

0.237

mir-243

343

72–176

0.305

0.091

0.216

0.060

0.672

0.408

mir-246

193

72–200

0.120

0.024

0.101

0.058

0.303

0.191

mir-793

177

72–237

0.158

0.046

0.094

0.043

0.341

0.258

Table 3.6: PmiRNA::GFP expression and autofluorescence are independently predictive. Correlation coefficients for
PmiRNA::GFP (slope and average), autofluorescence (slope and average of 95th percentile intensity), and joint
PmiRNA::GFP and autofluorescence regression against lifespan.

This suggests that although both act as biomarkers of future lifespan, they likely report on
different aspects of the aging process.

3.3.3 Variable expression of mir-47 and mir-243 are not determinants of
individual variability in lifespan

Expression of the PmiRNA::GFP constructs can only correlate with future lifespan if there is
some biological process which both (a) determines individual lifespan and (b) directly or
indirectly regulates transcription of the GFP reporters. To learn more about the nature of this
process, we investigated the genetic requirements for the correlation between lifespan and GFP
levels in the two most lifespan-predictive reporters, Pmir-47::GFP and Pmir-243::GFP.
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One straightforward possibility is that the PmiRNA::GFP constructs are honest reporters for their
endogenous, cognate miRNAs, which determine individual lifespan by variability in their own
expression (“Direct Causation” model; Figure 3.9a).

Figure 3.9: Non-involvement of endogenous miRNAs. (a) Two models of the possible relationship between the
endogenous miRNA and lifespan: “direct causation” in which the miRNA is directly involved in determining
individual lifespans, and “bystander correlation” in which it is not. The predicted effect of knocking out the
endogenous miRNA on the correlation between PmiRNA::GFP levels and future lifespan is shown for each scenario.
(b) Comparison of Pmir-47::GFP expression over time (top left), survival (top right), regression on slope and mean
of expression against lifespan (bottom right), and lifespan-predictive value (bottom left) between mir-47(+) (solid
lines) and mir-47(gk167) (dashed lines) backgrounds. The time windows for regression were those that maximized
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correlation with future lifespan: 72–194 and 72–215 hours post-hatch for mir-47(+) and mir-47(gk167),
respectively. (c) Comparison of Pmir-243::GFP expression over time (top left), survival (top right), regression on
slope and mean of expression against lifespan (bottom left), and lifespan-predictive value (bottom right) between
mir-243(+) (solid lines) and mir-243(n4759) (dashed lines) backgrounds. The time windows for regression were 72–
192 and 72–164 hours post-hatch for mir-243(+) and mir-243(n4759), respectively. The 90% survival ages for each
genotype are indicated by arrows. The 95% CI for each regression correlation coefficient is shown in brackets. In
scatter plots, the (o) and (+) symbols correspond to the regressions in wild-type or miRNA-mutant genotypes,
respectively.

Alternately, the endogenous miRNAs themselves may have nothing to do with the true lifespandetermining pathway; in this scenario reporter expression is a downstream readout of pathways,
processes and/or transcription factor activity that affect lifespan but do not require the activity of
the endogenous miRNA (“Bystander Correlation” model; Figure 3.9a). Under the former model,
activity of the cognate miRNA is a critical causal link to lifespan; absent that miRNA, variability
in GFP would be decoupled from variability in lifespan. Under the latter model, loss of the
miRNA would not influence the relationship between GFP expression and lifespan.
To distinguish these two possibilities, we tested whether Pmir-47::GFP and Pmir-243::GFP were
still predictive of lifespan in a genetic background lacking the cognate endogenous miRNAs
(mir-47(gk167) and mir-243(n4759), respectively). As before, we performed a regression on
average expression and the slope of the best fit line between 3 dph and the 90% survival
timepoint; we also measured the lifespan-predictive value of the reporters over time in discrete
24-hour time periods. The correlation of Pmir-47::GFP expression with lifespan was somewhat
reduced in the mir-47(gk167) mutant compared to mir-47(+) (R2 = 0.22 vs. 0.36) and exhibited a
slightly different temporal window for lifespan prediction (7–9 dph vs. 6–8 dph) (Figure 3.9b).
The correlation of Pmir-243::GFP expression with lifespan was actually increased in the mir243(n4759) mutant compared to mir-243(+) (R2 = 0.257 vs. 0.193), and exhibited a different
temporal window (6–7 dph vs. 7–8 dph) (Figure 3.9c). Overall lifespans were unaffected in mir47(gk167) and mir-243(n4759) compared to wild-type at those loci (median lifespan = 10.8 vs.
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10.2 days and 8.9 vs. 9.6 days, respectively). Because both reporters correlated positively with
lifespan, a short-lived phenotype might be expected if either miR-243 or miR-47 played a
functional role in determining lifespan. The lack of substantial lifespan difference observed
further suggests that neither miRNA plays a direct functional role in determining lifespan.
Overall, the correlation of Pmir-47::GFP and Pmir-243::GFP with lifespan was not abolished in
the absence of the endogenous miRNAs. This provides evidence for the “Bystander Correlation”
model of Figure 3.9a, implying that lifespan may be largely determined by transcriptional
regulators of the PmiRNA::GFP transgenes (and presumably of the endogenous miRNAs as
well), or regulatory pathways/processes even further upstream, rather than via the activity of the
miRNAs themselves.

3.3.4 Lifespan-predictive abilities of Pmir-47::GFP and Pmir-243::GFP are
independent of IIS
As the abundance and/or activity of miR-47 and miR-243 does not appear to directly affect

lifespan, Pmir-47::GFP and Pmir-243::GFP must instead serve as markers of other pathways or
processes that influence lifespan. We wondered if these might include insulin/insulin-like growth
factor (IGF-1) signaling (IIS), a canonical aging pathway in C. elegans that is highly conserved
across taxa70. The primary effector of the IIS pathway in C. elegans is the FOXO transcription
factor DAF-16, which modulates the expression of a number of downstream genes that influence
aging and lifespan.70,233 DAF-16 activity is a common genetic requirement for genes, pathways,
and processes that have been reported to increase lifespan in C. elegans, including several
microRNAs.41,79,82 It is therefore plausible that inter-individual variability in insulin signals or
signal-responsiveness leads to variability in DAF-16 activity and thus to inter-individual
differences in subsequent lifespan. Indeed, two previously-characterized lifespan-predictive
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gene-expression reporters, Psod-3::GFP and Pmir-71::GFP, both require functional DAF-16 to
correlate with future lifespan. This suggests those transgenes predict future lifespan by reporting
on inter-individual variability in DAF-16 (and presumably IIS) activity. To test if Pmir-47::GFP
and Pmir-243::GFP similarly report on IIS and/or DAF-16 activity, we examined whether GFP
levels still correlated with lifespan in the absence of DAF-16 (Figure 3.10a).
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Figure 3.10: Non-involvement of IIS. (a) For PmiRNA::GFPs to correlate with lifespan, each must report on some
lifespan-determining process. The reported-on process may be IIS-dependent (left) or IIS-independent (right); these
scenarios can be distinguished by the effects of knocking out the IIS effector daf-16 on the correlation between
PmiRNA::GFP and future lifespan. (b) Comparison of Pmir-47::GFP expression over time (top left), survival (top
right), regression on slope and mean of expression against lifespan (bottom right), and lifespan-predictive value
(bottom left) between daf-16(+) (solid lines) and daf-16(mu86) (dashed lines) backgrounds. The optimal time
windows for regression were 72–190 and 72–164 hours post-hatch for daf-16 wild-type and daf-16(mu86),
respectively. (c) Comparison of Pmir-243::GFP expression over time (top left), survival (top right), regression on
slope and mean of expression against lifespan (bottom left), and lifespan-predictive value (bottom right) between
daf-16(+) (solid lines) and daf-16(mu86) (dashed lines) backgrounds. The optimal time windows for regression
were 72–158 and 72–144 hours post-hatch for daf-16(+) and daf-16(mu86), respectively. The 90% survival ages for
each genotype are indicated by arrows. The 95% CI for each regression correlation coefficient is shown in brackets.
In scatter plots, the (o) and (+) symbols correspond to the regressions in daf-16(+) and daf-16(mu86), respectively.

Specifically, we crossed each reporter into a daf-16(mu86);spe-9(hc88) background and assayed
lifespan-predictive ability in side-by-side experiments with the reporter in the reference
background (spe-9(hc88) only).
Regression on average expression and the slope of the best fit line between 3 dph and the 90%
survival timepoint showed that the correlation of Pmir-47::GFP or Pmir-243::GFP expression
with lifespan was not substantially suppressed in the absence of daf-16 (bottom left panels of
Figure 3.10b and c, respectively). For Pmir-47::GFP, the R2 values vs. lifespan were 0.24 for daf16(+) and 0.37 for daf-16(-); for Pmir-243::GFP, the R2 values were 0.37 for daf-16(+) and 0.18
for daf-16(-). Similarly, plotting the lifespan-predictive value of Pmir-47::GFP or Pmir243::GFP over time shows that the predictive power of each reporter is not reduced in the daf16(mu86) background (bottom right of Figure 3.10b and c, respectively). As expected, the
predictive windows are slightly shifted between daf-16(mu86) and wild-type backgrounds due to
the short-lived phenotype of daf-16(mu86) (top right of Figure 3.10b and c). Interestingly, peak
levels of Pmir-243::GFP and Pmir-47::GFP were slightly but consistently reduced in the daf16(mu86) background, suggesting that DAF-16 may play a minor role in the transcriptional
regulation of these reporters.
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3.3.5 Pmir-240-786::GFP, Pmir-793::GFP, and Pmir-47::GFP hierarchically
report on a single lifespan-determining process.
The lifespan-predictive PmiRNA::GFP reporters we identified cannot all provide independent

information. Because the correlation coefficients with future lifespan (Table 3.2) sum to more
than one, at least some subset of these reporters must necessarily be redundant to some degree.
This raises an obvious question: to what degree are the reporters independent? At one extreme,
all ten reporters might redundantly reflect the activity of one single individual-lifespandetermining pathway. Alternately, there may be a small handful of such pathways that are
reported on by the PmiRNA::GFPs we identified.
If two reporters provide information about distinct, independent biological processes, then when
both reporters are measured in the same individual, the lifespan estimate using both reporters
will be better than when using either individually. More specifically, if the information that each
reporter provides about future lifespan is completely independent, then the R2 of a joint
regression using both measurements to predict future lifespan will be the sum of the R2-values
from the two single regressions. Alternatively, if two PmiRNA::GFP transgenes report on the
exact same process, then the joint regression will be no more predictive than either single
regression (Figure 3.11a).
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Figure 3.11: Redundancy of reporters. (a) Three models depicting possible additive or redundant relationships
between lifespan-determining processes X and Y and two PmiRNA::GFP reporters A and B, with respect to their
correlation vs. future lifespan. (b) Pmir-793::GFP and Pmir-47::GFP expression for different lifespan cohorts over
time (left) and regression on slope and mean of each reporter from 3 to 8 dph controlled for expression of the other
reporter (right). (c) Pmir-47::GFP and Pmir-240-786::GFP expression for different lifespan cohorts over time (left)
and regression on slope and mean of each reporter from 3 to 9 dph controlled for expression of the other reporter
(right). (d) Pmir-793::GFP and Pmir-240-786::GFP expression for different lifespan cohorts over time (left) and
regression on slope and mean of each reporter from 3 to 10 dph controlled for expression of the other reporter
(right). The tables for (A), (B), and (C) compare correlation coefficients for single PmiRNA::GFP reporters to the
joint correlation coefficient obtained by regressing on both reporters. In scatter plots, the (o) and (+) symbols
correspond to the uncontrolled and controlled regressions, respectively. (e) Schematic depicting two possible
models, consistent with these data, for the relationships among these three reporters and the reported-on lifespandetermining processes.
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To begin to count the number of lifespan-determining processes reported on by the
PmiRNA::GFPs we identified, we investigated the degree of redundancy among Pmir-47::GFP,
Pmir-793::GFP and Pmir-240-786::GFP. We chose these reporters because they are among the
strongest predictors of future lifespan and can be easily spatially resolved because they are
primarily expressed in distinct tissues. We thus constructed three dual-reporter strains
comprising all pairs of these three transgenes, and for each strain measured GFP levels of both
transgene independently. In specific, we manually annotated fluorescence images to delineate
tissues in which each transgene was specifically expressed, and extracted our GFP measurements
from those regions only, rather than the whole worm (see Methods and Figure 3.11b–d).
To determine whether each PmiRNA::GFP in the dual-reporter strain provided independent
information about longevity, we regressed each reporter individually against future lifespan and
compared the resulting R2-values to that produced by multivariate regression of both reporters
against lifespan. As a complementary analysis, we also calculated the semipartial correlation
coefficient between each single reporter and future lifespan, statistically controlling for the
expression of the other reporter. Specifically, the R2 from semipartial correlation between
reporter A and lifespan, controlling for reporter B, represents the fraction of variation in lifespan
that is uniquely associated with variability in reporter A but not reporter B. (One method for
computing semipartial correlation is to use linear regression to capture the relationship between
reporter A and reporter B, and then regress the residual reporter A levels – i.e. those not
accounted for by covariation with reporter B – against lifespan.) In the case that reporter A is
fully redundant with reporter B, then reporter A will no longer correlate with future lifespan at
all after controlling for the expression levels of reporter B (semipartial R2=0).
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In the dual Pmir-47::GFP; Pmir-793::GFP strain, expression of each reporter is individually
predictive of future lifespan, as we previously observed (Figure 3.11b, R2 = 0.37 and 0.23 for
Pmir-47::GFP and Pmir-793::GFP respectively). However, a joint regression incorporating both
reporters produces a correlation coefficient no greater than regressing against Pmir-47::GFP
alone (Figure 3.11b, R2 = 0.38). This suggests that Pmir-793::GFP levels provide no information
about future lifespan that is not also reflected in Pmir-47::GFP expression. As a confirmation,
the semipartial correlation between Pmir-793::GFP and lifespan, controlling for Pmir-47::GFP,
is (as expected) nearly zero (Figure 3.11b, left plot). In contrast, Pmir-47::GFP expression
remains somewhat predictive of lifespan even after controlling for Pmir-793::GFP. Thus, Pmir47::GFP and Pmir-793::GFP are not independent predictors of future lifespan and likely report
on a single lifespan-determining pathway. Because Pmir-47::GFP expression contains strictly
more information about lifespan than Pmir-793::GFP, we infer that Pmir-47::GFP likely reports
on activity of that pathway at a somewhat more downstream position with respect to lifespan
determination, or integrates additional information from a separate pathway (Figure 3.11a, center
and right).
Similar results were obtained for Pmir-47::GFP and Pmir-240-786::GFP. Expression of each
reporter was individually predictive of lifespan (Figure 3.11c, R2 = 0.46 and 0.15 for Pmir47::GFP and Pmir-240-786::GFP, respectively), but regression on both reporters again results in
a correlation coefficient nearly equal to regressing on Pmir-47::GFP alone (Figure 3.11c, R2 =
0.47). Semipartial correlation analysis was similar to the previous case, indicating that Pmir-240786::GFP is wholly redundant with Pmir-47::GFP but not vice-versa. We thus infer that, of the
reporters we examined, Pmir-47::GFP expression either integrates information most broadly
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across lifespan-determining pathways, or reports on a step the farthest downstream in a single
lifespan-determining pathway.
Unsurprisingly, Pmir-240-786::GFP and Pmir-793::GFP also did not act as independent
predictors of lifespan (Figure 3.11d; R2 = 0.13 and 0.24 for Pmir-240-786::GFP and Pmir793::GFP, respectively, with a joint R2 = 0.25, which is close to the figure for Pmir-793::GFP
alone and much less than 0.37, the sum of the two individual values. Confirmed by semipartial
correlation analysis, this suggests that Pmir-240-786::GFP is almost wholly redundant with
Pmir-793::GFP (save approximately 4% of lifespan variation which the former transgene can
predict independent of Pmir-793::GFP). We infer that Pmir-793::GFP reports on information
that is downstream of (or more broadly integrated than) Pmir-240-786::GFP, with respect to
lifespan determination.
Overall, the most parsimonious interpretation of these results is that Pmir-240-786::GFP, Pmir793::GFP, and Pmir-47::GFP expression provides information about an ordered lifespandetermining pathway, with Pmir-47::GFP providing the most downstream report on the lifespandetermination process (Figure 3.11e, left). It is also possible that Pmir-47::GFP reports on three
distinct lifespan-determination pathways, Pmir-793::GFP reports on two of those, and Pmir-240786::GFP on a single pathway (Figure 3.11e, right). Last, it could also be that each transgene
reports on the exact same step of a single pathway, but that the different transgenes also reflect
different degrees of extraneous, unrelated transcriptional input. Each model has in common,
however, the key fact that the bulk of the three transgenes’ correlation with lifespan is due to
their mutual transcriptional relationship with a single lifespan-determining process.
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It is particularly interesting in this context to recall that each of these reporters is expressed in
distinct tissues; moreover the expression trend of Pmir-240-786::GFP (increasing throughout
life) is quite different from the other two reporters (which peak at mid-adulthood and decline).
Thus, three independent reporters, expressed in different temporal and spatial patterns, all
nevertheless provide largely redundant information about a single lifespan-determining process.
We interpret this as evidence that Pmir-47::GFP, Pmir-793::GFP, and Pmir-240-786::GFP likely
report on a global, cell non-autonomous (and IIS-independent) process of lifespan
determination, which affects the entire animal’s physiology.

3.4 Discussion

In order to understand the relationship between inter-individual variation in transcriptional /
gene-regulatory states and future lifespan, we used tools previously developed by our lab208,223 to
examine expression of 22 PmiRNA::GFP reporters192, across hundreds of individuals throughout
life. This dataset provides a window into transgene-expression dynamics at a temporal and
spatial resolution unprecedented for longitudinal experiments (whole-body fluorescence and
brightfield images at 1.3 µm/pixel, recorded every four hours from hatching to death). Compared
to previous work which followed a candidate-gene approach41,218,219, this is the first systematic,
unbiased examination of the relationship between promoter activity and future lifespan. Overall,
we find that the ability to predict future lifespan is not a rare property, as 10 of the 22 transgenes
tested were robustly and repeatably correlated with individual longevity. We were not able to
identify a clear pattern among lifespan-predictive vs. non-predictive miRNA promoters in terms
of tissue of expression or temporal pattern in gene expression; instead it appears that many
transgenes, across many tissues, report on the activity of a smaller number of lifespandetermining processes. While previous studies have implicated inter-individual differences in IIS
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in lifespan variability, we have identified at least one distinct, organism-wide transcriptional
program that acts independently from IIS in reflecting or determining future lifespan.
When measured while at least 90% of the population remained alive, 10 PmiRNA::GFP reporters
met our criteria as predictors of longevity (Figure 3.3, Table 3.2), explaining between 17 and
33% of the variability in lifespan among genetically identical individuals. Overall, we found that
longevity is generally associated with the preservation of young-adult reporter expression states.
Among microRNA reporters that predict lifespan, those with high young-adult levels that
decrease with age are positively correlated with longevity, such that long life is associated with
high and/or non-decreasing GFP expression. Conversely, the single lifespan-predictive reporter
that has low young-adult levels and increases with age is negatively correlated with lifespan;
long life is associated with maintenance of low / non-increasing GFP levels. The fact that both an
individual’s average level of expression and the slope of expression over time can inform future
lifespan suggests that both magnitude and maintenance of expression may be important for
longevity. However, it is important to note that not all genes that change with time are predictive
of future lifespan. For 12 of the 22 reporters examined, maintenance of “youthful” expression
patterns had no relationship with lifespan.
Nevertheless, we were surprised to find that nearly half of the PmiRNA::GFP reporters we tested
did correlate with lifespan, especially as we did not take into account any prior association with
aging or lifespan in selecting which reporters to examine. We conclude that the ability of a
transcriptional reporter to predict future lifespan is not particularly rare, at least among those
driven by microRNA promoters. However, this property is also not a completely generic
property of GFP transgenes either: in addition to the 12/22 the PmiRNA::GFP reporters that did
not correlate with future lifespan, neither of the non-miRNA reporters we tested correlated
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strongly with lifespan (Figure 3.4); negative results for other transcriptional reporters have also
been published.218.These negative results also suggest that it is not simply the case that the ability
to express any GFP transgene reflects a healthy, pro-longevity state. This conclusion is also
bolstered by the observation that there exist promoter::GFP constructs whose expression
negatively correlates with future lifespan (identified both in the present work and in previous
publications41). Larger-scale studies will be necessary to determine whether a substantial fraction
of promoters across the genome act in a lifespan-responsive fashion, or whether this property is
enriched among promoters of regulatory genes like miRNAs or transcription factors.
No simple properties distinguish the PmiRNA::GFP reporters that predict future lifespan from
those that do not. For every lifespan-predictive reporter, there are non-predictive reporters with
nearly identical temporal trends in expression (Figure 3.1; Table 3.2), and non-predictive
reporters with expression in the same tissues/organs (Table 3.1, Figure 3.2). This suggests that no
single tissue is critical for individual lifespan, but instead that lifespan-determining processes act
organism-wide, involving multiple tissues in a cell non-autonomous manner.
We next set out to determine the identity of the lifespan-determining cellular or genetic processes
that these PmiRNA::GFP transgenes report on. The most straightforward hypothesis is that if
expression of a PmiRNA::GFP reporter is positively correlated with lifespan, that is because the
endogenous, reported-on miRNA acts to prolong lifespan. In this scenario, high levels of the
PmiRNA::GFP simply act as an honest reporter for high levels of – and thus high biological
activity of – the lifespan-extending miRNA. Several lines of evidence, however, suggest that this
is not generally the case. First, the majority of predictive reporters we identified correspond to
miRNAs with no published lifespan or aging phenotype (Table 3.1). lin-4, mir-228, and mir-246
have been previously associated with longevity; knockout and overexpression studies have
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reported lin-4 and mir-246 as positive regulators of lifespan and mir-228 as a negative
regulator.79–81 We found that as expected, reporters for lin-4 and mir-246 correlate positively
with lifespan; surprisingly, Pmir-228::GFP also correlates positively with lifespan. It is
important to note, however, that it should not be assumed that genes that change the population’s
mean lifespan when removed or overexpressed are necessarily those that act to determine interindividual variation in lifespans among a genetically unperturbed population. In particular, the
presence of regulatory feedback and buffering processes can dramatically complicate this
relationship.
Regardless, a second line of evidence also suggests that the relationship between several of the
PmiRNA::GFP reporters and lifespan is not via the activity of the endogenous, reported-on
miRNA. Specifically, the correlation of two of the predictive reporters, Pmir-243::GFP and
Pmir-47::GFP, with lifespan is not abrogated in the absence of the endogenous miRNA (Figure
3.9). Were these microRNAs a key part of the lifespan-determining transcriptional program
reported on by the GFP levels, the correlation between GFP levels and lifespan would have
disappeared absent the microRNAs themselves. In addition, we also observed no substantial
difference in lifespan between wild-type and mir-243 and mir-47 loss of function mutants.
These results indicate that neither mir-243 nor mir-47 play a direct functional role in determining
lifespan in wild-type individuals. Our results are not surprising given most single miRNA234 or
even entire miRNA family235 loss-of-function mutants are not required for normal development
or viability; often phenotypes are only observed in sensitized backgrounds236 or when multiple
members of a miRNA family are absent.229 While mir-243 is not reported to be part of a family,
mir-47 shares over 70% sequence identity with mir-46237; thus, redundancy between family
members could mask a functional role for mir-47 in aging.
108

Overall, this suggests that Pmir-243::GFP and Pmir-47::GFP (and potentially other of the
lifespan-predictive reporters we identified) act as indirect, transcriptional reporters of some
separate lifespan-determining process. Inspection of the promoter regions of these genes can
provide hypotheses about the factors that may be both acting to determine lifespan and to control
expression of these GFPs. While little is known in general about transcriptional control of
miRNAs, much less the individual transcription factors involved238, there is suggestive evidence.
Yeast one-hybrid assays performed with C. elegans genes239 identify PQM-1, ELT-4, and HLH30, transcription factors that are known to promote longevity240–242, as likely to bind to the
promoter sequence of mir-243. ZTF-8, a transcription factor that mediates the DNA damage
response243, may interact with the mir-47 promoter.
Regardless of the immediate transcriptional control of Pmir-243::GFP and Pmir-47::GFP, it is
nevertheless the case that the expression of these reporters must in some way be linked to one or
more lifespan-determining processes or pathways. As the insulin/IGF-1-like signaling pathway
(IIS) is arguably the best-studied “longevity pathway” in C. elegans, we asked whether these
transgenes predict lifespan by correlating with the level of IIS activity. Because the reporters still
predict lifespan in an IIS-deficient daf-16 mutant, we conclude that this is not the case (Figure
3.10). This is surprising given that many other longevity-predictive reporters, such as Pmir71::GFP and Psod-3::GFP, do require IIS to correlate with future lifespan.41,218 (Note that these
latter results are as expected, because the endogenous miRNA mir-71, interacts genetically with
IIS to functionally influence lifespan80, and because sod-3 is a direct transcriptional target of
DAF-16.218) However, despite the importance of IIS in determination of lifespan, both at a
population and an individual level, Pmir-243::GFP and Pmir-47::GFP report on one or more
processes or pathways that are genetically distinct from IIS.
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Beyond the precise identity of the lifespan-determining processes that are reported on by these
PmiRNA::GFPs, we also attempted to estimate the overall number of such processes that might
be at play. Because the correlation coefficients sum to greater than one (Table 3.2), some of the
PmiRNA::GFPs must redundantly report on the same processes. We thus wondered whether we
had identified ten transgenes that each served as noisy measures of one single process (one
extreme), or reporters for six to eight independent lifespan-determining processes. Fortunately,
several of the highly lifespan-predictive PmiRNA::GFPs (including Pmir-47::GFP, which we had
extensively analyzed as above) were expressed in distinct, non-overlapping tissues. This allowed
us to simultaneously measure the lifespan-predictive signal from pairs of reporters in the same
individuals. We found that Pmir-793::GFP and Pmir-240-786::GFP did not provide any
information about future lifespan that was not already captured by Pmir-47::GFP expression.
Furthermore, Pmir-240-786::GFP was completely redundant with Pmir-793::GFP. The simplest
model consistent with these results is a single, hierarchical lifespan-determining pathway in
which Pmir-47::GFP reports on the relatively downstream-most step and Pmir-240-786::GFP
reports on the relatively most upstream step. This redundancy stands in stark contrast with the
fact that these genes are expressed in very distinct tissues (Table 3.1; Figure 3.2) and with
distinct temporal expression patterns (Figures 3.1 and 3.3). This suggests that Pmir-47::GFP,
Pmir-793::GFP, and Pmir-240-786::GFP report on a cell non-autonomous process that affects
and integrates among multiple tissues throughout aging.
High-resolution analysis of lifespan curves has suggested that a single state of “biological
resilience” emerges from the interactions of multiple, densely-interlinked lifespan-determining
genes/processes.244 Such a state of resilience might be expected to be cell- and tissueautonomous; if so, it is possible that these PmiRNA::GFPs report on some aspects of overall
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resilience or biological reserve. Note, however, that Pmir-47::GFP expression, measured
specifically from the vulva, does provide significant prediction of future lifespan that is not
captured by Pmir-793::GFP or Pmir-240-786::GFP. Thus, in addition to shared cell- and/or
tissue-non-autonomous processes, Pmir-47::GFP may also report on separate, tissue-specific
processes. Indeed, vulval tissue integrity has been identified as an important determinant of
health and survival C. elegans.245
We set out to explore the hypothesis that inter-individual differences in lifespan arise from fatecommitment-like mechanism, whereby certain individuals persistently maintain transcriptional
states that assure future stress resistance and extended lifespan. Overall, our results clearly
demonstrate that individuals with distinct future fates can in fact be distinguished on the basis of
gene-regulatory states (as read out by a number of PmiRNA::GFP reporters). A developmental,
or even young-adult, origin to these transcriptional states we identified appears unlikely,
however: none of the reporters were particularly predictive of lifespan before approximately the
third day of adulthood. Despite substantial inter-individual variation in GFP expression early in
adulthood (Figure 3.7), the window in which that expression variability correlates with
remaining lifespan begins roughly a day or so before the start of the population die-off and ends
when approximately 25% of the population remains alive (Figure 3.5). This suggests that the
lifespan-determining transcriptional processes that the PmiRNA::GFPs report on are set relatively
late in life. This contrasts with the early-adult window in which major changes to the stressresponse machinery take place246, which we had originally suspected might be a key inflection
point at which inter-individual differences in lifespan-determining stress-resistance pathways
emerge.
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The hypothesis that gene-regulatory programs determine individual lifespan should be compared
against the null hypothesis that inter-individual variability in lifespan is solely due to stochastic
differences in accumulation of damage throughout life. It is possible that the lifespan-predictive
PmiRNA::GFPs we identified are simply very early reporters of the transcriptional consequences
of lifespan-limiting stochastic damage (such as pathogenesis247,248 or intestinal
permeabilization249). This would be consistent with “youthful” gene-expression levels predicting
long life: a change in gene expression would be indicative of an individual having received a
potentially lethal insult. Alternately, and equally consistent with our data, it may be that loss of
youthful, protective gene-expression states is a risk factor for suffering exogenous insults (e.g.
for becoming bacterially infected), or for being unable to recover from such insults (e.g. for
unsuccessfully countering a bacterial infection). In this scenario, differences in the timing of the
departure from an optimal gene-expression program drives differences in individual lifespan.
The fact that the reporters remain somewhat predictive of future lifespan even when excluding
individuals that die within the subsequent 24 to 48 hours (Figure 3.6) provides some evidence for
this latter view. However, it is also possible that the transgenes report on stochastic damage that
leads only slowly to death. Further genetic and functional analysis of these lifespan-predictive
reporters will be necessary to conclusively determine whether they lie upstream or downstream
of exogenous, lifespan-limiting insults.
Overall, we find that it is quite common for microRNA promoters to drive reporter-transgene
expression in a manner predictive of individual lifespan, at mid-to-late adulthood. Moreover,
several of these promoters appear to redundantly reflect a single, cell-non-autonomous, IISindependent, organismal state that relates to future lifespan. Ultimately, this work raises a host of
questions. What is the origin and identity of this state: is it a state of early responses to fatal
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damage? A state that controls the risk of suffering such damage? What specific transcription
factors define this state, and/or act on the microRNA promoters in a lifespan-predictive fashion?
We believe that answering these questions will shed light on the overall nature of the aging
process, and help identify gene-regulatory states that can not only identify prospectively shortlived individuals, but can be manipulated to switch those individuals toward long-lived fates.

3.5 Materials and Methods
3.5.1 Strains

The following reporter strains were obtained from the Caenorhabditis Genetics Center (CGC):
VT1735 (Pmir-788::GFP), VT1541 (Pmir-360::GFP), VT1733 (Pmir-60::GFP), VL405 (Pmir63::GFP), VL440 (Pmir-47::GFP), VT1153 (Plet-7::GFP), VT1072 (Plin-4::GFP), VL412
(Pmir-79::GFP), VT1379 (Pmir-59::GFP), VT1474 (Pmir-243::GFP), VT1189 (Pmir241::GFP), VT1607 (Pmir-246::GFP), VT1485 (Pmir-228::GFP), VT1600 (Pmir-85::GFP),
VT1481 (Pmir-51::GFP), VT2020 (Pmir-793::GFP), VT2021 (Pmir-794::GFP), VL370 (Pmir240-786::GFP), VT1470 (Pmir-242::GFP), VT1160 (Pmir-84::GFP), VT1589 (Pmir-90::GFP),
VT1665 (Pmir-1::GFP), PD4793 (Pmyo-2::GFP; Ppes-10::GFP; F22B7.9::GFP), B010652
(Pcpna-2::GFP) CF1038 (daf-16(mu86)), MT15454 (mir-243(n4759)), VC328 (mir-47(gk167)) .
All reporter strains were crossed into BA671 (spe-9(hc88)), a temperature-sensitive sterile
mutant with a wild-type lifespan at 25.5°C. 250 Strains were maintained at 20°C and assays were
performed at 25°C to prevent reproduction in the single-animal culture apparatus.

3.5.2 Single-Animal Culture

For longitudinal analysis, C. elegans were reared in high-density single-animal culture devices
(‘worm corrals’), which we have described previously. 208,223 In brief, 8-armed PEG-thiol
(Jenkem Technology) and PEG-diacrylate (Sigma-Aldrich) are dissolved in a modified nematode
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growth medium (NGM) at concentrations of 133 mg/mL and 37 mg/mL respectively. The PEGs
are mixed in a 1:1 ratio with 4 µL/mL cholesterol, poured into an aluminum frame adhered to a
glass slide with PDMS (Dow Corning) and allowed to cure into a solid hydrogel at room
temperature for approximately two hours. E. coli OP50-1, resuspended to 50% w/v from an
overnight culture, is deposited into an array of 0.4 µL droplets onto the gel. A pretzel-stage
embryo is placed into each droplet via eyelash pick. Approximately 1 mL liquid PDMS is poured
onto the gel; the PDMS crosslinks to the gel and cures into a solid form within 48 hours. The
culture devices were housed on a microscope stage (Leica) in a custom-built climate chamber
held at 25°C and 90% relative humidity.

3.5.3 Image Acquisition

Images of individual animals were automatically acquired every 4 hours at 5× magnification
using custom-built image acquisition and autofocus software. A bright-field, autofluorescence,
and fluorescence image were taken of each animal at each timepoint. Autofluorescence and
fluorescence images were taken with a DAPI/FITC/TRITC filter (Semrock, DA/FI/TX-3X-A000) and Lumencor Spectra X light source and were used to measure accumulation of
autofluorescence material and transgene expression, respectively. For autofluorescence, an
exposure time of 70 ms and 556/20 nm (center wavelength/bandwidth) excitation filter was used;
fluorescence in the red channel increases linearly with age and has been shown to correlate well
with remaining lifespan.222 An exposure time of 30-70 ms was chosen for each reporter strain (as
strains vary considerably in brightness); 40 ms was most commonly used, and chosen exposure
times were consistent within strains. A 480/17 nm excitation filter was used for all fluorescence
imaging. Flat-field images of a fluorescent slide (Chroma) were collected before every image
acquisition to control for spatial variation in illumination.
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3.5.4 Image Measurement

All images were corrected for sensor noise (dark-current) and spatial variation in illumination
(flat-field). Images were automatically segmented to determine pixels contained within the
worm, and whole-animal summary measurements (e.g., 99th percentile intensity) were calculated
from these pixels. All measurements were performed in this fashion unless specifically indicated.
For some strains with dim, spatially restricted fluorescence, measurements were performed on
specific structures (e.g. head) rather than whole-worm images to avoid inadvertently measuring
autofluorescence. We manually annotated the center of these structures from brightfield images
and extracted summary measurements from fluorescence-image pixels within a circle of defined
radius from those center-points. For Pmir-1::GFP, a circle with a radius of 5 pixels (6.5 µm)
centered at the pharynx was used. For Pmir-241::GFP, a circle with a radius of 25 pixels (32.5
µm) centered at the pharynx was used. For Pmir-59::GFP, a circle with a radius of 25 pixels
(32.5 µm) centered at the vulva was used to extract expression measurements.
For dual reporter strains, Pmir-47::GFP and Pmir-793::GFP expression was extracted from
manually annotated circular regions centered at the vulva and pharynx. These are the
predominant areas of detectable expression, especially in aged animals. Pmir-240-786::GFP
expression was measured from areas of the worm excluding the manually annotated region for
Pmir-47::GFP or Pmir-793::GFP. Varying the radius of the circular region did not substantially
affect correlation with lifespan (data not shown).
For dual reporter strains, Pmir-47::GFP and Pmir-793::GFP expression was extracted from
manually annotated circular regions centered at the vulva and pharynx. These are the
predominant areas of detectable expression, especially in aged animals. Pmir-240-786::GFP
expression was measured from areas of the worm excluding the manually annotated region for
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Pmir-47::GFP or Pmir-793::GFP. Varying the radius of the circular region did not substantially
affect correlation with lifespan (data not shown).
Time of hatch, first egg lay, and death were annotated manually for all animals to determine
lifespan. Individuals that hatched prior to the start of the experiment were annotated as hatching
at t=0; this timepoint is within at most 3 hours the actual hatch time.208 No more than 5% of eggs
in a given experiment fail to hatch in our system; often all hatch successfully. Of those that do
hatch, < 5% (typically 1–2%) are excluded from further imaging and analysis due to production
of offspring (the majority of the excluded individuals) or larval arrest (a small minority). In a
minority of cases, additional individuals were excluded due to localized failure of the “worm
corral” device: mold contamination and/or gel desiccation. The remaining individuals were
indistinguishable from those in other biological replicates.

3.5.5 Data and Statistical Analysis

For visualizing population-level or cohort-level expression over time, each biological replicate
was rescaled by median expression intensity and median lifespan before pooling. Expression
data were fit to trendlines using LOWESS smoothing to facilitate visualization of expression
levels over time. For regression and other correlative analyses, all expression values were ztransformed relative to each biological replicate and time rescaled by median lifespan of the
replicate to facilitate data pooling and prevent replicate-dependent effects. Regression results
from raw data from each biological replicate were consistent with the pooled analyses.
Single and multivariable regression of biomarkers versus lifespan was performed using ordinary
least-squares regression, and the coefficient of determination (R2) calculated according to the
standard formula. We aimed for a minimum sample size of 80 individuals, which leads to a
statistical power of 95% to identify a true correlation of R2 > 0.15 with p < 0.05. Multivariable
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regressions for PmiRNA::GFP reporters were performed using both average expression and the
slope of a least-squares linear fit line to an individual’s expression data points in a defined time
window. Confidence intervals for correlation coefficients were determined by bootstrap analysis.
Each pooled reporter sample was resampled with replacement 1000 times and regressions were
performed on the resampled data. The 2.5th and 97.5th percentiles of the resampled correlation
coefficients were used to construct the 95% confidence interval.
Individuals were included in each analysis based on survival throughout the specified time
window. Unless otherwise noted, the time window was chosen such that 10% or less of the total
population was excluded.

3.5.6 Data and software availability

Our custom image acquisition software and image processing and statistical analysis software are
open-source and freely available at https://github.com/zplab/rpc-scope and
https://github.com/zplab/elegant respectively.
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Chapter 4: A developmental timing
microRNA predicts individual lifespan in C.
elegans
4.1 Introduction

Aging and human lifespan is highly variable, and the source of this variability remains to be fully
understood. While differences in genetics and environment certainly contribute to variability in
lifespan, extensive studies of identical twins demonstrate that only a portion of the variance (less
than 30%) can be attributed to these factors alone.202–205 Thus, it remains to be understood
exactly how and why differences in individual lifespan are established.
In C. elegans, individual variation in lifespan can be studied without being confounded by
genetic and environmental differences between individuals. Because C. elegans are selffertilizing, isogenic populations can be easily generated and reared in highly homogeneous
environments. Surprisingly, even under these conditions a wide distribution of lifespans is still
observed (Figure 4.1).
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Figure 4.1: Lifespan distribution for Plin-4::GFP; spe-9(hc88) individuals pooled from five biological replicates.
Animals are binned into color-coded quintiles based on eventual lifespan.

The observation that lifespan is highly variable in the absence of genetic and environmental
variation suggests that lifespan is at least in part determined stochastically. This leads to the
question—how are stochastic events translated into observable differences in lifespan between
otherwise identical individuals?
One working hypothesis is that stochastic differences in expression of important regulatory genes
early in life may be responsible for eventual differences in lifespan. While these differences are
initially small and brief, feedback loops and other regulatory mechanisms could stabilize and
amplify these effects, similar to a snowball growing larger as it rolls down a hill, trapping
individuals into different and persistent gene expression states that manifest in observable
differences in lifespan. We aimed to identify upstream factors that set these gene expression
states into motion by screening for regulatory genes whose expression early in life predicts
lifespan, hoping to eventually characterize the different gene expression states initiated by these
regulatory genes.
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In order to identify regulatory genes whose expression predicts lifespan, we previously utilized a
library of microRNA (miRNA) transcriptional reporters192 to quantify gene expression in
individual animals. We then assessed whether gene expression correlates with lifespan in the
same individual (see e.g., Chapter 3). With this approach, we found a number of reporters that
correlate with lifespan, including a transcriptional reporter for the developmental timing miRNA
lin-4 (maIs134). lin-4 plays a critical role in the proper developmental timing of C. elegans251,
exhibits homology with human miRNAs252, and has relatively well-characterized targets.225,253,254
Furthermore, genetic perturbations to lin-4 have been previously shown to cause lifespan and
aging phenotypes, although the role of lin-4 in aging and adult biology is generally not wellcharacterized.79 Thus, lin-4 became our primary candidate for further investigation.
Here we validate our previous findings with an independent transcriptional reporter of lin-4,
zaIs1, that also predicts individual longevity. We used this reporter (herein referred to as Plin4::GFP) to investigate the functional pathways linking Plin-4::GFP expression to lifespan. Our
findings show that Plin-4::GFP requires activity of both endogenous lin-4 and canonical target
lin-14 to predict lifespan, implicating the lin-4—lin-14 axis as a functional determinant of wildtype lifespan. Furthermore, we found that the lin-4 reporter is independent of the insulin/insulinlike signaling (IIS) pathway in its ability to predict lifespan. Overall, our results provide
additional evidence that the developmental timing miRNA lin-4 plays an important role in
modulating aging and lifespan of adult animals.

4.2 Results
4.2.1 lin-4 expression in zaIs1 reporter strain predicts future longevity

Our previous work demonstrated that lin-4 expression, as measured in a Plin-4::GFP transgenic
strain (herein referred to as maIs134) from a larger miRNA reporter library192, correlates
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positively with future lifespan when measured in middle age in wild-type C. elegans (see e.g.,
Chapter 3). In order to determine whether this result was reporter-specific or generic to lin-4
expression itself, we sought to replicate this result using an independent lin-4 transcriptional
reporter generated by Frank Slack’s group (herein referred to as zaIs1).255–257 In zaIs1, 507 base
pairs of genomic sequence (positions –513 to –7) upstream of the mature lin-4 promoter region
drive GFP expression, followed by an unc-54 3’ UTR (Figure 4.2a). In maIs134, 2,408 base pairs
of genomic sequence (positions -2408 to 0) upstream of the mature lin-4 promoter region are
used (Figure 4.2b).

Figure 4.2: Promoter sequences of two independent lin-4 transcriptional reporters. (a) Promoter sequence of zaIs1,
spanning positions 5901756 to 5902262 to encompass 507 base pairs. F59G1.6a denotes the mature lin-4 sequence.
(b) Promoter sequence of maIs134, spanning positions 5899860 to 5902268 to encompass 2409 base pairs.
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As before, we crossed zaIs1 into the temperature-sensitive sterility mutant spe-9(hc88) and used
an individual animal-culture device developed by our lab to track and image hundreds of animals
longitudinally throughout their lifetimes (Figure 4.3a). Similar to the trend previously observed
in maIs134, Plin-4::GFP expression decreases with age in zaIs1 (Figure 4.3b). This finding is
consistent with previously published small RNA sequencing and qRT-PCR data80,258, suggesting
that the zaIs1 reporter faithfully captures age-related trends in endogenous expression.

Figure 4.3: Plin-4::GFP expression in zaIs1 over time. (a) Schematic of high-density single animal culture device
and representative brightfield and fluorescent images acquired from a single zaIs1; spe-9(hc88) individual. (b)
Timecourse of Plin-4::GFP expression for a single animal from hatch until death (left). Expression is measured as
the 95th percentile pixel intensity within the image region comprising that individual, from images acquired every
four hours. LOWESS regression showing the average population timecourse of Plin-4::GFP expression, collated
from five biological replicates comprising nearly 500 individuals (right).

To determine whether Plin-4::GFP expression correlates with longevity in zaIs1, we binned the
population into cohorts based on eventual lifespan and plotted average reporter expression for
122

each lifespan-cohort over time (Figure 4.4a). The average expression level and rate of change of
expression differed substantially between cohorts in mid- to late- adulthood, with short-lived
animals exhibiting lower expression values overall and a steeper decline in expression with age.
To determine whether reporter expression was predictive of individual lifespan, we performed a
multivariate regression on each individual animal’s average level of GFP expression (as
measured by 95th percentile intensity) and the trend in GFP expression against future lifespan
(Figure 4.4b). The time window for data included in the regression extends from the first day of
adulthood to the timepoint at which 90% of the population is still alive (Figure 4.4c). Using this
approach, we found that both average value and change in expression of Plin-4::GFP over time
exhibits a strong positive correlation with lifespan, explaining over a third of the variance in
lifespan when combined (mean r2 = 0.191; slope r2= 0.236, joint R2 = 0.352).

Figure 4.4: Plin-4::GFP expression in zaIs1 vs. future lifespan. (a) LOWESS regression of each lifespan quintile’s
average Plin-4::GFP expression (as measured by 95th percentile intensity per individual at each timepoint) is plotted
over time. (b) Joint regression of both the mean level of each individual’s Plin-4::GFP expression between 72 and
187 hours post-hatch, and the slope of that expression over that time, against future lifespan yields an R2 of 0.352.
Each dot represents an individual animal and is color-coded based on lifespan. (c) Parameters and correlation
coefficients for single and joint regressions.
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Although similar trends in Plin-4::GFP expression and correlation with lifespan were observed in
both zaIs1 and maIs134, we did note significant differences in temporal and spatial expression
between the two strains. Transgenic expression is much brighter in zaIs1, which is unsurprising
given the higher copy-number (the transgene in maIs134 is present at relatively low copy
number, as the strain was made via bombardment192). Temporally, zaIs1 animals begin to
express the Plin-4::GFP transgene as embryos, while maIs134 animals express the transgene
starting at the L1 stage. Furthermore, the adult spatial expression of Plin-4::GFP is dominated by
the intestine and pharynx in zaIs1 and the vulva, body wall muscle, and pharynx in maIs134
(Figure 4.5).

Figure 4.5: Expression patterns in maIs134 and zaIs1 transgenic strains.
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4.2.2 Correlation of Plin-4::GFP with lifespan in zaIs1 is not driven by
insertional gene inactivation

Like many C. elegans transgenic strains, zaIs1 was created through random integration of a highcopy extrachromosomal array.255 When crossing zaIs1 males with wild-type hermaphrodites, we
observed that F1 males did not express the transgene, while their hermaphrodite siblings showed
normal expression (data not shown). Because C. elegans exhibit sex chromosome imbalance259
(males receive a single X chromosome from a hermaphrodite mother, and no sex chromosome
from the father), we were able to narrow the location of the transgene to the X chromosome.
However, the exact integration site of the transgene in the genome is unknown. Because the Plin4::GFP transgene is a large, high-copy number construct, we wondered if the strong correlation
with lifespan is driven by unintended insertional gene inactivation (Figure 4.6a and b).
Transgenes can randomly integrate into important coding regions of the genome, resulting in a
confounding genetic background specific to the transgenic line; thus, we wanted to determine
whether the correlation of Plin-4::GFP with lifespan in zaIs1 requires homozygosity of the
transgene. To test this, we crossed zaIs1;spe-9(hc88) males with temperature-sterilized spe9(hc88) hermaphrodites, ensuring that all progeny were cross- rather than self-progeny. Progeny
contain only one copy of the transgene, which should eliminate insertional gene inactivation
effects (assuming such an effect is recessive). The resulting embryos were placed in the highdensity single-animal culture device and expression over time and lifespan measured as before
(Figure 4.6b). In these experiments, all male progeny (~50%) were censored, as previous
experiments dealt exclusively with hermaphrodites, and male aging and lifespan differs
significantly from that of hermaphrodites.260 In the Plin-4::GFP heterozygous hermaphrodite
population, we observed similar trends in expression over time and correlation with lifespan (R2
= 0.283) as was previously observed in Plin-4::GFP homozygous animals (Figure 4.4c).
125

Therefore, it is unlikely that the predictive ability of the Plin-4::GFP transgene in zaIs1 is driven
by insertional gene inactivation; however, we cannot eliminate the possibility of other positional
effects.

Figure 4.6: Correlation of Plin-4::GFP expression in zaIs1 is not driven by insertional gene inactivation. (a)
Schematic showing the possible integration of the Plin-4::GFP construct into a coding gene region, leading to a
genetic background that is homozygous null for the endogenous gene. (b) Schematic showing the expected
outcomes for Plin-4::GFP correlation that is or is not driven by the transgene-specific genetic background. (c)
Expression of Plin-4::GFP over time for different lifespan cohorts (left) and regression on slope and mean of Plin4::GFP expression from 72 to 207 hours post-hatch.

126

4.2.3 Plin-4::GFP fails to predict lifespan in absence of endogenous lin-4

Expression of Plin-4::GFP must correlate with future lifespan because of a process or pathway
that influences both lifespan and transcription of the reporter. The most straightforward scenario
is one in which Plin-4::GFP directly reports on the activity of endogenous lin-4, which then
determines lifespan through modulation of downstream targets (Figure 4.7a). If this is true, the
reporter should no longer correlate with lifespan in the absence of endogenous lin-4.
Alternatively, Plin-4::GFP may act as a “bystander”, reporting on a lifespan-determining
pathway or process that does not rely on the activity of lin-4 (Figure 4.7b). If this scenario is
correct, one would expect that the reporter continues to correlate with lifespan in the absence of
lin-4.
To distinguish between these two models, we crossed the Plin-4::GFP reporter into the loss-offunction mutant lin-4(e912) (see Methods) and tested whether the reporter correlated with
lifespan as before. lin-4(e912) mutants exhibit a vulvaless phenotype that results in retention of
embryos (Figure 4.7c) and matricide when the embryos hatch, making bona fide lifespan studies
difficult. To prevent this, we used bacteria expressing dsRNA against pos-1 to sterilize the
animals in our single-animal culture system.223 The pos-1 RNAi does not prevent embryo
retention, but does greatly reduce subsequent hatching and premature death.
We performed a regression on average Plin-4::GFP expression and the slope of the best fit line
between 3 dph and the 90% survival timepoint, and plotted the lifespan-predictive value over
time (Figure 4.7d). Plin-4::GFP expression failed to correlate significantly with future lifespan in
the lin-4(e912) background (R2 = 0.029). We also observed a much shorter than average lifespan
(median = 6.0 days) in these animals consistent with previously-published results.79 These results
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are consistent with a model in which the Plin-4::GFP reporter correlates with lifespan because
endogenous lin-4 is directly involved in setting lifespan (Figure 4.7a).

Figure 4.7: Plin-4::GFP fails to correlate with lifespan in absence of lin-4. (a) “Direct causation” model in which lin4 directly determines individual lifespan. (b) “Bystander correlation” model in which lin-4 is not involved. (c)
Brightfield and fluorescence image of typical adult Plin-4::GFP;lin-4(e912) animal showing embryo retention. (d)
Regression on slope and mean of expression against lifespan (left), and lifespan-predictive value (right). The time
window for regression was 72–97 hours post-hatch. Arrow indicates 90% survival timepoint.
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4.2.4 Knockdown of canonical lin-4 target reduces Plin-4::GFP correlation
with lifespan

Because lin-4(e912) results in developmental abnormalities and shortened lifespan, the lack of
correlation between Plin-4::GFP and lifespan in lin-4(e912) could result from the general
“unhealthiness” of these animals, rather than the lack of lin-4 specifically. In other words, it is
possible that any reporter capable of predicting lifespan in wild-type animals would no longer
correlate with lifespan in the lin-4(e912) background, as these animals differ greatly from wildtype. Thus, we wanted to test whether the lifespan-predictive power of Plin-4::GFP relies on lin4 functionality without the confounding effects of severe phenotypes caused by lin-4(e912).
Instead of targeting lin-4 for knockdown, we chose the lin-4 target lin-14. The LIN-14 protein,
believed to have transcription factor activity261, localizes to the nucleus of specific cell types
during development, forming a temporal gradient that directs the sequence of cell lineages.262
This gradient is modulated post-transcriptionally through binding of lin-4 to the 3’UTR of lin14.225 Genetic perturbations to lin-14 cause lifespan phenotypes consistent with those observed
in lin-4(e912)—adult-specific loss of lin-14 results in lifespan extension, while lin-14 gain-offunction mutations (eliminating the lin-4 3’ UTR binding site) cause lifespan reduction similar to
that observed in lin-4(e912).79 Thus, we wondered whether eliminating or reducing the activity
of LIN-14 would eliminate or reduce the correlation of Plin-4::GFP with lifespan (Figure 4.8a
and b). Ideally, we wished to test whether Plin-4::GFP still predicts lifespan in the lin-14(n179)
background, which contains a temperature-sensitive allele that results in loss of function at 25°C.
Unfortunately, since both the reporter and lin-14 are located on the X chromosome, we were
unable to achieve recombination. Thus, we used lin-14 RNA interference (RNAi) to knockdown
lin-14 in our single-animal culture system (see Methods). We performed side-by-side
experiments with Plin-4::GFP;spe-9 animals on bacteria expressing either dsRNA targeting lin129

14 or an empty vector. As before, we performed a regression on average expression and the
slope of the best fit line between 3 dph and the 90% survival timepoint and measured the
lifespan-predictive value of Plin-4::GFP over time. We saw that lin-14 RNAi reduced the
correlation of Plin-4::GFP with lifespan compared to the empty control (R2 = 0.02 vs. 0.11) and
the overall lifespan predictive value (Figure 4.8c and d). We did not observe a reproducible
extension in lifespan using lin-14 RNAi, although this result has been published previously.79
Regardless, in combination with our data showing loss of Plin-4::GFP correlation in lin-4(e912),
these results provide some evidence for the “Direct Causation” model of Figure 4.8a.
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Figure 4.8: Knockdown of lin-14 reduces correlation of Plin-4::GFP with lifespan. (a) “Direct causation” model in
which lin-4 target lin-14 is directly involved in determining individual lifespans. (b) “Bystander correlation” model
in which lin-4 and lin-14 are not involved. (c) Comparison of Plin-4::GFP expression over time (top left), survival
(top right), regression on slope and mean of expression against lifespan (bottom left), and lifespan-predictive value
(bottom right) between control (solid lines) and lin-14 RNAi conditions (dashed lines). The time windows for
regression were 72–235 hours post-hatch for control and lin-14 RNAi, respectively. Arrows indicate the 90%
survival cutoff.
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4.2.5 Lifespan-predictive ability of Plin-4::GFP in zaIs1 is independent of IIS

We also wondered if Plin-4::GFP expression in zaIs1 acts as marker of other canonical pathways
or processes that influences lifespan, such as the insulin/insulin-like growth factor (IGF-1)
signaling (IIS) pathway. In C. elegans, the primary effector of the IIS pathway is the
transcription factor DAF-16, which modulates expression of many genes that ultimately
influence aging and lifespan.70,233 DAF-16 activity is commonly required for genes and pathways
that increase lifespan in C. elegans, including several microRNAs.41,79,82 Furthermore, lifespan
extension of the loss-of-function mutant lin-14(n179) is daf-16 dependent, suggesting that the
lin-4—lin-14 axis may exert its effects on lifespan through daf-16.79 Therefore, it seemed
possible that inter-individual variability in Plin-4::GFP expression may report on variability in
DAF-16 activity and thus inter-individual differences in subsequent lifespan. To test if Plin4::GFP reports on IIS and/or DAF-16 activity in the zaIs1 transgenic strain, we examined
whether Plin-4::GFP levels correlated with lifespan in the absence of DAF-16 (Figure 4.9a).
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Figure 4.9: Non-involvement of IIS. (a) For Plin-4::GFP to correlate with lifespan, each must report on some
lifespan-determining process. The reported-on process may be IIS-dependent (left) or IIS-independent (right); these
scenarios can be distinguished by the effects of knocking out the IIS effector daf-16 on the correlation between Plin4::GFP and future lifespan. (b) Comparison of Plin-4::GFP expression over time (left), and survival (right) between
daf-16(+) (solid lines) and daf-16(mu86) (dashed lines) backgrounds. (c) Comparison of regression on slope and
mean of Plin-4::GFP expression against lifespan (right), and lifespan-predictive value (left) between daf-16(+)
(solid lines) and daf-16(mu86) (dashed lines) backgrounds. The optimal time windows for regression were 72–186
and 72–165 hours post-hatch for daf-16 wild-type and daf-16(mu86), respectively.
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zaIs1;spe-9(hc88) was crossed into a daf-16(mu86);spe-9(hc88) background and lifespanpredictive ability was assayed in side-by-side experiments with the reporter in the reference
background (spe-9(hc88) only).
Regression on average expression and the slope of the best fit line between 3 dph and the 90%
survival timepoint showed that the correlation of Plin-4::GFP expression with lifespan was not
substantially suppressed in the absence of daf-16 (Figure 4.9c, left). Similarly, plotting the
lifespan-predictive value of Plin-4::GFP over time shows that the predictive power not
eliminated in the daf-16(mu86) background (Figure 4.9d). As expected, the predictive windows
are slightly shifted between daf-16(mu86) and wild-type backgrounds due to the short-lived
phenotype of daf-16(mu86) (Figure 4.9b, right). Peak levels of Plin-4::GFP were also reduced in
the daf-16(mu86) background, suggesting that DAF-16 may play a role in the transcriptional
regulation of Plin-4::GFP (Figure 4.9b, left).

4.3 Discussion

Here we examined the relationship between expression of Plin-4::GFP in the zaIs1 transgenic
strain and lifespan in wild-type, isogenic C. elegans populations. We found that this reporter
robustly predicts future lifespan, explaining over a third of the variance in longevity between
individuals (Figure 4.4b and c). Like other PmiRNA::GFP reporters we examined previously,
maintenance of “youthful” levels of Plin-4::GFP expression with age is generally associated with
longer life; in other words, animals who exhibit higher expression of Plin-4::GFP with age than
their peers tend to live longer. Furthermore, both average expression and change in expression
over time are positive predictors of lifespan, implying that both overall expression value and
preservation of those values are indicators of longevity.
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Next, we wished to determine what biological processes or pathways underlie the reporter’s
ability to predict lifespan; namely, whether these processes or pathways involved the endogenous
miRNA lin-4. We hypothesized that Plin-4::GFP correlates with lifespan because it acts as a
proxy for endogenous lin-4 activity, which then modulates lifespan through downstream targets.
If this is true, Plin-4::GFP should no longer predict lifespan in the absence of lin-4 (Figure 4.7a).
Our analysis of the reporter in the lin-4 loss-of-function background lin-4(e912) showed that the
correlation of Plin-4::GFP with lifespan is eliminated in the absence of lin-4 activity (Figure
4.7d). This supports a model where Plin-4::GFP correlates with lifespan because it reports on the
activity of lin-4, and lin-4 determines lifespan (Figure 4.7a). Indeed, we and others79 have
observed a greatly truncated lifespan in lin-4(e912) (Figure 4.7d), which is consistent with a
potential role of lin-4 as a positive modulator of lifespan.
While these results were promising, we did not feel confident relying solely on this analysis, due
to possible confounding effects of the lin-4(e912) phenotype. lin-4(e912) animals are vulvaless
and thus fill with embryos over time, likely contributing to their very short lifespan. It is
therefore possible that these animals do not actually experience biological aging, but rather die
prematurely from their deformities. Previous publications have reported an increased rate of
intestinal autofluorescence accumulation in lin-4(e912), which may be indicative of accelerated
aging.79 Regardless, we wondered if any reporter that predicts lifespan in wild-type animals
would no longer do so in lin-4(e912) due to marked physiological differences between the two
backgrounds. Therefore, we wanted to test whether the predictive power of Plin-4::GFP relies on
lin-4 activity while maintaining wild-type physiology as much as possible. To do so, we decided
to target lin-14, a known post-transcriptional target of lin-4.225 lin-14 loss of function results in
lifespan extension in wild-type animals and also rescues the short-lived phenotypes of lin135

4(e912).79 The opposing lifespan phenotypes of lin-4 and lin-14 suggests that lin-4 may regulate
lifespan through lin-14 (Figure 4.8a). It reasons that if Plin-4::GFP correlates with lifespan due
to lin-4 activity, this may be due in part to the modulation of lin-14 by lin-4. We used RNAi
against lin-14 in our single-animal culture system and tested whether Plin-4::GFP still correlated
with lifespan. The correlation of Plin-4::GFP with lifespan was greatly reduced in animals on
lin-14 RNAi compared to those on empty vector controls (Figure 4.8c). While this is consistent
with a model where predictive power of Plin-4::GFP relies on lin-4 modulation of lin-14 (Figure
4.8a), we did not see the expected lifespan extension with lin-14 RNAi (Figure 4.8c). Because
RNAi is notoriously variable in penetrance, it is possible that the lin-14 RNAi is sufficient to
disrupt the predictive power of Plin-4::GFP but not to robustly extend lifespan. Unfortunately,
we were not able to use a true loss-of-function mutant, undoubtedly a better alternative, due to
close proximity of our reporter and the lin-14 locus. Future experiments that test Plin-4::GFP
directly in the lin-4 loss-of-function background, perhaps using CRISPR to introduce a lin-4
lesion, will be able to more cleanly determine whether the predictive power of Plin-4::GFP relies
on lin-14 and lin-4 activity.
Because Plin-4::GFP expression correlates with lifespan, it likely reflects the activity of one or
more lifespan-determining processes or pathways, such as the insulin/IGF-1-like signaling
pathway (IIS). IIS is a canonical aging pathway in C. elegans that is primarily effected through
the transcription factor DAF-16. The lifespan phenotypes of lin-4 and lin-14 appear to be IISdependent; knockdown of lin-14 no longer extends lifespan in the absence of the daf-16, and
knockdown of daf-16 results in no further lifespan reduction in lin-4(e912).79 Since the
correlation of Plin-4::GFP expression with lifespan appears to rely on lin-4 and lin-14 activity,
we hypothesized that the correlation should also rely in IIS activity (Figure 4.9a). However, we
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observed that the reporter still predicts lifespan in the IIS mutant daf-16(mu86), although the
correlation is somewhat reduced (Figure 4.9c). While surprising, this result indicates that the
Plin-4::GFP reports on a pathway distinct from IIS (Figure 4.9b). LIN-14 is suspected to have
transcription factor activity261; however, its targets are relatively uncharacterized. It is possible
that Plin-4::GFP activity reports on a yet-unknown LIN-14-regulated pathway that ultimately
determines lifespan independently of IIS.
Overall, we have demonstrated that a reporter for a developmental timing miRNA, lin-4, robustly
predicts lifespan in isogenic individuals. Our previous results (see Chapter 3) indicate that the
ability of a microRNA promoter::GFP construct to predict lifespan is not particularly
uncommon. However, we also present evidence linking expression of the predictive Plin-4::GFP
reporter to both endogenous lin-4 and LIN-14 activity, implicating these canonical
developmental timing regulators as modulators of adult aging and lifespan. This modulation may
in part be independent of the IIS pathway, as indicated by the ability of Plin-4::GFP to predict
lifespan in the absence of DAF-16. Ultimately, further experimentation may be needed to fully
characterize the linkage between Plin-4::GFP expression, LIN-14 activity, and regulation of
downstream targets and lifespan. However, our work helps to shed light on a potential source of
variability in wild-type lifespan mediated through a developmental timing miRNA and its target.

4.4 Materials and methods
4.4.1 Strains

The zaIs1 strain was obtained from Frank Slack. VT1072 (maIs134), and VT573 (lin4(e912);lin-14(n179)) were provided by the Caenorhabditis Genetics Center (CGC), which is
funded by NIH Office of Research Infrastructure Programs (P40 OD010440). zaIs1 and
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maIs134 were crossed into BA671 (spe-9(hc88)), a temperature-sensitive sterile mutant with a
wild-type lifespan at 25.5°C 250.
Because lin-4(e912) animals lack a vulva, we used the lin-4(e912);lin-14(n179)) strain to cross
the zaIs1 transgene into the lin-4(e912) background. lin-14(n179) is a temperature sensitive
allele that partially suppresses the lin-4(e912) vulvaless phenotype at 25°C. lin-4(e912);lin14(n179)) embryos were reared at 25°C, and hermaphrodites with normal vulval morphology
were selected for crossing with zaIs1;spe-9 males at 25°C. GFP (+) L4 offspring were selected
and allowed to self propagate at 15°C to homozygose lin-4(e912). GFP(+) offspring displaying
the lin-4(e912) phenotype were then replica plated at 25°C to check for the presence of the lin14(n179) allele (indicated by offspring with normal vulval morphology). Animals lacking the
lin-14(n179) allele were then allowed to self to homozygose lin-4::GFP.
Strains were maintained at 20°C and assays were performed at 25°C to prevent reproduction
unless otherwise noted.

4.4.2 Single-Animal Culture

For longitudinal analysis, C. elegans were reared in high-density single-animal culture devices
(‘worm corrals’), as described previously 208,223. Briefly, 8-armed PEG-thiol and PEG-diacrylate
are dissolved in a modified nematode growth medium (NGM) and mixed in a 1:1 ratio with 4
µL/mL cholesterol, poured into an aluminum frame adhered to a glass slide, and cured into a
solid hydrogel at room temperature. E. coli OP50-1, resuspended to 50% w/v from an overnight
culture, is deposited onto the gel in 0.4 µL droplets. Embryos are placed into each droplet via
eyelash pick and liquid PDMS is poured onto the gel. The culture devices were housed on a
microscope stage in a climate chamber held at 25°C.
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Longitudinal analysis of Plin-4::GFP;lin-4(e912) was performed similarly but with some
modifications. The gel and bacteria were prepared following the methods described in “RNA
interference” below and OP50 containing dsRNA targeting pos-1 was used. The climate chamber
was held at 20°C due to the inability of the strain to tolerate 25°C.

4.4.3 Image Acquisition and Measurement

Images were automatically acquired every 4 hours at 5× magnification using custom-built image
acquisition and autofocus software. A bright-field, autofluorescence, and fluorescence image
were taken of each animal at each timepoint. For autofluorescence, an exposure time of 70 ms
and 556/20 nm. For GFP fluorescence, an exposure time of 40 ms and a 480/17 nm excitation
filter was used. Flat-field images of a fluorescent slide (Chroma) were collected before every
image acquisition to control for spatial variation in illumination.
All images were corrected for sensor noise (dark-current) and spatial variation in illumination
(flat-field). Images were automatically segmented to determine pixels contained within the
worm, and whole-animal summary measurements (e.g., 99th percentile intensity) were calculated
from these pixels.

4.4.4 Data and Statistical Analysis

For visualizing population-level or cohort-level expression over time, each biological replicate
was rescaled by median expression intensity and median lifespan before pooling. Expression
data were fit to trendlines using LOWESS smoothing to facilitate visualization of expression
levels over time. For regression and other correlative analyses, all expression values were ztransformed relative to each biological replicate and time rescaled by median lifespan of the
replicate to facilitate data pooling and prevent replicate-dependent effects. Regression results
from raw data from each biological replicate were consistent with the pooled analyses.
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Single and multivariable regression of biomarkers versus lifespan was performed using ordinary
least-squares regression, and the coefficient of determination (R2) calculated according to the
standard formula. Multivariable regressions were performed using both average expression and
the slope of a least-squares linear fit line to an individual’s expression data points in a defined
time window. Confidence intervals for correlation coefficients were determined by bootstrap
analysis. Each pooled reporter sample was resampled with replacement 1000 times and
regressions were performed on the resampled data. The 2.5th and 97.5th percentiles of the
resampled correlation coefficients were used to construct the 95% confidence interval.
Individuals were included in each analysis based on survival throughout the specified time
window. Unless otherwise noted, the time window was chosen such that 10% or less of the total
population was excluded.

4.4.5 RNA interference

We adapted standard RNAi protocols for use in the ‘worm corral’, which we have shown
previously to robustly induce target knockdown.223 Single colonies of bacteria from the Ahringer
RNAi library containing either the L4440 empty control vector or dsRNA targeting lin-14 were
inoculated overnight at 37oC. Cultures were then centrifuged and resuspended to 50% w/v. The
corral media was prepared as described above, but with the addition of 100 µg/mL ampicillin
and 1mM IPTG. Efficacy of the lin-14 RNAi clone was evaluated by placing embryos on RNAi
plates and induced bacteria prepared as above. While the RNAi did not have any phenotypic
effects on the parent generation, the offspring exhibited the protruding vulva phenotype
characteristic of lin-14.
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Chapter 5: Conclusions and Future
Directions
Aging is a deteriorative process with the same terminal endpoint in nearly all organisms, from
complex mammalian species like humans to the roundworm nematode C. elegans. Decades of
scientific research have been devoted to identifying perturbations, both genetic and
environmental, that can extend (and truncate) average lifespan. However, these approaches have
neglected to explore differences in individual lifespan, which is inherently variable in even the
most homogeneous populations, or how such differences are established. Thus, our
understanding of the factors that drive variability in individual lifespan, particularly in wild-type
organisms, is greatly lacking. The research presented in this dissertation has aimed to advance
understanding of aging in individuals, primarily by identifying gene expression states underlying
lifespan variability in isogenic populations of C. elegans. Characterization of these gene
expression states may shed light on the genes and pathways involved in aging and lifespan
determination in wild-type individuals.
To accomplish our aims, we first developed an automated, high-throughput screening platform
designed to identify fluorescent reporters whose expression correlates with longevity in C.
elegans (e.g. “biomarkers of lifespan”, see Chapter 2). The development of this platform
required us to overcome many of the technical challenges outlined in Section 1.3, namely
reversible immobilization of animals, parallel single-animal culture, and automated image
acquisition and analysis. Our platform relies on 384 well plates, automated microscopy,
software-determination of lifespan, and modified flatbed scanners to allow for identification of
lifespan biomarkers with a fraction of the manual labor required by traditional screens. We used
this platform to screen a library of promoter::GFP reporters, primarily covering microRNA
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(miRNA) promoters; our methods were able to identify a known biomarker of lifespan, Pmir71::GFP, as well a novel biomarkers, Plet-7::GFP. Future studies may expand to screening a
larger library of promoter::GFP reporters, or use this platform for small molecule or RNAi
screens for modulators of individual lifespan.
We also used a single-animal culture device developed by our lab to study the relationship
between longevity and expression of over 22 different microRNAs in individual C. elegans (see
Chapter 3). Using promoter::GFP constructs, we showed that expression of nearly half of these
reporters predicts lifespan. This is an important result because it demonstrates that long- and
short-lived individuals can be characterized by different expression states. We performed
functional analyses for two predictive reporters, Pmir-243::GFP and Pmir-47::GFP, and found
that these constructs do not report on activity of the endogenous miRNA or the insulin/insulinlike growth factor signaling (IIS) pathway. Because most biomarkers to date have been shown to
report on IIS activity, the fact that our reporters may be linked to a pathway distinct from IIS is
significant. Furthermore, we showed that there is significant redundancy between PmiRNA::GFP
constructs expressed in different tissues, indicating that they report on a whole-organism-level,
cell-nonautonomous process that determines lifespan. The identity of this process or processes is
a subject for future research.
Finally, we performed detailed functional analysis of a lifespan-predictive transcriptional
reporter corresponding to the miRNA, lin-4 (see Chapter 4). Interestingly, lin-4 plays a critical
role in developmental timing in C. elegans, but our work and that of others points to an
additional role in adult aging and lifespan determination. Unlike the predictive reporters we
examined in Chapter 3, elimination of endogenous lin-4 eliminated the correlation of the lin-4
reporter (Plin-4::GFP) with lifespan. Furthermore, knockdown of the canonical lin-4 target lin142

14 also reduced the lifespan-predictive power of Plin-4::GFP. Both lines of evidence indicate a
potential role for lin-4 and target lin-14 in setting adult lifespan in a wild-type, isogenic
population.
This dissertation has aimed primarily to characterize the gene expression states underlying
variability in individual lifespan; however, we have only scratched the surface of this topic, and
there are many aspects remaining for further investigation. Here we identified multiple miRNAs
whose expression can be used to prospectively distinguish between long- and short-lived
animals, but there are likely many other genes, including miRNA targets and transcription
factors, that differ between these two cohorts. An active area of investigation in our group is to
characterize the full set of gene expression states associated with long- and short-life. Because
the reporters identified herein are longevity biomarkers, they can be used to separate individuals
into prospectively long-and short-lived groups. RNA-sequencing can then be performed on each
group, providing information on the types of transcriptomes that are associated with longevity. If
specific pathways or networks are consistently identified by such analyses, they may be potential
candidates for the yet-identified cell-nonautonomous processes that modulate reporter expression
and lifespan.
In a similar vein, we do not yet know the identity of the transcription factors that act on the
lifespan-predictive microRNA promoters; in general, transcriptional regulation of miRNAs is not
well understood. Identifying the specific upstream factors that mediate differential miRNA
reporter (and potentially endogenous miRNA) expression may shed light on how and why the
aging process is set into motion. Ultimately, further characterization of the gene-regulatory states
underlying longevity not only allows for prospective identification of short- and long-lived
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individuals, but also raises the possibility that such states can be manipulated to propel
individuals toward longer life.
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I've been lately thinking about my life's time
All the things I've done and how it's been
And I can't help believing in my own mind
I know I'm gonna hate to see it end.
The days they pass so quickly now
Nights are seldom long
And time around me whispers when it's cold
The changes somehow frighten me
Still I have to smile
It turns me on to think
Of growing old.
For though my life's been good to me
There's still so much to do
So many things my mind has never known
I'd like to raise a family
I'd like to sail away
And dance across the mountains on the moon.

—John Denver, Poems, Prayers and Promises
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